stock_BMY r_down	heart:1 attacks:1 least:1 banking:1 bad:1 can:1 foreclosures:1 failures:1 cause:1 must:1
stock_BMY r_down	fourth-quarter:1 19.3:1 cents:2 share:2 period:1 expenses:1 widened:1 65:1 year:1 research:2 5.01:1 therapeutics:1 $:4 revenue:2 due:1 41:1 year-ago:1 net:1 development:1 earlier:1 's:1 increased:2 boosted:1 company:1 million:4 molecule:1 said:1 alliances:1 loss:1 53:1 small:1
stock_BMY r_down	already:1 associated:1 adults:1 years:1 episodes:1 old:1 said:1 $:1 been:1 application:1 treat:2 closed:1 new:1 has:1 manic:1 approved:2 supplemental:1 10:1 17:1 drug:2 patients:1 mixed:1
stock_BMY r_down	own:1 financial:1 restless:1 investors:1 show:1 money:1 into:2 transform:1 have:1 year:1 love:1 your:1 hitches:1 yourself:1 looked:1 similarities:1 having:1 would:1 investing:2 ideas:1 people:1 differences:1 predictions:1 their:2 another:1 much:1 portfolios:1 really:1 approach:1 agreed:1 surprised:1 styles:1 eyes:1 his:2 's:4 bold:1 business:1 altar:1 company:1 each:2 eternal:1 but:1 half:1 not:1 one:1 respect:1 than:1 he:1 pledge:2 getting:1 --:1 could:1 married:1 appreciate:1 've:1 n't:1 thing:1 does:2 tenure:1 other:2 investments:1 comes:1
stock_BMY r_down	advocacy:1 last:1 increased:1 most:1 --:1 average:1 brand-name:1 according:1 elderly:1 their:1 medicines:1 7.4:3 year:1 prices:1 group:1 makers:1
stock_BMY r_up	upper:2 named:2 shuffle:2 succeeds:1 issued:1 executive:2 period:1 one:2 elected:1 recommending:1 during:1 financial:3 its:4 --:1 giant:1 said:1 tablet:1 also:1 addition:1 positive:1 remain:1 been:1 pharmaceuticals:1 board:1 responsibility:1 new:1 has:2 announced:1 chairman:2 recently:1 finance:1 company:1 after:2 most:1 operating:4 served:1 president:3 approval:1 month:2 continued:2 effective:1 vice:3 ranks:2 31:1 transition:1 assume:1 chief:8 replaced:1 officer:7 tapping:2 senior:1 opinion:1
stock_BMY r_down	upper:1 shuffle:1 pharmaceuticals:1 ranks:1 company:1 after:1 month:1 its:1 chief:2 hired:1 operating:1 chairman:1 appointed:1 new:1 naming:1 financial:1 continued:1 than:1 officer:2
stock_BMY r_up	modestly:1 lower:3 after:1 financial:1 lead:2 dips:1 move:1 forecast:1 drug:2 its:1 early:1 trading:1 shares:1 reaffirmed:1 2008:1 stocks:3 day:1
stock_BMY r_up	900,000:1 financial:2 help:1 into:1 move:2 laggard:2 broader:1 president:1 temporary:1 1.92:1 its:2 market:1 pharmaceutical:1 said:2 mostly:2 severance:1 positive:1 payment:1 also:1 program:1 under:1 new:1 territory:1 markets:1 lending:1 executive:1 global:1 's:2 extend:1 boosted:1 company:1 million:1 agreement:1 base:1 separation:1 news:1 stocks:3 former:1 $:4 salary:1 stabilize:1 vice:1 receive:1 annual:1 according:1 filing:1 chief:1 officer:1 pay:1 climb:3 order:1
stock_BMY r_up	twelve:1 own:2 version:1 investors:1 guidelines:1 some:2 play:2 '':1 ended:1 see:2 market:1 trading:1 want:1 $:1 its:2 panel:1 municipal:1 sell:1 securities:4 said:3 cancer:1 working:1 provide:1 guidance:2 support:2 had:1 same:1 their:3 concerns:1 rates:2 unit:1 interest:2 under:2 new:2 auction-rate:4 before:1 markets:1 public:1 congressional:1 can:2 division:1 hurting:1 's:2 holding:1 received:1 may:2 company:1 million:1 pharmaceutical:1 sales:1 director:1 fix:2 suffering:1 regulatory:2 approval:1 role:2 firms:2 ``:1 munis:2 works:2 98:1 --:1 many:1 could:2 months:1 companies:1 drug:1 final:1 large:1 generic:1 without:1 surging:2 relief:2 auctions:4 testimony:1 2008:1 bond:2 start-ups:1 liquidity:1 triggering:1 issuers:3
stock_BMY r_up	states:1 defunct:1 turning:1 raise:1 government:1 increasingly:1 money:1 fix:1 seeking:1 cash:1 securities:1 waiting:1 health:1 nearly:1 get:1 funds:1 authorities:1 money-market:1 auction-rate:1 market:1
stock_BMY r_up	increasingly:1 money:1 states:1 turning:1 market:3 raise:1 fix:1 seeking:1 waiting:1 other:2 health:1 get:1 auction-rate:3 exodus:2 government:1 funds:1 nearly:1 authorities:1 debt:2 defunct:1 --:1 cash:1 securities:1 prompts:2 money-market:1
stock_BMY r_down	1.2:1 developed:1 health-care:1 resistance:3 years:2 chronic:1 through:1 year:1 fifth:1 said:1 $:2 no:1 data:1 hepatitis:1 11.3:2 treatment:2 new:1 low:1 's:2 company:1 million:2 confer:1 reported:1 virus:1 five:2 analyzed:1 continued:1 additional:1 developing:1 patients:3 products:1 2007:2
stock_BMY r_up	1.6:1 13.5:2 said:2 $:9 incentive:1 also:1 bonuses:2 health:1 provider:1 performance:1 1.35:1 stock:1 million:5 awards:1 plan:1 filed:1 salary:1 received:2 valued:2 1.06:1 products:1 2007:4 options:1 proxy:1
stock_BMY r_up	agreed:1 allegations:2 sale:1 '':1 through:1 settlement:1 children:1 unit:1 pharmaceutical:1 use:3 said:1 $:3 has:1 pay:1 marketed:1 approved:1 4:1 manufacturer:1 more:1 ``:1 treat:1 million:1 uses:1 although:1 resolves:1 not:1 off-label:1 than:1 antipsychotic:1 resolve:1 according:1 drug:2 2002:1 patients:1 pediatric:1 2005:1 promoted:1 adolescents:1
stock_BMY r_up	heart:1 cancer:1 deaths:2 years:1 not:1 have:1 using:1 recommendations:1 insurance:1 make:1 information:1 said:5 would:1 review:3 agency:2 least:1 completes:1 increase:3 safety:2 treat:2 health:1 diabetes:1 might:3 product:2 's:2 risk:3 leg:2 drugs:2 after:3 were:1 plan:1 foot:2 article:1 approved:2 gel:2 suggested:2 received:1 conducting:2 database:1 --:2 study:3 attacks:1 19:1 patients:2 published:1 did:1 age:1 history:1
stock_BMY r_down	heart:1 over:2 battered:1 any:1 additional:2 generic:1 shares:3 their:1 clinical:1 take:2 details:1 plunge:2 hit:3 cheaper:1 react:1 wake:1 gain:2 others:2 not:1 data:1 both:1 effective:1 showed:1 battling:1 --:1 study:5 disease:1 drug:2 leaving:1 retreating:1 cholesterol:2 release:2 more:1 skids:1
stock_BMY r_up	heart:1 's:3 increased:1 --:1 medical:1 according:1 site:1 may:1 attack:1 treatment:1 published:1 journal:1 article:1 linked:1 risk:1
stock_BMY r_down	biotech:1 because:1 punishing:1 sales:1 licensing:1 partner:1 its:2 based:1 trial:1 failed:1 which:1 has:2 royalties:1 's:4 company:1 effect:1 agreement:1 drug:1 news:1 now:1 advanced:1 treating:1 suffers:1 15:1 lost:1 --:1 uncertain:1 double-digit:1 value:1 receive:1 bad:1 future:1 melanoma:1 late-stage:1
stock_BMY r_up	heart:3 previously:1 issued:1 one:1 not:1 interim:1 differs:1 its:3 superior:1 said:2 melanoma:2 trials:1 guidance:1 fight:1 attack:1 clinical:2 treatment:1 chemotherapy:1 shows:2 used:1 risk:1 after:1 standard:1 halted:1 nearly:1 review:1 backed:1 data:1 appears:1 advanced:1 showed:1 double:1 study:2 drug:4 trial:1 patients:1 risks:2 discontinued:1 researchers:1
stock_BMY r_down	acquisitions:1 nutrition:1 smaller:1 's:2 business:1 up:1 bulk:1 looks:1 expected:1 eacute:3 now:1 its:1 market:1
stock_BMY r_down	selected:1 investors:1 signs:1 reduce:1 disappointing:1 used:2 against:1 company:2 year:2 reached:2 settlement:2 its:3 financials:1 said:4 $:4 candidate:1 patent:2 treat:1 make:1 six:1 moderately:1 payment:2 symptoms:1 infringement:2 safety:1 health:1 earnings:1 suit:1 collaborative:1 release:1 three-part:1 drug:1 treatment:2 development:1 product:1 arthritis:4 's:1 efficacy:1 5:1 may:1 initial:1 sold:1 regional:1 wave:1 worries:1 fell:1 compound:1 active:1 assessed:1 stocks:1 lawsuit:1 approved:1 2:1 severely:1 12:2 last:1 older:1 --:1 amid:1 study:1 alleging:1 companies:1 according:1 reports:1 milestone:1 receive:1 patients:1 products:1 pediatric:1 were:1 banks:1 works:1 rheumatoid:2 maker:1 million:2
stock_BMY r_down	issued:1 table:1 pharmaceutical:1 lead:3 patent:1 selected:1 shares:1 listed:2 sliding:1 analysts:1 week:1 buy:1 approvals:1 after:1 released:1 neutral:1 stocks:3 downgraded:1 drugmaker:1 lower:3 companies:2 drug:3 patents:1 were:1 following:1 biotechnology:1 stock:1 order:1 medical-device:1
stock_BMY r_up	biotech:1 pipeline:1 's:2 additional:1 products:1 drug:1 only:1 continue:1 uses:1 can:1 new:1 climb:1 its:1 thanks:1
stock_BMY r_down	major:1 said:1 's:1 --:1 efforts:1 medicines:1 up:1 its:1 drugs:1 other:1 gaps:1 team:1 pipeline:1 new:1 part:1 drugmakers:1 might:1 company:1 experimental:1 fill:1
stock_BMY r_up	giants:1 major:1 says:1 executive:1 gaps:1 financial:1 open:1 its:1 fill:1 pharmaceutical:1 said:1 seek:1 other:1 between:1 interview:1 new:1 has:1 might:1 more:1 development:2 's:4 drugs:1 company:1 published:1 lower:1 director:1 part:1 article:1 pipeline:1 --:1 medicines:1 companies:1 up:1 drug:2 arrangements:1 risks:1 team:1 become:1 efforts:1 drugmakers:1 industry:1 experimental:1 first:1
stock_BMY r_down	decline:1 because:1 first-quarter:1 longer:1 prepare:1 revenue:1 --:1 pandemic:1 drop:1 flu:1 sales:1 drug:1 possible:1 bulk:1 reported:1 4:1 sharp:1 hit:1 no:1 buying:1 governments:1
stock_BMY r_up	spreads:1 financial:2 lenders:2 investors:2 measure:2 past:2 likes:2 write-downs:3 signs:2 insurance:1 ground:2 even:2 index:1 debt:3 swaps:1 since:3 system:2 40:1 its:1 take:2 expected:2 has:2 type:1 tumbled:1 writedowns:1 risk:4 company:1 benchmark:2 possibility:1 falls:3 sharply:2 credit-default:1 firmer:2 tracking:1 look:1 fallen:1 against:1 looked:1 credit:1 massive:2 have:1 banks:2 corporate:1
stock_BMY r_down	medication:1 revenue:2 cents:2 share:2 sales:1 dropped:1 year:1 's:1 $:2 its:1 dysfunction:1 conference:1 missed:1 rose:1 top:1 expectations:1 comments:2 seller:1 add:1 call:1 income:1 net:1 higher:1 earlier:1 first-quarter:1 million:1 but:1 reported:2 demand:1 strong:1 analyst:1 97:1 antipsychotic:1 billion:1 erectile:1 1.06:1 drug:2 antidepressant:1 47:1 maker:1 profits:1
stock_BMY r_up	comment:1 false:1 pharmaceutical:1 deal:1 guilty:1 agreed:1 year:2 blood-thinning:1 focus:2 trade:1 see:1 session:1 recommending:1 immediately:1 reached:1 fine:1 its:1 whose:1 indicted:1 said:2 funding:1 $:1 patent:2 pay:1 agency:1 shares:1 1:1 failed:1 treatment:1 statements:1 under:1 expected:1 dispute:1 arthritis:1 's:5 allegedly:1 government:2 company:1 million:1 attempt:1 representative:1 active:1 president:1 former:1 resolve:1 last:2 vice:1 --:2 rheumatoid:1 could:1 companies:1 drug:2 n't:2 federal:1 connection:1 country:1 making:1 senior:1 plead:1 lying:1
stock_BMY r_up	profits:1 over:1 executive:2 allegations:1 results:1 trade:1 not:1 planning:1 through:2 comments:1 settlement:1 its:9 25:1 cut:1 20:6 $:13 earned:1 rose:2 than:2 charge:2 4:1 quarterly:1 struck:1 agreed:1 modestly:1 increased:1 government:2 material:1 early:1 matters:1 fall:1 report:1 --:3 drop:2 posts:1 securities:1 session:1 quarter:2 deal:2 declines:1 blood-thinning:1 competition:1 rate:2 trading:1 settled:1 113:2 year:7 2.2:1 estimated:1 out:1 indicted:2 said:1 competitor:1 profit:4 projected:1 shares:2 forecast:1 companies:1 various:1 market:1 net:6 public:4 announced:3 cost-cutting:1 recently:1 business:4 whose:1 million:9 agreement:1 reported:2 restructuring:4 focused:1 active:1 news:1 relating:1 first-quarter:8 33:3 months:1 according:3 35:3 keep:1 amount:1 products:1 analysts:2 threat:1 wringing:1 mixed:3 slightly:1 maker:2 first:1 year-end:1 into:2 nutritional:7 three:1 down:1 initiative:1 post:2 unit:2 decline:1 additional:1 basis:1 initial:4 anti-clotting:1 due:1 much:1 suit:1 expected:1 entered:1 disclosed:1 slips:2 fiscal:1 ``:1 offering:4 tax:2 company:4 part:3 favorable:2 former:2 hold:1 analyst:1 posted:5 third-quarter:1 16:1 lying:2 up:4 transformation:1 auction:1 while:2 were:1 more:1 looms:1 world-wide:1 division:3 cents:10 share:7 sales:2 36:1 '':1 drug:6 file:1 gains:2 sell:5 compared:1 end:2 4.2:6 patent:3 47:1 45:1 42:1 backs:1 also:1 costs:1 5:1 earnings:7 which:1 income:6 impairment:1 stock:1 's:10 plans:4 see:1 may:2 price:1 earlier:3 fell:2 included:2 productivity:1 stocks:3 ago:1 lower:1 off:1 largely:2 charges:3 traded:1 interval:1 investments:1 generic:1 reflecting:1 2007:2 pay:1 filing:1 came:1 latest:2
stock_BMY r_down	says:3 cancer:1 declines:1 into:1 revised:1 drug:2 financial:1 its:1 ground:1 said:2 melanoma:1 additional:1 would:1 but:1 shares:2 makers:3 delay:2 application:3 treatment:2 tumbles:1 quarterly:1 survival:1 earnings:1 development:1 requested:1 plans:1 timeline:1 dive:2 after:1 overall:1 broker:1 resign:3 restructuring:1 cut:1 online:1 they:2 fall:2 not:1 data:1 advanced:1 posted:1 working:1 license:2 submitted:1 companies:1 biologics:1 chief:1 costs:1 officer:1 lose:1 following:1 2008:1 filing:1 profits:3
stock_BMY r_up	1.6:1 managers:1 deal:1 cents:2 warrants:1 share:2 purposes:1 62:1 sale:1 fiscal:1 active:1 see:1 session:1 trading:1 first-quarter:1 forecast:1 proceeds:1 repayment:1 sell:1 whose:1 story:1 said:2 $:3 lead:1 credit:1 general:1 45:1 two:1 shares:2 its:1 report:1 parts:1 health:1 earnings:2 which:1 expected:2 extensions:1 net:1 include:2 polled:1 midday:1 stock:2 flat:1 analysts:2 's:2 plans:1 may:1 familiar:1 company:1 time:2 undisclosed:1 use:1 preferred:2 priced:1 acquisitions:1 mixed:2 +1.65:2 favorable:1 filed:1 possible:1 post:1 debt:3 trade:1 care:1 billion:1 financing:1 subsidiaries:1 redemption:1 --:2 follows:1 companies:1 according:3 securities:4 person:1 amount:1 products:1 common:1 depositary:1 were:2 following:1 through:1 quarter:1 corporate:1 investments:1 second:1
stock_BMY r_down	1.6:1 600:1 1.2:1 400:1 agreed:1 small-cap:1 trade:1 rate:1 actively:1 4:1 's:2 floating:1 rebate:1 proceeds:1 finance:2 sell:1 use:1 said:1 $:7 personal:1 due:4 its:1 1:4 health:1 2018:1 provider:1 biggest:2 got:1 net:1 include:2 public:1 day:1 unsecured:1 gaining:2 product:1 led:1 plans:1 offering:1 government:1 company:1 million:2 expected:1 convertible:1 stocks:3 2008:1 declining:2 care:1 billion:3 debentures:1 consumer-discretionary:1 notes:5 companies:1 checks:1 federal:1 redemptions:1 repayment:1 senior:1 higher:1 first:1
stock_BMY r_up	agreed:2 adjustments:1 four:3 fine:2 its:3 fifth:1 therapeutics:1 based:1 $:6 personal:1 equity:1 weeks:2 has:5 might:2 move:2 read:2 provider:1 cutting:1 not:2 companies:4 quarter:2 audited:2 because:2 financial:2 leaders:2 deal:1 'horsemen:2 some:3 competition:1 close:2 makers:2 84:2 subject:2 said:1 extend:2 federal:2 profitability:1 research:2 health:1 consumer-electronics:2 capital:1 print:2 firms:1 boost:1 seeks:1 business:2 concentrate:1 members:2 beginning:1 care:2 both:2 working:1 ahead:2 changed:1 allows:2 drug:4 credit:4 products:2 faces:1 private-equity:1 statements:2 ago:2 private:1 parties:2 unit:1 would:2 legislation:2 two:2 been:1 confident:2 expected:2 'll:2 main:1 selling:1 funds:1 delivery:1 made:2 wise:2 ride:2 signed:2 n't:2 can:1 closing:1 urging:2 his:1 certain:2 tax:4 renewed:2 assumptions:2 experts:2 have:2 yet:2 sell:3 4.1:2 generic:1 wound:1 write:2 details:1 which:1 out:2 pan:2 development:2 's:4 looming:1 forecasts:3 letter:2 end:2 expired:2 tune:1 recent:2 billion:2 transaction:1 off:2 assets:1 third:2 profit:2 costs:3 so:1 2007:4 2008:4 consumer:1 restored:2
stock_BMY r_down	15:1 drugs:1 amid:1 promising:1 sales:2 slowing:1 two:1 regulators:1 rejection:1 slash:1 cholesterol:1 medicine:1 force:1 its:1
stock_BMY r_down	gaining:2 whose:1 's:3 companies:1 shares:1 trade:1 expected:1 see:1 session:1 biggest:2 stocks:2 active:1 declining:2
stock_BMY r_down	operations:1 rate:1 minimum:1 through:1 reaffirmed:1 its:6 unit:1 sell:1 said:2 addition:1 forecast:1 other:1 does:1 earnings:1 include:1 2010:1 reaffirming:1 product:1 plans:1 business:1 continuing:1 expectation:1 base:1 amp:2 grow:1 15:3 excluding:1 items:2 annual:1 n't:2 growth:1 2007:1 evaluating:1 time:1 2008:1 maker:1 view:1
stock_BMY r_up	seeing:1 previously:1 trade:1 session:1 pregnancy:1 's:4 worrisome:1 thought:1 $:4 since:1 shares:2 increase:1 insider:1 babies:1 provider:1 biggest:2 100,000:1 stock:1 gaining:2 recently:1 far:1 company:2 million:1 problems:1 levels:1 chances:1 active:1 such:1 stocks:2 data:1 than:1 declining:2 purchase:1 lower:1 average:1 companies:1 according:1 worth:1 2002:1 each:1 found:1 bought:2 filing:1 researchers:1 first:1
stock_BMY r_down	sector:2 developed:1 over:4 move:2 expects:6 trade:1 shares:2 alternative:2 its:7 ground:1 announcement:3 giant:1 $:1 it’s:1 late:3 under:2 hit:2 possible:2 soon:2 background:2 drugmaker:2 name:2 --:9 follows:2 small:3 says:3 pledge:3 blood-thinning:1 competition:2 2.3:1 close:1 said:8 defend:3 anticlotting:1 legal:1 forecast:2 version:13 generics:5 medicine:2 bought:1 threatened:3 sold:2 million:1 weak:3 pressure:2 regulatory:7 approval:7 launch:9 could:3 drug:16 analysts:1 options:1 patents:3 comment:4 followed:3 losing:1 verge:2 stocks:1 takes:2 anti-clotting:6 launching:2 firm:2 ``:1 offering:2 successful:2 company:5 analyst:1 getting:1 up:2 believes:1 near:2 ratchet:2 evaluating:1 called:3 sales:1 '':1 dropped:1 face:2 if:2 blockbuster:1 generic:20 imminent:6 fears:1 detail:1 which:3 brand:2 product:3 's:19 after:6 tied:1 plan:1 authorities:3 cheaper:2 rallied:3 lower:3 amid:1 maker:5 jitters:1
stock_BMY r_down	sector:1 biotech:1 because:2 financial:1 weight:1 rating:1 issued:1 due:2 brought:1 conflicts:5 second:1 against:1 have:5 apartheid:3 corporations:2 11th:1 throughout:1 situation:3 one:2 said:3 court:3 $:2 works:2 holdings:2 trying:3 three:2 shares:1 eighth:1 their:1 triggered:2 details:2 justices:5 400:2 appeal:3 case:1 defendant:1 higher:3 justice:2 son:2 business:3 seeking:2 seventh:1 after:1 stop:3 falls:2 flurry:3 item:1 too:3 background:1 fall:1 downgrade:3 during:3 stocks:2 than:2 billion:2 reaction:1 has:2 rare:2 era:3 17:1 16:1 --:3 many:3 companies:4 equal:1 drug:1 33:7 third:1 edge:3 analysts:1 benchmarks:1 act:3 did:3 more:2 stock:2 lawsuits:3 12th:1
stock_BMY r_down	heart:1 all:1 help:1 global:1 reduce:1 slowdown:1 economic:1 including:1 its:2 size:1 25:1 said:1 $:1 million:1 personal:1 payment:1 attack:1 health:2 provider:1 entered:1 has:1 development:2 product:1 used:1 turned:1 company:1 attention:1 fund:1 part:2 upfront:1 haven:2 care:4 pact:1 receive:1 hunt:1 cash:1 trial:1 future:1 biotechnology:1 havens:1
stock_BMY r_up	his:1 1.7:1 cancer:2 soon:2 stand-alone:1 manager:1 growth:2 lung:2 forecast:1 broader:1 year:2 pharmacy:1 estimated:1 use:1 $:2 lead:1 generic:1 support:1 initial:2 had:1 40:1 approved:1 current:1 only:1 2:1 which:1 largest:1 new:2 newly:1 higher:1 used:3 's:3 increased:1 than:1 medicines:1 drugs:1 million:1 delayed:2 sales:2 uses:1 benefits:1 chemotherapy:2 report:1 prescription:1 nation:1 data:1 analyst:1 after:2 billion:1 '07:2 last:2 according:1 study:3 clients:1 up:1 together:1 more:1 patients:1 2006:1 2012:1 could:2
stock_BMY r_down	his:3 1.7:3 cancer:4 soon:3 four:1 growth:3 lung:3 forecast:3 broader:3 year:3 ailing:1 estimated:3 current:3 use:3 appear:1 million:3 bottom:1 support:3 initial:3 had:3 40:3 approved:3 late:1 prognosis:1 which:3 chemotherapy:3 newly:3 include:1 thousands:1 higher:3 used:3 's:3 than:3 after:3 delayed:3 sales:6 early:1 released:1 uses:3 additional:1 new:3 article:2 data:3 analyst:3 $:6 billion:3 last:3 lead:3 --:1 study:6 up:3 together:3 healthy:1 while:1 2006:3 published:2 2012:3 studies:2 could:6
stock_BMY r_up	...:2 named:1 position:1 old:1 effective:1 vice:1 --:1 42:1 new:1 years:1 chief:1 part:1 officer:1 provider:1 services:1 immediately:1 senior:1 president:1 technology:2
stock_BMY r_up	advisory:2 deal:1 private:1 trade:1 see:1 session:1 tablets:2 been:2 talks:1 formally:2 acid:4 its:6 whose:1 said:2 would:1 decision:2 medicine:2 shares:1 withdrawn:2 application:4 equity:1 expected:1 has:4 gaining:2 's:2 combination:2 marketing:4 biggest:2 75:4 active:1 stocks:2 declining:2 panel:2 --:2 signal:1 companies:1 drug:1 regulator:1 withdraw:2 time:1
stock_BMY r_up	among:1 set:1 letters:1 determine:1 cancer:1 increasingly:1 certain:1 doctors:1 radio:1 against:1 have:1 year:1 battle:1 station:1 their:1 said:1 details:1 showcase:1 generic:1 beginning:1 make:1 anti-clotting:1 been:1 its:1 successful:1 splash:1 health:1 treatment:1 generics:1 policy:1 call:1 forcing:1 meeting:1 hope:1 more:1 's:2 may:1 becoming:1 version:1 but:1 groups:1 address:1 cancers:1 approval:1 effort:1 bigger:1 like:1 received:1 has:1 look:2 --:3 medical:1 companies:2 drug:2 maker:1 large:1 place:1 efforts:1 2009:1 options:1 care:1
stock_BMY r_up	represent:1 oncology:2 increasingly:1 agreed:4 domestic:1 focus:4 trade:2 session:2 radio:1 developer:2 whose:2 giant:1 therapeutics:1 $:17 stockholders:1 seems:1 treatment:1 marks:1 deducting:2 has:3 over:1 real:1 premium:1 increased:1 5.50:8 get:1 nation:1 early:2 30:1 during:1 month:1 drugmaker:1 like:1 --:3 companies:3 rockets:2 stock:2 prevent:1 deal:2 tumble:1 some:1 190:4 cash:5 past:1 see:1 year:1 estimated:1 concern:1 gross:1 said:3 projected:2 shares:4 net:3 bought:1 million:4 agreement:2 takeover:2 active:2 news:1 declining:2 both:1 annual:1 drug:2 1.65:1 place:1 published:1 mixed:1 gene:1 slightly:1 options:1 first:1 letters:1 cancer:2 reaches:1 determine:1 article:1 reached:1 shareholders:1 working:1 three:1 mark:1 station:1 call:1 biggest:2 more:1 buy:6 sending:1 drugs:1 company:2 acquire:1 but:1 expected:1 gain:1 doctors:1 than:2 look:2 cells:1 rate:2 cancers:1 were:2 closing:2 balance:2 0.9:1 months:2 have:1 certain:2 share:6 0.6:1 triple:1 seen:1 rally:3 pay:1 six:1 struggling:1 becoming:1 higher:1 gaining:2 product:1 's:12 may:1 price:4 after:2 significant:1 such:1 stocks:5 ago:1 purchase:1 faster:1 futures:1 biotechnology:1
stock_BMY r_up	operations:3 results:1 four:1 its:2 slot:1 $:10 guidance:2 volatile:1 has:1 presentation:1 return:1 buyout:1 day:3 bank:1 drugmaker:1 --:2 predicted:1 financial:1 growth:1 expect:1 reaffirmed:1 close:2 investment:1 financials:1 subject:1 provided:1 said:1 showcase:1 profit:1 selected:1 1.70:2 consecutive:1 sorts:1 ointment:1 led:1 decline:1 sold:1 continuing:2 backed:1 approval:1 estimate:1 received:1 annual:1 according:1 surge:1 climb:1 discontinued:1 cancer:1 revenue:1 names:1 unit:1 pharmaceutical:1 shareholders:1 riskier:1 leading:1 two:1 more:1 company:1 lift:1 1.46:3 share:3 2.2:1 cream:1 sell:1 confab:1 generic:1 make:1 small-capitalization:1 also:1 earnings:2 which:1 papers:1 1.36:1 higher:3 oil:3 's:1 price:1 falls:2 robust:1 stocks:4 approved:1 billion:1 treats:1 third:3 2008:6 investments:1
stock_BMY r_down	cancer-drug:2 help:1 show:3 move:2 identify:1 five-day:3 its:1 adding:1 candidate:1 fared:1 failed:1 treatment:3 usage:2 do:2 worse:1 updates:3 --:4 companies:3 benefit:1 lung:1 respond:4 some:1 likely:3 shown:1 while:1 shares:1 research:1 increase:2 newly:2 shows:3 ends:3 notably:1 worthy:1 news:1 both:1 providing:3 benefits:2 study:3 annual:5 drug:7 diagnosed:2 published:2 gene:5 studies:4 first:1 cancer:11 shortened:1 primary:1 promise:1 article:2 market:1 conference:3 pharmaceutical:3 meeting:5 until:1 more:2 option:1 drugs:2 but:2 released:2 specialists:3 those:1 regimen:1 work:1 n't:2 patients:9 stages:2 biotech:3 proved:1 slip:1 certain:3 itself:1 unlikely:1 have:1 rally:1 blockbuster:1 confirmed:2 details:1 week:3 's:14 may:3 earlier:2 includes:1 most:1 stocks:3 data:4 narrow:1 disease:3 without:2 time:1 breast:1
stock_BMY r_down	treating:1 use:1 's:2 cancer:1 prompting:1 --:1 study:1 comparing:1 together:1 large:1 released:1 chemotherapy:1 data:1 advanced:1 revision:1
stock_BMY r_up	pipeline:1 see:1 top:1 line:1 major:1
stock_BMY r_down	sector:3 appeals:2 financial:2 show:1 saga:1 requiring:2 some:2 number:1 recusals:2 performance:1 individual:2 involvement:1 year:1 close:2 disclosures:2 market:2 if:2 highlighted:1 whose:1 court:2 $:1 confirm:1 holdings:3 shares:1 1:1 their:2 justices:4 certain:2 upbeat:1 before:3 numerous:2 stock:3 them:1 million:1 gains:2 forced:1 sold:3 handful:2 but:2 released:1 involving:2 excess:1 put:1 cases:1 hold:2 come:2 10:1 last:1 assets:1 largely:1 --:2 sit:1 companies:2 reduced:1 continue:2 tech:2 2007:2 action:1 highlight:2 latest:1 out:1 investments:3 stakes:1
stock_BMY r_down	30:1 need:1 's:1 its:5 based:2 decision:2 been:2 current:1 application:3 under:1 medicine:1 has:2 formally:2 marketing:3 company:1 time:1 letter:1 regarding:1 document:1 --:2 official:1 request:1 submitted:1 2007:1 withdraw:2 withdrawal:2 review:1
stock_BMY r_down	even:1 releasing:1 also:1 long-acting:1 dip:2 rebound:1 after:1 effectiveness:1 shares:1 data:2 its:1 version:1 favorable:1 slip:1 known:1 drug:1 stocks:3 rebounds:2 study:1 diabetes:1
stock_BMY r_up	n't:1 top:1 expects:1 drug:2 maker:1 labs:1 hear:1 victory:1 easy:1 betting:1 its:1 experimental:1
stock_BMY r_up	private-equity:1 deal:1 people:1 being:1 developed:1 grabs:1 setback:1 one:1 say:1 suffered:1 telecoms:2 year:1 investment:1 $:2 anticlotting:1 its:1 5:1 between:1 biggest:1 potentially:1 firms:3 's:4 far:1 familiar:1 6:1 delayed:1 plan:2 throw:1 billion:2 whether:1 could:1 up:2 drug:1 deals:1 circle:2 so:1 ruling:1 situation:1 approve:1
stock_BMY r_up	firm:1 deal:1 private-equity:1 bump:1 issued:1 grabs:1 mixed:3 one:1 performance:1 say:1 good:1 telecoms:2 year:1 table:1 firms:1 its:1 unit:1 even:1 pharmaceutical:1 circles:2 $:2 patent:1 review:1 selected:1 two:1 investment:2 till:1 potentially:1 listed:2 equity:2 biggest:1 5:1 weeks:1 week:1 extended:1 's:2 see:1 far:1 approvals:1 6:1 between:1 released:1 gain:2 situation:1 put:1 news:1 stocks:3 throw:1 people:1 billion:2 15:3 acquisition:1 antitrust:1 --:1 could:1 companies:2 up:2 deals:1 so:1 patents:1 familiar:1 were:1 following:1 biotechnology:1 drugs:1 cholesterol:1 order:1 medical-device:1
stock_BMY r_down	stocks:3 investors:1 state:1 into:3 negative:3 grapple:1 slide:2 economy:1 slip:1 territory:2 data:1 red:1 more:1
stock_BMY r_up	saying:2 diabetics:2 need:2 its:2 cardiovascular:2 raise:2 expert:2 prove:2 leading:2 increase:2 new:2 prominent:1 do:2 drugs:4 killer:2 approving:2 they:1 diabetes:2 --:1 medical:2 companies:1 disease:2 urged:2 standards:2 n't:2
stock_BMY r_down	biotech:1 targets:1 they:1 presence:2 previously:1 expanding:1 collaboration:1 n't:2 diabetics:1 simply:1 something:1 diabetes:1 committed:2 need:1 research:2 pills:2 roots:1 really:1 looking:2 certainly:1 said:2 raise:1 expert:1 prove:1 rather:1 leading:1 had:2 been:2 its:8 chemical:2 pioneer:1 potential:1 developed:2 cardiovascular:1 new:1 increasing:2 company:1 therapies:2 implied:1 development:2 do:1 ``:2 selling:2 's:5 drugs:4 sold:2 published:2 story:1 approving:1 lucrative:2 saying:1 not:1 article:1 killer:1 expand:2 prominent:1 '':2 has:2 developing:2 --:3 many:1 medical:1 disease:2 urged:1 standards:1 traditional:2 surrendering:1 p.m.:1 time:2 biologic:2 previous:1 increase:1
stock_BMY r_up	all:1 just:1 move:1 back:1 years:2 kill:1 sell:1 resisting:1 studying:1 should:1 few:1 only:1 internal:1 vehicle:1 's:2 couple:1 after:1 director:1 pressure:1 eight:1 external:1 brands:2 such:1 now:1 former:1 ago:1 off:1 months:1 urged:1 keep:1
stock_BMY r_down	oil:2 's:2 covered:1 cancer:1 climbs:2 dips:2 healthcare:1 dollar:2 system:1 drug:1 leads:1 news:1 rally:2 stocks:3 its:1 vaccine:1 upward:1
stock_BMY r_up	sector:3 financial:1 raise:1 largely:1 trend:1 earnings:1 bellwethers:1 after:1 drug:2 forecasts:1 their:1 reports:1 '08:2 favorable:1 amp:2 stoke:2 2008:1 stocks:1 issue:1 second-quarter:1 higher:1
stock_BMY r_up	oncology:1 lead:2 positive:1 rise:1 drug:3 helped:1 news:1 stocks:3 higher:2
stock_BMY r_down	firm:1 buy:1 's:1 business:1 --:1 wound:1 private:1 equity:1 cleared:1 care:1
stock_BMY r_down	produces:1 numbers:1 executive:1 results:1 including:1 its:3 gamut:1 $:3 personal:1 had:3 than:1 breaches:1 tape:1 4:1 equity:1 employee:1 has:4 local:1 worth:1 surprised:1 his:1 around:1 putting:1 theft:1 basement:2 world:1 buyouts:1 --:4 companies:2 notifying:1 security:1 difficult:1 spokeswoman:1 blood-thinner:1 because:1 says:1 series:1 past:1 second:1 year:1 natural-gas:1 explores:1 newsletter:2 regulator:2 said:3 current:1 version:3 unit:1 generics:2 capital:2 learned:1 across:1 told:1 earlier:1 recently:1 bargains:2 wo:1 marketing:1 million:1 others:1 approval:3 gained:1 launch:1 region:1 days:1 reports:1 afternoon:1 analysts:1 backup:1 maker:1 major:1 450:1 one:1 suspended:1 total:1 market:2 given:1 data:1 there:1 two:1 been:2 few:1 editor:1 expected:1 dozens:1 today:1 more:1 firm:1 posting:1 form:1 brings:1 company:3 gas:1 delayed:1 fund:1 former:1 second-quarter:1 buying:1 customer:1 stolen:1 work:1 plunged:1 up:1 n't:1 exploration:1 can:1 employees:2 launched:2 history:1 predict:1 drug:2 heels:1 seen:1 information:1 containing:1 no:1 generic:2 began:1 earnings:1 largest:1 stock:2 week:1 requested:1 's:4 after:3 involving:1 letter:1 stocks:1 revealed:1 natural:1 chief:1 components:1 time:1 corporate:1 latest:1
stock_BMY r_up	biotech:1 because:1 financial:3 investors:1 focus:2 trade:1 past:1 surrounding:1 see:1 session:1 raises:1 diabetes:1 its:3 whose:1 cancer:1 marketed:1 seems:1 investigational:1 shares:2 forecast:3 only:1 future:1 treatment:2 which:1 under:1 inch:2 has:1 type:1 drug:1 announced:1 higher:1 development:1 product:1 's:3 climbs:2 company:1 after:1 expected:1 cultural:1 link:1 gain:1 30:1 active:1 such:1 stocks:3 than:1 icon:1 2:1 inhibitor:1 tangible:1 submission:1 joint:1 --:3 uncertainty:1 companies:1 up:2 cloudy:1 edge:1 become:1 2008:1 more:1
stock_BMY r_up	shave:1 seeing:1 illness:1 sees:1 mental:1 cancer:3 cents:4 testing:1 plans:1 expects:1 additional:1 up:1 helped:2 36:1 lung:1 higher:1 file:1 year:1 moves:1 its:1 cardiovascular:1 drugs:3 1:1 use:1 8.2:4 $:5 fourth:1 profit:1 positive:1 top:1 43:1 increase:1 indicate:1 costs:1 rates:1 treat:1 which:1 income:2 new:1 net:2 effectiveness:1 boost:2 announced:1 earnings:2 cost-cutting:2 million:2 's:2 increased:3 exchange:1 may:1 boosted:1 measures:1 continuing:1 sales:6 acquisition-related:1 reported:3 38:1 favorable:1 strong:2 second-quarter:3 earlier:1 posted:2 billion:1 quarter:1 improved:1 --:1 31:1 well:1 disease:1 drug:5 operations:1 their:1 charges:1 savings:1 future:1 rose:2 long-term:1 including:1 share:3 gene:1 maker:1 profits:1 2012:1
stock_BMY r_up	stock:1 saying:1 illness:1 announces:1 mental:1 cancer:1 seeing:1 sales:1 quarters:1 helped:1 trading:2 comments:1 second-quarter:1 its:1 cardiovascular:1 treat:1 surprises:2 shares:1 strategy:3 advisories:2 earnings:1 fourth:1 biggest:2 new:1 include:1 higher:2 gaining:2 's:3 increased:1 though:1 drugs:1 after:3 update:2 but:2 slides:2 reported:1 gain:1 fall:1 prices:1 world:1 stocks:5 beginning:1 day:1 declining:2 drugmaker:1 roundup:1 improved:1 third:1 updates:1 future:1 companies:1 disease:1 reports:1 edge:2 afternoon:1 activity:1 executives:1 corporate:1 profits:2 latest:1
stock_BMY r_down	dealing:1 held:1 allowed:1 partner:1 decisions:1 market:1 blow:1 said:1 court:2 generic:1 anticlotting:1 two:1 subsidiary:1 their:1 version:1 appeal:1 administrative:1 enforcement:1 marketing:2 immediate:1 immediately:1 along:1 --:1 drug:1 products:1 onto:1 order:1
stock_BMY r_down	operations:1 have:2 global:1 some:1 stressing:1 begun:1 go:2 their:1 international:3 firms:3 nature:1 reach:2 important:1 they:1 others:1 buyout:1 themselves:2 organizations:1 stress:2 calling:2 deals:3 so:1 become:1
stock_BMY r_down	seeing:1 significant:1 year:1 results:1 60:2 against:1 economic:3 trading:1 numbers:1 have:1 close:1 hit:2 seek:1 its:1 market:1 she:1 delivered:1 said:1 end:3 $:2 her:1 cherry:1 jump:1 note:2 also:1 only:1 concerns:1 call:1 too:1 strong:1 which:1 biggest:2 performance:1 type:1 important:1 stock:1 gaining:2 's:4 ability:1 big:1 price:1 pipeline:1 but:1 hand:1 mixed:3 fell:1 weaker-than-expected:1 sharply:1 approval:1 leukemia:1 stocks:6 declining:2 jobless:1 following:1 lower:1 most:1 resurface:1 developing:1 drug:2 leaving:1 n't:1 growth:1 those:1 can:1 rose:1 worries:2 claims:1 movement:1 mean:1
stock_BMY r_up	just:1 advisors:1 course:1 own:4 rejecting:2 committee:1 fifth:1 undervalues:9 $:8 has:3 move:1 bid:6 possible:1 updates:2 background:1 not:1 buyout:2 --:1 stopped:2 because:2 says:3 fair:1 substantially:2 83:3 n't:3 said:7 per:1 access:1 does:4 new:1 before:1 issue:1 announced:1 full:2 opening:1 takeover:1 opposition:1 beginning:1 declining:1 pipeline:1 determining:1 study:1 days:1 greatly:3 action:1 comes:1 comment:1 already:4 bell:1 60:1 appropriate:1 total:1 opposed:2 statement:2 firm:4 ``:7 buy:1 offer:10 offered:1 formed:1 took:1 but:2 prices:2 he:2 made:1 believes:1 spokeswoman:1 share:1 '':8 his:1 4.5:5 information:1 pay:1 shares:1 also:2 details:1 advise:1 company:6 stock:2 acquire:3 's:11 after:1 ownership:1 70:2 response:2 billion:5 short:2 third:1 biotechnology:5
stock_BMY r_up	sector:2 summer:1 own:1 arbitragers:1 together:1 hard-hit:1 set:1 40:1 steamy:1 positive:1 worry:1 firmly:1 sell:1 upgrade:3 merger:1 broad:2 shares:3 its:1 twins:1 territory:1 drink:1 stock:1 evening:1 's:4 gains:2 after:1 gain:1 trouble:2 hold:1 stocks:1 has:1 amid:2 drug:2 remain:1 analysts:1 double:2 climb:2 out:1
stock_BMY r_up	eyes:1 45:1 kept:1 normal:1 jumped:1 company:1 after:1 times:1 traders:1 their:1 activity:1 level:1
stock_BMY r_down	some:1 sales:1 rising:2 6.1:1 its:1 suggest:1 rivals:1 resilient:1 net:1 more:1 's:3 may:1 price:1 results:1 first-half:1 offset:1 prices:1 eacute:2 than:1 commodity:1 items:1 increases:1 costs:1 rose:1 latest:1
stock_BMY r_up	current:1 unsolicited:1 own:1 little:1 get:1 much:1 bid:1 cares:2 stake:1 n't:2 does:2 either:1 all:1 83:1 you:1 feeling:1 its:2 care:1 too:2
stock_BMY r_up	1.7:2 's:6 $:2 cancer:1 rights:1 could:1 fight:1 hinge:1 treatment:1 follow-up:1 battle:1 has:1 over:1
stock_BMY r_down	pioneering:1 investors:2 developed:1 energy:1 exist:1 have:1 close:1 need:1 patient:1 trending:1 had:1 other:1 company:1 bid:1 more:1 bets:1 's:1 believe:1 effect:1 but:1 advocates:1 cheered:1 they:1 biotechnology:1 ties:1 strong:1 recent:1 lower:1 commodities:1 costs:1 unusually:1 stock:1 chilling:1
stock_BMY r_up	even:1 heart:1 's:2 payouts:1 irony:1 had:1 problem:1 month:2 securities:2 reputation:2 week:2 scandal:1 auction-rate:1 meltdown:2
stock_BMY r_down	prices:1 sector:1 sees:1 driving:1
stock_BMY r_down	even:1 has:1 's:2 worse:2 politicians:1 bad:2 reputation:3 know:1 pretty:1 you:1 gets:2 low:1
stock_BMY r_up	thinner:1 soars:2 over:2 results:1 bounce:2 attempts:1 against:1 surpass:1 disclosures:1 technology:1 its:1 litigation:1 proceed:1 patent:1 expectations:1 shares:2 3:1 quarterly:1 higher:2 analysts:1 's:1 after:1 shareholder:1 blood:1 judge:1 lawsuit:1 ruled:1 advance:1 regarding:1 made:1 --:1 heavyweight:1 drug:1 2002:2 federal:1 settle:1 can:1 popular:1 maker:1 nearly:1
stock_BMY r_up	oncology:1 increasingly:1 over:3 move:2 attempts:1 thinner:1 decisions:1 its:2 litigation:1 one:1 has:1 do:1 employers:1 judge:1 manageable:1 ruled:1 regarding:1 --:2 medicines:1 benefit:1 settle:1 popular:1 some:1 cost:1 wander:1 lead:1 federal:1 shares:1 health:1 reimbursements:1 increasing:1 sold:1 agreement:1 pressure:1 news:1 lawsuit:1 could:1 drug:1 keep:1 maker:1 high-priced:1 tough:1 cancer:1 into:4 two:1 agents:1 proceed:1 meaningful:1 negative:3 their:1 expected:1 entered:1 territory:3 more:1 offer:1 drugs:3 hurt:1 gain:1 demand:1 effort:1 made:1 n't:1 while:1 can:1 control:2 prompting:1 cited:1 high:1 tag:1 against:1 disclosures:1 patent:1 make:1 which:1 insurers:1 development:1 tighten:1 's:1 may:1 price:1 treatments:1 shareholder:1 blood:1 stocks:3 cost-effectiveness:1 reimbursement:1 clear:1 cover:1 costs:2 modestly:1 healthcare:1 order:1
stock_BMY r_down	end:1 hostile:1 start:1 married:1 up:1 often:1 movies:1 only:1 other:1 characters:1 each:1 friends:1 best:1 out:1
stock_BMY r_up	's:2
stock_BMY r_down	outlook:1 weaker:2 they:1 ominous:1 sales:2 anticlotting:1 move:1 some:1 results:1 one:1 disappointing:1 postponing:1 see:1 growth:1 trading:2 signs:1 clothing:1 its:1 market:1 concern:1 whose:1 use:1 said:1 remainder:1 lead:1 down:1 rose:1 hurricane:1 posts:1 shares:2 late:1 application:1 potential:1 issues:1 closed:1 expected:2 stung:2 announced:1 economy:1 gaining:2 's:5 year:1 marketing:1 highs:1 after:1 13:1 focus:2 volume:1 biggest:2 retailer:1 although:1 active:1 approval:1 stocks:3 trade:1 second-quarter:1 declining:2 session:1 sending:2 lower:3 amid:1 off:1 corners:1 companies:1 drug:1 trial:1 profit:1 actively:1 light:1 decliners:1 stock:2 late-stage:1
stock_BMY r_up	financial:2 investors:1 tumble:2 energy:2 close:2 orders:1 viewed:1 cancer:1 woes:2 durable:1 hurricane:1 due:1 shares:3 its:1 clinical:1 safety:1 spike:1 crude:1 conditions:1 dive:1 higher:3 temporary:1 applaud:1 price:1 rise:1 therapy:1 key:1 news:1 stocks:4 prostate:1 concerns:1 reaction:1 goods:1 drug:2 trial:1 mixed:1 climb:1 paced:2
stock_BMY r_up	prevent:2 help:2 heart:3 being:1 developed:1 according:2 second:2 doses:1 shown:2 death:1 addition:2 top:1 had:1 chest:1 current:1 attack:3 potentially:2 details:1 mid-stage:2 researchers:1 has:2 pill:1 therapies:2 low:1 used:3 pain:1 clots:2 after:1 standard:2 compared:1 blood:3 background:1 those:1 lower:1 --:2 could:3 stroke:3 drug:2 trial:2 patients:1 experimental:2 thinners:1 found:1 taking:1 block:2 designed:2
stock_BMY r_up	week:1 pharmaceutical:1 medical-device:1 patent:1 issued:1 selected:1 companies:2 released:1 were:1 listed:2 biotechnology:1 following:1 table:1 approvals:1 order:1 patents:1
stock_BMY r_up	used:2 widely:2 effective:2 can:2 --:2 developed:2 addition:2 effects:2 treatments:2 jointly:2 side:2 few:2 according:2 details:1 background:1 has:2 data:2 pill:2 experimental:2 diabetes:4
stock_BMY r_down	sector:1 outlook:2 investors:2 energy:1 executive:1 back:1 bounce:1 trade:1 scaled:1 hiring:3 mild:1 curb:2 battered:1 's:1 indexes:1 technology:1 its:3 financials:2 bolster:2 end:2 solace:1 announces:1 top:1 third-quarter:2 shares:3 find:1 only:1 run:1 helps:1 finances:3 higher:2 recently:1 gains:3 exec:2 company:1 earlier:1 affirmation:2 plan:3 boosts:2 stocks:3 drugmaker:1 up:3 value:1 shore:1 lift:1 mildly:2 rallies:2 found:1 stock:1 maker:1 chip:1
stock_BMY r_up	stock:1 advisors:1 committee:1 talks:2 its:4 announcement:1 discloses:1 $:2 disappointed:1 willing:1 board:1 weeks:1 bid:5 nearly:1 suitor:1 buyer:1 buyout:3 wring:1 day:1 mystery:1 large:1 works:1 discussing:1 direct:1 eyeing:2 merits:1 our:3 special:1 concern:1 even:2 deals:1 said:6 stands:1 touts:2 new:1 announced:1 we:1 earlier:1 were:1 takeover:3 unnamed:1 comes:1 first:1 60:1 another:2 month-long:2 pharmaceutical:1 too:1 low:1 firm:1 ``:3 buy:1 offer:4 company:1 acquire:2 rejected:2 prices:1 effort:2 buying:1 us:1 n't:1 learn:1 more:1 bidder:1 history:1 inadequate:1 share:1 '':3 4.5:1 pay:1 six:1 interested:1 out:1 higher:3 's:2 though:2 price:1 after:1 yesterday:1 letter:1 fresh:1 response:1 billion:1 transaction:1 calls:4 without:1 enter:2 push:2 biotechnology:1
stock_BMY r_up	infant:1 because:1 female:1 give:1 contaminant:1 move:1 some:1 all:1 one:1 '':1 been:1 have:1 year:1 years:1 its:1 contaminated:1 pharmaceutical:1 containing:1 said:3 group:1 pet:1 make:1 agency:1 had:1 same:1 1:1 pharmaceuticals:1 asking:1 tainted:1 biggest:1 formula:5 struggling:1 health:1 more:1 melamine:1 woman:1 's:7 announcement:1 food:1 company:2 after:3 conglomerate:1 finding:1 recalled:1 not:1 suspected:1 industry:1 than:1 care:1 timely:1 ``:1 eight:1 last:1 follows:1 ill:1 56:1 reports:1 retire:1 retiring:1 country:1 become:1 succession:1 head:1 maker:1 executives:1
stock_BMY r_down	satisfy:1 financial:1 investors:1 obligations:1 into:3 number:1 owned:1 negative:1 broader:3 news:1 follow:3 offered:1 proceeds:1 market:3 bankruptcy:1 one:1 use:1 said:1 initial:1 connection:1 shares:1 its:1 grapple:1 largest:1 territory:1 price:1 red:2 stock:1 disclose:1 's:1 offering:3 company:1 separation:1 filed:2 subsidiary:1 stocks:3 has:1 did:1 public:1 n't:1 range:1 common:1 corporate:1 institutions:1 prospectus:1
stock_BMY r_down	biotech:3 walking:3 consider:3 investors:3 we:1 walk:2 '':1 shares:1 its:4 conference:1 $:3 situations:1 away:5 comments:1 willing:1 details:1 which:1 company:3 sliding:1 told:3 ``:1 's:2 offer:3 bid:1 slides:2 takeover:3 doubts:2 news:1 stocks:3 --:2 might:4 analysts:3 mixed:3 maker:2
stock_BMY r_down	infant:1 broader:1 previously:1 nutritional:1 major:1 unit:1 trading:2 unveiled:1 its:2 best:1 pharmaceutical:1 six:1 trend:1 finally:1 concerns:1 health:1 details:1 formula:1 firms:1 announced:1 week:1 brand:1 took:1 but:1 slides:1 market:1 plan:1 known:1 day:1 lower:3 third:1 industry:1 months:1 trends:2 banking:1 midday:2 pediatric:1
stock_BMY r_up	billion:1 buy:1 's:2 $:1 consumers:1 reeling:1 products:1 country:1 industry:1 foreign:1 formula:1 other:1 dairy:1 baby-formula:1 widens:1 flocking:1 scandal:1 21:1
stock_BMY r_up	infant:1 previously:1 nutritional:1 known:1 unit:1 unveiled:1 its:2 best:1 details:1 contained:1 chemical:1 finally:1 declined:1 toxic:1 formula:2 weeks:1 announced:1 discovery:1 disclose:1 's:1 brand:1 plan:1 baby:1 pediatric:1 popular:1
stock_BMY r_down	sector:2 all:1 proposed:2 ending:1 prices:1 session:1 per:1 derided:1 fine:1 its:6 before:4 $:13 assuage:1 stockholders:2 previously:1 add:1 board:3 has:4 details:2 rescue:2 government:1 big:1 bid:9 sweetened:5 possible:2 valued:1 discuss:1 bank:1 skeptical:1 increasing:1 --:1 drop:1 slide:2 stock:2 deal:2 revised:1 700:2 cash:1 likely:2 economic:1 sight:1 seal:2 edged:1 revises:1 said:2 broad:1 testify:1 shares:1 bailout:2 between:1 print:1 previous:1 specialist:1 full:2 led:1 climbs:2 takeover:1 proxy:2 news:1 received:3 hostile:1 package:1 losses:1 among:1 raised:1 letter:1 appeared:1 within:1 increased:1 hearing:5 60:2 62:3 directly:1 approval:1 throughout:1 little:1 failed:1 initial:2 due:1 fight:2 traction:1 their:2 until:2 more:2 buy:1 offer:10 turned:1 acquire:3 fund:1 gain:2 known:2 injection:1 he:2 troubled:1 rival:2 up:2 n't:2 while:1 owns:1 spotlight:2 control:2 outstanding:1 inadequate:1 share:4 swung:1 gains:1 sell:1 4.7:2 bear-market:1 generic:1 rout:1 fears:1 feature:1 indexes:1 lifts:4 take:1 higher:2 16.6:1 's:13 plans:2 after:1 drift:2 depths:1 fell:1 plan:2 waver:2 stocks:4 response:1 billion:4 lower:5 assets:1 commodity:1 amid:1 futures:4 directors:1 reception:1 claims:2 make:1 came:1
stock_BMY r_up	seeing:1 trade:1 clot:3 soaring:1 session:1 its:1 whose:1 use:1 said:1 syndrome:1 positive:1 shares:2 recommended:1 screening:1 under:1 test:1 new:1 has:1 soar:2 gaining:2 's:8 prenatal:1 biggest:2 active:1 stocks:5 declining:2 drugmaker:1 --:1 study:1 companies:1 drug:1 edge:1 climb:2 higher:1
stock_BMY r_up	among:1 blood-clot:2 cost:1 drug:2 vote:1 watchdog:3 moves:1 market:1 use:3 giving:1 agency:1 scrutinizes:1 recommended:1 those:1 biggest:2 new:1 has:1 pill:2 stock:1 gaining:2 recommends:2 's:3 notable:1 confidence:1 important:1 stocks:2 declining:2 made:1 medicines:1 companies:1 value:1
stock_BMY r_up	heart:1 just:1 executive:1 four:1 optimistic:1 resigned:1 its:2 sell:1 said:1 goal:1 remains:1 review:1 board:1 has:1 gaining:1 his:1 's:4 complete:1 company:1 after:1 but:1 approval:1 nomination:1 did:1 months:1 drug:1 n't:1 directors:1 experimental:1 prasugrel:1
stock_BMY r_down	major:1 withdraw:1 told:1 global:1 sales:1 offerings:1 ended:1 offer:1 6.1:1 year:1 its:1 unit:1 subject:1 sell:1 provided:1 said:1 based:1 $:3 no:1 large:1 make:1 initial:2 had:1 due:1 2.6:1 1:1 market:1 net:1 has:2 public:2 stock:1 nutrition:1 around:1 offering:1 pharmaceutical:1 any:1 could:1 company:2 acquire:1 involving:1 filed:1 brands:1 diligence:1 end:1 proposal:1 billion:3 well-known:1 either:1 made:1 15:1 longer:1 reopen:1 31:1 up:1 summary:1 deals:1 common:1 pediatric:1 following:1 2007:1 guide:1 prospectus:1 history:1
stock_BMY r_up	broader:1 its:4 previous:1 votes:2 bailout:2 voted:1 has:2 increased:1 rebound:3 day:1 ruled:1 --:1 banking:2 continue:1 set:1 says:2 tumble:2 blood-thinning:1 competition:1 pass:1 dives:1 fails:1 said:2 competitor:1 decision:1 marketed:1 research:1 version:1 boost:1 announced:1 schedule:3 crippled:1 news:1 faced:1 pipeline:3 ahead:3 day-ago:2 industry:2 against:1 plunging:1 efforts:1 maker:2 comment:1 thinner:1 formerly:1 down:3 chronic:1 approval:1 ailing:1 objections:1 market:1 top:1 legislation:1 due:1 enforcement:1 plunge:1 drugs:1 prospects:1 immediate:1 known:1 line:1 bill:2 can:1 country:1 following:1 aid:1 high:1 drug:3 blockbuster:1 advancing:2 fill:1 court:1 generic:3 rout:2 dismissed:1 which:1 erosion:1 development:1 's:1 after:6 running:1 blood:1 stocks:6 provide:1 relief:1 resolution:1
stock_BMY r_down	among:1 serving:1 prompt:1 deal:1 decliner:1 move:1 dollar:1 dead:1 large-cap:1 6.1:1 measure:1 talks:1 terms:1 should:1 its:1 issues:1 earlier:1 pharmaceutical:1 giant:1 $:2 rose:1 any:1 1:1 market:1 formal:1 company:1 midday:2 acquisitions:1 global:1 's:2 offer:1 bid:1 acquire:1 notable:1 volume:1 action:2 stocks:3 advanced:1 raise:1 billion:2 third:1 year:1 could:1 968:1 traditional:1 mixed:3 quarter:1 mergers:1
stock_BMY r_down	cancer-drug:1 ready:1 6.1:4 cancer:1 people:1 sell-off:2 into:1 revised:1 share:1 ``:1 '':1 n't:2 likely:1 economic:1 oral:1 broader:3 talks:6 received:1 short-selling:1 moves:1 its:1 market:5 developer:2 even:1 decline:1 said:1 $:6 start:1 merger:2 been:1 selling:1 preventing:1 indicate:1 citing:1 version:1 advanced:1 biggest:2 new:1 has:2 type:1 more:1 gaining:2 mystery:1 700:1 buy:3 's:2 rescue:1 reportedly:2 offer:1 gets:2 familiar:1 clots:1 after:1 notable:1 extended:1 reported:1 fell:1 blood:1 70:1 report:2 approval:3 engaged:1 stocks:5 data:1 approved:1 declining:2 billion:5 restrictions:1 include:1 join:3 package:1 bidder:1 could:1 futures:1 companies:1 drug:4 recession:1 matter:1 takeover:1 making:1 2008:2 stock:2 fallen:1 spotlight:2 aimed:1
stock_BMY r_up	comment:1 biotech:2 questions:2 move:2 raises:2 6.1:2 $:2 add:1 interest:2 company:2 stock:1 mystery:2 updated:1 's:6 may:2 bid:2 prudence:2 but:2 reported:2 prices:1 billion:2 unidentified:2 --:2 solve:2 making:2 bidder:2
stock_BMY r_down	cancer-drug:1 saying:1 all:1 proposed:1 unsolicited:3 ending:3 6.5:11 6.1:1 battle:2 its:5 developer:1 announcement:1 $:25 had:3 written:1 should:1 16.6:1 crack:1 include:1 recasts:1 chairman:1 outbid:1 finance:1 bid:3 effects:1 not:1 affect:1 month:1 disappointed:1 lost:3 --:5 try:1 did:1 says:1 deal:7 some:1 searching:3 sea:1 83:1 out:2 said:3 stands:1 open:1 acting:1 new:1 conditions:1 bold:1 superior:3 agreement:3 along:1 last:1 acquisition:2 getting:1 months:3 drug:2 drama:3 credit:1 chemical:1 planned:1 defeat:1 maker:2 comes:1 comment:1 ability:1 own:1 one:1 60:2 62:1 licensing:1 stockholder:1 reached:1 throughout:2 singing:1 pharmaceutical:1 use:1 raise:1 would:2 support:1 two:3 strategy:1 pearl:1 statement:2 markets:1 more:1 firm:1 buy:4 offering:1 offer:4 successful:1 company:3 acquire:8 but:3 gain:1 bidding:1 all-cash:1 prices:1 effort:1 analyst:1 financing:1 has:4 14:1 17:1 cash:1 signed:3 n't:3 sour:1 owns:1 bet:1 biotech:1 uncertainty:1 share:5 comfortable:1 have:2 sounding:1 any:1 if:1 goal:1 began:1 stake:2 1:4 other:1 pivotal:1 details:1 which:3 instead:1 subject:1 offered:1 stock:1 's:8 plans:1 may:1 after:1 plan:1 ownership:1 70:2 billion:12 third:1 severe:1 time:2 biotechnology:3 nearly:1
stock_BMY r_down	outlook:1 uncertainty:2 deal:1 agreed:1 demand:1 700:1 one:1 weighed:1 6.6:2 second:1 battered:1 work:1 yet:1 market:3 narrowly:1 5.1:2 $:4 support:1 implosion:2 shares:2 next:1 their:1 bailout:2 which:1 crude:2 has:1 over:2 stock:2 get:1 price:2 acquire:1 averted:1 stellar:1 maimed:2 fell:1 experiences:1 sink:2 despite:2 prices:1 stocks:4 declining:1 billion:2 peers:1 kept:1 straight:1 bill:2 6.5:3 looked:1 banks:1 worst:1 sell-offs:1 history:1 plan:1
stock_BMY r_up	150:1 note:1 ending:1 course:1 session:1 trading:3 have:1 if:1 pharmaceutical:1 said:1 $:3 would:1 merger:1 pay:1 negative:1 day:1 late:1 under:1 territory:1 flat:1 hover:1 around:1 completed:1 million:1 agreement:1 bullish:1 modest:1 fee:1 not:1 comeback:1 line:1 stocks:7 beginning:1 between:1 after:1 stage:1 reverse:1 companies:1 turn:2 while:1 afternoon:5 action:2 termination:1 climb:2 south:2
stock_BMY r_down	summer:1 major:1 term:1 deal:1 most:1 --:1 large:1 after:1 soon:1 anytime:1 n't:1 insured:1 likely:1 near:1 shareholder:1 unlikely:1 making:1 speculation:1 wo:1 acquirer:1 bought:1
stock_BMY r_down	drugmakers:1 into:2 cap:1 negative:1 large:1 most:1 trading:3 see-saw:3 territory:1 stocks:3 red:2 afternoon:2
stock_BMY r_down	considering:1 's:1 center:1 company:1 dairy:1 scandal:1 tainted:1 milk:1 buying:1
stock_BMY r_down	supplement:1 emerging:4 antibiotic:1 210:4 well:1 move:1 share:1 sales:1 trade:1 four:1 footprint:3 session:1 further:1 comments:1 close:1 portfolio:4 its:4 market:2 whose:1 said:4 end:2 $:12 leading:1 acquire:1 disease:1 shares:1 accelerate:1 occupy:1 iron:1 declining:2 biggest:2 main:1 markets:4 gaining:3 such:1 continues:3 's:9 around:1 business:1 pharmaceutical:2 drugs:1 company:1 million:4 treatments:1 expected:2 antibiotics:1 blood:1 active:1 20:2 buy:1 stocks:2 buying:3 areas:1 extend:1 branded:1 older:1 --:4 positions:1 medicines:3 companies:1 9:1 growth:1 products:2 including:1 mature:4 expand:3 become:1 selling:1 acquisition:2 pressure:1
stock_BMY r_down	fence:1 hard:1 one:1 '':1 damaged:1 said:2 no:1 spokesman:1 tail:1 8:1 struck:1 injured:1 ``:1 's:1 leg:1 after:2 but:1 landed:1 landing:2 helicopter:3 he:1 made:1 shortly:1 drug:1 morning:1 a.m.:1 maker:1
stock_BMY r_up	heart:2 have:1 determine:1 any:1 best:1 said:1 their:1 forces:1 status:1 clots:1 after:1 but:1 they:2 rare:1 received:1 protect:1 word:1 dangerous:1 medical:1 companies:1 drug:1 n't:1 stents:1 patients:1 treated:1 experimental:1 joining:1
stock_BMY r_up	confidence:1 investors:1 ahead:3 government:1 positive:1 global:1 stabilize:1 've:2 n't:2 finally:1 broader:3 cruise:2 action:1 amp:2 effect:1 stocks:3 markets:1 having:1 market:3 greater:1
stock_BMY r_up	prescription-drug:1 poorest:1 consider:1 driving:1 people:1 assistance:1 programs:1 aimed:1 normally:1 more:1
stock_BMY r_down	issued:1 focus:2 trade:1 see:1 session:1 table:1 whose:1 patent:1 selected:1 shares:1 listed:2 expected:1 week:1 pharmaceutical:1 approvals:1 released:1 active:1 companies:3 patents:1 were:1 following:1 biotechnology:1 order:1 medical-device:1
stock_BMY r_up	infant:1 global:1 adjusted:1 discovered:1 through:1 settlement:2 fine:1 its:12 previous:1 litigation:2 group:1 $:5 application:1 disposal:1 seems:1 blog:1 economy:1 charge:3 disclosed:2 dressing:1 must:1 complaint:2 gains:1 government:2 very:1 rise:1 focus:2 fusion:1 nearly:1 report:1 amp:2 loss:8 --:3 companies:2 settle:2 each:1 release:1 higher:3 prasugrel:1 still:1 worldwide:1 says:1 posts:1 250,000:1 prediction:1 related:1 year:2 margins:1 makers:1 special:1 85:1 project:1 said:2 tussle:1 bottom:1 profit:5 review:1 comments:1 forecast:2 unit:2 navigating:1 sixth:1 formula:1 net:2 weekly:1 announced:1 quarter:1 triples:2 business:3 exchange:1 marketing:3 million:3 notable:1 regulators:1 tripled:3 paid:1 although:1 offset:1 directions:1 along:1 strong:1 beginning:1 declining:2 antipsychotic:1 reaction:1 almost:1 cautious:1 license:2 site:1 items:1 losses:1 according:2 drug:6 infringe:1 takeover:1 due:1 high-tech:1 maker:2 experimental:1 among:1 raised:1 previously:1 into:4 period:1 third-quarter:7 drove:1 market:2 conference:1 swings:2 jobless:1 monthly:1 anti-clotting:1 two:2 next:1 their:2 much:1 call:1 biggest:2 entered:1 company’s:1 billion:1 ``:1 received:2 company:3 466:1 defunct:1 but:1 hurt:1 taken:1 gain:2 filed:3 prices:1 analyst:1 those:1 posted:3 pact:1 high:1 has:1 14:3 rights:1 recession:1 while:2 sum:1 following:1 making:1 steep:1 firm:1 futures:1 cents:2 lines:1 share:2 sales:7 '':1 patents:1 brutal:1 triple:1 seem:1 moves:1 saw:1 proceeds:1 alive:1 different:1 compared:1 4.1:1 patent:1 rout:1 claiming:1 43:1 same:1 far:1 earnings:2 income:1 outlook:1 document:1 swung:4 stock:3 gaining:2 extended:1 's:14 investigations:3 after:1 lump:1 includes:1 allowing:1 end:1 stocks:2 payment:1 ago:1 charges:2 alleging:1 cover:2 sale:5 antidepressant:1 costs:2 2007:1 21:1 claims:1 2008:1 filing:1
stock_BMY r_down	stock:1 sector:1 broader:2 less:1 within:1 bellwether:1 energy:3 alongside:2 share:1 insulated:1 medical-technology:1 seesaw:2 economic:2 soars:2 dropped:2 another:2 year:1 rally:4 throughout:1 several:1 market:2 impact:1 pouring:2 hide:2 additional:1 shares:1 plunges:1 rose:1 swoon:2 mount:2 comments:1 indexes:2 late:2 health:1 details:1 tumbles:2 care:1 economy:2 updated:1 health-care:1 declined:1 gains:2 than:1 pharmaceutical:1 seesaws:1 big:1 safe:2 weak:1 water:2 prices:4 heads:2 stocks:2 data:1 analyst:1 declining:1 areas:1 tracking:1 viewed:1 industry:2 companies:2 drug:1 economically:1 while:1 afternoon:1 place:2 profits:1 have:1 trading:3 more:1 notion:2 south:2
stock_BMY r_up	's:2
stock_BMY r_up	into:1 move:1 number:1 innovative:1 market:1 diseases:1 $:2 which:1 provider:1 new:2 bought:1 health-care:1 plans:1 get:1 drugs:1 part:1 plan:1 70:2 services:1 than:2 expand:1 areas:2 faster:1 pursue:1 halve:1 medicines:1 more:1
stock_BMY r_down	rocket:2 issued:1 move:1 soon:1 broader:3 table:1 rally:3 market:3 pharmaceutical:1 patent:1 selected:1 warms:1 rates:1 listed:2 interest:1 week:1 approvals:1 further:1 released:1 hopes:1 amp:2 stocks:3 lower:1 companies:2 patents:1 were:1 following:1 biotechnology:1 order:1 medical-device:1
stock_BMY r_up	treating:1 use:1 said:1 neck:1 cancer:2 review:1 blockbuster:1 head:1 drug:1 its:1 priority:1 application:1 accepted:1 broaden:1 supplemental:1
stock_BMY r_up	use:1 said:1 cancer:1 review:1 blockbuster:1 drug:1 priority:1 application:1 accepted:1 broaden:1 supplemental:1
stock_BMY r_up	lawyer:2 through:1 have:3 fifth:1 said:1 court:2 $:2 comments:1 analyst:3 late:1 6:2 letter:1 scheme:3 fled:3 more:2 may:3 million:2 former:3 filed:1 probing:3 insider-trading:3 than:2 criminal:3 prosecutors:3 third:1 --:2 country:3 guilty:3 according:2 charges:3 filing:2
stock_BMY r_down	comment:1 lawyer:1 office:1 issued:1 ninth:1 have:1 table:1 pharmaceutical:1 said:1 guilty:1 $:1 no:1 patent:1 selected:1 analyst:1 late:1 listed:2 6:1 criminal:1 fled:1 more:1 week:1 's:1 than:1 may:1 approvals:1 million:1 released:1 court:1 letter:1 filed:1 probing:1 insider-trading:1 former:1 scheme:1 prosecutors:1 --:1 country:1 companies:2 according:1 filing:1 charges:1 patents:1 were:1 following:1 biotechnology:1 order:1 medical-device:1
stock_BMY r_down	blow:1 sell:1 attempt:1 generic:1 anti-clotting:1 drug:1 version:1 which:1 dealt:1 's:2 blockbuster:1
stock_BMY r_up	prevent:3 medication:1 often:1 findings:1 people:3 also:1 encouraging:2 clot:1 known:1 artery:1 blocks:1 've:3 its:2 unit:1 looked:1 shown:2 said:3 additional:3 3rd:1 trial:3 leading:1 anti-clotting:2 detail:1 comments:1 company:2 attack:4 potential:3 treatment:3 mid-stage:2 clinical:3 suffered:3 has:5 type:3 pill:3 treat:1 ``:6 's:2 pharmaceutical:2 forming:3 clots:4 were:1 problems:3 results:2 released:2 involving:3 designed:3 new:3 phase:3 2:1 now:1 advanced:1 syndrome:3 '':6 tested:1 --:4 oral:1 study:5 drug:4 keep:3 heart:7 suggests:3 patients:3 healthcare:1 rivaroxaban:1 starting:2 researchers:1 blood:5
stock_BMY r_down	heart:2 blood-thinner:2 thinner:1 defensive:1 people:2 certain:1 heartburn:4 guidelines:1 sales:1 50:1 high:1 itself:1 taking:1 have:1 shake:2 pills:3 market:2 approved:1 compared:1 treat:1 working:3 their:1 affects:1 make:1 direction:1 event:1 drugs:2 attack:1 other:1 combine:1 treatment:1 new:1 several:2 type:1 pill:1 pharmacy-benefits:1 play:1 good:1 risk:1 may:3 company:2 did:1 failure:1 blood:2 background:1 doctors:1 cardiac:1 changing:1 eighth:1 those:1 diabetes:1 like:1 pressure:1 --:2 could:2 according:2 drug:4 keep:3 n't:3 suggests:1 benefit:1 found:2 higher:1 study:5
stock_BMY r_down	among:1 blood-pressure:1 form:1 show:1 study:1 patients:1 drug:1 heart:1 failed:1 benefit:1 common:1 failure:1
stock_BMY r_up	flow:1 years:1 say:1 through:1 expect:1 flush:1 exclusivity:1 its:1 market:1 acceleration:1 pharmaceutical:1 said:1 $:2 top:1 increase:1 few:1 going:1 inventory:1 better:1 2011:1 billion:1 750:1 shopping:1 plans:1 mid-sized:1 drugs:1 million:1 but:1 1:1 they:1 not:1 acquisitions:1 loss:1 companies:2 cash:2 drug:1 're:1 steps:1 small:1 management:1 other:1 executives:1
stock_BMY r_up	because:2 some:2 dose:2 hypertension:1 slumped:1 's:2 its:1 concern:2 said:2 unable:2 much:1 due:2 failed:2 version:1 treatment:2 full:2 handle:2 after:1 part:1 effects:2 potential:2 38:1 trial:2 patients:2 were:2 biotechnology:2 oral:1 side:2
stock_BMY r_down	cancer-drug:1 strengthen:1 executive:1 its:1 market:1 said:1 attractive:1 pursuing:1 downturn:1 has:1 more:1 's:1 such:1 recent:1 acquisitions:1 pipeline:1 made:1 license:1 --:1 drug:1 deals:2 chief:1 maker:1
stock_BMY r_up	14:2
stock_BMY r_up	gaining:2 whose:1 's:3 seeing:1 companies:1 shares:1 trade:1 active:1 session:1 biggest:2 stocks:2 declining:2
stock_BMY r_up	'':1 infant:1 said:1 trace:1 very:1 positive:1 melamine:1 containing:1 one:1 sample:1 levels:1 low:1 formula:1 found:1 ``:1
stock_BMY r_up	saying:1 melamine:1 marketed:1 officials:1 have:1 trace:1 do:1 country:1 pose:1 infant:2 tiny:1 n't:1 levels:1 health:2 allow:1 found:1 formula:1 consumption:1 concerns:1 safe:1
stock_BMY r_down	advisory:1 credit:1 alfa:1 another:1 backing:1 over:1 executive:1 orphan:1 finance:1 slowing:1 chronic:1 hypertension:1 changes:1 file:2 throughout:1 crisis:1 spurring:1 adults:1 he:1 said:2 asthma:1 21:1 would:1 immune:1 creating:1 positive:1 review:2 treatment:2 turnover:1 lights:1 version:1 5:2 details:1 medicine:1 new:6 several:1 implantable:1 authorization:1 treat:1 week:1 203:1 experienced:1 's:3 plans:1 combination:1 essential:1 drugs:2 big:1 company:1 began:1 increasing:1 introduce:1 expected:1 five:1 adult:1 demand:1 regulatory:2 approval:1 active:1 panel:1 professionals:1 contraceptive:1 economy:1 takes:1 --:2 pressures:1 medicines:1 days:1 drug:4 called:1 regulator:1 receive:1 chief:1 green:1 2007:1 birth-control:1 time:1 opinion:1 2009:3 disorder:1 maker:1 executives:1
stock_BMY r_up	infant:3 office:3 departing:2 issued:1 focus:2 crime:3 his:1 food:1 safe:2 possible:2 finding:1 new:1 level:1 --:3 always:1 companies:2 she:2 financial:2 likely:3 year:2 2.5:1 said:4 selected:1 per:1 contained:1 formula:4 told:1 drink:1 stance:1 white-collar:3 approvals:1 sold:1 million:1 article:2 last:1 could:2 priorities:1 amount:1 published:2 patents:1 major:2 industrial:1 consume:1 into:2 one:1 determine:1 table:1 crisis:2 pharmaceutical:1 takes:2 would:1 top:1 there:1 least:1 next:4 listed:2 assessment:1 melamine:3 partly:1 brand:1 released:1 reflecting:1 reverses:1 present:1 he:2 exception:1 n't:1 below:1 determined:1 were:1 following:1 tenure:1 if:1 patent:1 chemical:1 parts:1 stemming:2 interview:1 terrorism:1 week:2 's:2 trace:1 after:1 allow:1 time:1 biotechnology:1 order:1 medical-device:1
stock_BMY r_up	stance:1 infant:6 industrial:2 consume:1 ran:1 safety:1 tests:1 related:2 one:2 decided:1 per:1 determine:1 trace:2 determined:1 establish:1 2.5:1 after:2 information:1 said:4 raise:1 would:2 there:1 28:1 below:1 least:2 p.m.:1 chemical:2 contained:1 concerns:1 health:1 finding:2 formula:8 has:1 ever:1 public:1 drink:1 can:1 melamine:6 used:1 partly:1 combination:1 food:1 brand:2 setting:1 exception:1 chemicals:2 if:1 sold:2 new:1 not:2 reverses:1 present:2 additional:1 both:1 safe:2 level:2 --:2 assessment:1 could:2 parts:1 against:1 standards:1 n't:3 item:1 amount:2 implied:1 does:1 allow:2 time:1 10th:1 million:1
stock_BMY r_up	development:2 being:1 expanding:1 into:1 global:1 competitive:1 one:1 assess:1 including:1 its:1 market:1 pharmaceutical:1 develop:2 trials:1 two:2 research:1 their:1 investigational:1 clinical:1 safety:1 treatment:1 between:1 entered:1 include:1 type:1 announced:1 giants:1 enable:1 efficacy:1 drugs:1 collaboration:3 under:1 expansion:1 joint:1 jointly:1 2:1 diabetes:2 several:1 worldwide:1 excluding:1 countries:1 --:1 companies:2 drug:2 2007:1 dapagliflozin:3 plan:1
stock_BMY r_up	biotech:1 appeals:2 cancer:1 challenged:1 intellectual:1 '':1 thinner:2 year:1 pleased:1 confirmed:1 generic:3 court:2 $:1 patent:4 pay:1 decision:3 least:1 its:2 spokesman:1 drugs:1 version:1 upheld:1 which:1 rejected:1 happy:1 ``:1 's:6 very:1 marketing:1 company:1 million:1 here:1 blood:2 key:1 own:1 judge:1 drugmaker:1 13:1 last:1 affirm:1 --:2 challenge:1 rights:1 told:1 drug:2 federal:3 barred:1 amplifications:1 popular:2 property:1 maker:2 affirmed:1 240:1
stock_BMY r_down	full:1 court:1 reported:1 ruling:1 disregard:1 news:1 headlines:1 latest:1
stock_BMY r_up	comment:2 named:1 because:1 followed:1 deal:1 retires:1 guidance:2 despite:2 years:1 previously:1 full-year:2 set:1 including:1 unveiled:2 year:1 financial:1 drug-industry:2 its:8 plans:2 sell:2 confirmed:2 said:1 1982:1 lead:2 served:1 patent:1 make:1 since:1 next:1 also:1 charge:2 longtime:2 weakening:2 under:1 probably:2 has:1 conditions:2 beverages:1 fourth:2 business:1 replacing:1 sixth:1 company:3 acquire:2 consolidation:2 new:1 pressure:1 protection:1 coming:1 such:2 analyst:3 he:1 10:2 off:2 last:1 --:2 industry:3 lose:1 according:2 drug:2 maker:1 large:2 chief:1 beverage:1 products:1 officer:1 cholesterol:1 biotechnology:2 quarter:2 top:1 businesses:1
stock_BMY r_down	move:1 focus:2 trade:1 session:1 including:1 questions:1 its:3 whose:1 cut:1 group:1 $:1 guidance:1 recommending:1 better:1 2010:1 pending:1 seeking:1 outlined:1 immediately:1 --:2 companies:1 businesses:1 works:1 force:1 see:1 cost:1 year:1 makers:1 2.5:1 said:1 affects:1 shares:1 future:1 safety:1 active:1 approval:2 last:1 involved:1 annual:1 drug:3 products:1 gene:1 maker:1 raised:1 cancer:1 assess:1 colon:1 another:1 two:1 attack:1 clinical:1 treat:1 expected:1 type:1 more:2 drugs:2 than:1 those:1 10:1 target:1 work:1 full-year:1 patients:1 growth:1 risks:1 were:1 toward:1 heart:1 certain:1 stroke:1 unveiled:1 sell:1 confirmed:1 trials:1 agency:1 application:1 document:1 used:1 's:2 plans:2 after:1 forecasts:1 applications:1 such:1 diabetes:2 billion:1 off:1 effective:1 well:1 disease:1 savings:1 beverage:1
stock_BMY r_up	heart:1 raised:1 heart-attack:1 affects:1 move:1 assess:2 stroke:2 including:1 questions:1 year:1 said:2 trials:2 guidance:1 agency:1 recommending:2 better:2 application:1 attack:1 clinical:2 safety:1 document:1 pending:1 more:3 's:2 drugs:2 outlined:1 after:1 immediately:1 applications:1 such:1 approval:1 than:1 those:1 diabetes:3 effective:1 --:1 well:1 drug:2 1,000:2 future:1 risks:2 were:1
stock_BMY r_down	sector:2 saying:1 investors:1 companies:1 focus:1 awaited:1 quarters:1 trading:1 file:1 spin-off:2 its:2 unit:2 $:6 open:1 surprises:2 initial:2 1:6 advisories:2 setting:2 earnings:1 statement:1 under:1 crude:1 public:2 announced:2 stock:1 files:2 nutrition:2 oil:1 plans:3 offering:2 auto:1 symbol:1 market:1 part:2 plan:2 filed:1 prices:1 raise:2 billion:4 lower:1 last:2 --:2 slightly:1 industry:1 futures:1 list:1 up:2 reports:1 spotlight:2 banking:2 future:1 pediatric:2 corporate:1 roundup:1 latest:1
stock_BMY r_up	associated:1 certain:1 into:1 portfolio:1 market:1 pharmaceutical:1 said:1 $:1 leading:1 occupy:1 which:1 entered:1 has:1 over:1 acquire:2 definitive:1 million:2 agreement:1 key:1 brands:1 areas:1 --:1 many:1 30:1 disease:1 positions:1
stock_BMY r_up	respond:1 less:1 political:1 agent:1 openness:1 seem:1 contributions:1 its:1 use:1 said:1 no:1 anticlotting:1 version:1 seeks:1 business:1 normal:1 funds:1 than:1 those:1 improve:1 longer:1 drug:1 gene:2 corporate:1 maker:1
stock_BMY r_down	violating:1 's:1 1.1:1 office:1 antitrust:1 pay:1 agreed:1 million:1 allegations:1 agreement:1 drug:2 according:1 2003:3 settle:1 release:1 news:1 has:1 involving:1 $:3
stock_BMY r_down	bankruptcies:1 since:1 financial:1 defensive:1 less:1 money:3 combining:1 bring:1 dig:1 economic:1 economy:1 year:2 foreclosures:1 portfolio:1 face:1 its:1 out:1 debt:1 end:1 position:1 ways:1 make:2 there:2 administration:1 ideas:2 investment:2 printing:1 rates:1 low:1 interest:1 you:2 save:1 markets:1 more:1 cutbacks:1 do:1 we:1 10:1 stimulate:1 next:1 reason:1 train:1 worst:1 they:1 coming:1 losing:1 funding:1 believe:1 projects:1 your:1 ago:1 faith:1 keeping:1 12:1 incoming:1 contracting:1 --:4 light:1 losses:1 companies:1 job:1 times:1 try:1 tunnel:1 part:1 can:2 truth:1 strategies:1 2009:4 spend:1
stock_BMY r_down	tough:1 joining:1 may:1 commercial:1 soon:1 times:1 flights:1 anger:1 's:1 mean:1 more:1
stock_BMY r_up	heart:2 30:1 help:1 proposed:1 advisory:1 anti-clotting:1 blood-thinning:2 soon:1 cardiac:1 likely:1 another:1 yet:1 considering:2 information:1 said:1 would:1 application:1 federal:1 decision:1 agency:1 anticlotting:1 genetic:2 least:1 label:2 delay:1 wo:1 3:3 medicine:2 include:2 meeting:1 until:1 handing:1 used:1 's:2 means:1 may:2 showing:1 after:1 act:1 regulators:2 asked:1 recent:1 doctors:1 not:1 interfere:2 data:1 updating:2 panel:2 effective:1 developing:1 receive:1 could:2 factors:2 companies:1 drug:6 face:1 n't:1 --:2 patients:2 were:1 studies:1 review:1 prasugrel:2
stock_BMY r_down	crash:2 investors:1 over:1 thing:1 finally:1 '08:2 through:2 2008:1 wreckage:2 's:1 best:1
stock_BMY r_up	1.5:1 's:1 $:1 fuming:1 consultant:1 million:1 well:1 cash:1 drug:1 possible:1 takeout:1 contract:1 shares:1 growing:1 lawmakers:1 awarded:1 bode:1 maker:1 profits:1
stock_BMY r_down	sending:1 trying:1 fix:1 disease:1 long:1 smoke:1 suffered:1 has:1 problem:1 out:1
stock_BMY r_down	fourth-quarter:1 right:1 deal:2 eventually:1 companies:1 warns:2 focus:2 trade:1 bring:2 see:1 session:1 shares:2 recover:1 decline:1 giant:1 swings:1 develop:2 $:3 their:1 hepatitis:3 1:3 start:2 earnings:2 certain:1 expected:1 over:2 treatment:3 paying:1 collaborate:1 's:1 whose:1 season:2 after:1 met:1 active:1 than:2 billion:4 loss:3 milestones:1 aluminum:1 receive:1 could:3 posts:2 team:1 more:2 dollars:1
stock_BMY r_down	week:1 fourth-quarter:1 little:1 sidelines:1 's:1 investors:1 did:1 declines:1 over:1 under:1 800:2 pressure:1 earnings:1 erase:1 nearly:1 season:1 worries:1 kept:1 stocks:1 worth:1 small-caps:1
stock_BMY r_up	medicine:1 them:1 because:1 costly:1 effective:1 cancer:1 tested:1 --:1 tumors:1 get:1 research:1 n't:1 their:1 patients:1 those:1 have:1 not:1 organization:1 gene:1 urging:1 treatment:1
stock_BMY r_down	retail:1 financial:1 offer:1 downbeat:1 broad:1 after:1 sales:1 send:2 recession:1 pace:1 slide:1 shares:3 latest:1 stocks:2 market:1 lows:2
stock_BMY r_up	emerging:2 move:2 domestic:1 results:1 including:1 questions:1 its:7 than:1 has:3 pending:1 earnings:1 allergy:1 government:1 worst:1 report:1 world:1 drugmaker:2 countries:3 --:3 busiest:1 50:1 quarter-century:1 quarter:1 deal:2 rate:1 arm:1 gross:1 said:2 outside:2 between:1 new:1 business:2 million:1 drug:1 range:1 products:1 first:1 comment:1 fourth-quarter:2 raised:1 cancer:1 lending:1 number:1 down:1 lung:1 pharmaceutical:1 management:1 least:1 their:1 much:1 treat:1 interest:1 expected:1 markets:2 500:1 more:1 posting:1 drugs:2 season:1 company:1 acquire:1 benchmark:1 part:2 analyst:1 paying:1 wide:1 made:1 type:1 programs:1 cash:1 signed:2 near:1 reviewing:1 epilepsy:1 5.4:1 zero:1 application:1 potential:1 details:1 which:1 meeting:1 several:1 week:1 product:2 differences:1 's:10 after:1 treatments:1 grow:2 purchase:2 third:1 older:2 components:1 spend:1
stock_BMY r_down	comment:1 says:1 less:4 certain:4 site:2 focusing:3 second:1 fifth:1 information:2 said:3 review:5 marketed:3 anticlotting:1 looking:1 safety:3 fourth:1 communication:2 announced:2 stock:2 updated:2 's:2 anti-clotting:3 company:1 early:2 involving:2 background:1 prices:2 posted:2 conducting:3 natural:1 effective:4 whether:4 industry:1 drug:7 --:3 patients:4 mature:1 conclusion:1 starting:1
stock_BMY r_up	sector:1 caused:2 results:1 trade:1 glum:1 thanks:1 year-earlier:4 its:1 whose:1 antipsychotic:2 rose:2 nearly:2 4:2 rebound:1 psychiatric:2 focus:4 updates:1 not:1 advanced:1 loss:4 like:1 companies:1 bad:1 session:1 quarter:5 financial:1 bounce:1 see:1 growth:2 financials:1 profit:5 anticlotting:4 shares:1 new:1 15th:1 seventh:1 reported:2 host:2 industrials:2 active:1 beginning:2 climbed:1 against:1 maker:3 fourth-quarter:2 revenue:2 down:2 likes:1 market:1 swings:2 one-time:1 strategy:1 expected:1 more:1 reversed:2 but:1 0.7:1 beaten-down:1 helped:3 solid:2 up:1 while:2 growing:1 acquisition:1 pessimistic:1 proved:1 ran:1 sales:5 agent:4 weighed:2 drug:6 swung:3 worry:1 comments:1 stake:1 details:1 fourth:4 performance:1 stock:2 product:1 finish:1 's:2 price:1 forecasts:1 charges:4 futures:1 sale:1 green:1 corporate:1 profits:1 gain:1
stock_BMY r_down	comment:1 week:1 raise:1 saying:1 being:1 companies:1 site:1 8217:2 month:2 reports:1 600:1 fifth:1 out:1 $:5 much:1 two:4 long:2 research:1 advisories:2 other:2 earnings:1 which:1 formula:2 weeks:2 scheduled:2 million:1 parent:1 after:2 baby:2 2:4 quarters:1 shaping:2 winter:2 roundup:1 publisher:1 launch:2 hiatus:2 up:2 aims:1 deals:2 s:2 future:1 promising:2 latest:1 corporate:1 maker:2 surprises:2
stock_BMY r_down	destocking:1 weaker:1 fourth-quarter:1 sales:2 offerings:1 month:1 weighed:1 full-year:1 year:1 swung:1 its:2 market:1 out:1 pharmaceutical:1 missed:1 initial:1 28:3 flat:1 charge:1 fourth:1 lower-than-expected:1 net:1 euro:1 public:1 franc:1 earlier:1 's:2 unveiling:1 may:1 company:1 rise:1 forecasts:1 $:3 billion:1 loss:1 booked:1 breaks:1 --:1 slumber:1 clients:1 roughly:1 against:1 while:1 '08:2 were:1 quarter:1 maker:1 acquisition:1
stock_BMY r_down	unemployment:1 over:1 month:1 stability:1 spinoff:1 still:1 $:1 do:1 good:1 around:1 far:1 auto:1 rise:1 they:1 grim:1 --:1 fewer:1 large:1 slide:1 retailers:1 team:1 small:1 found:1 fixed:1 deal:1 declines:1 streets:1 some:1 rate:1 economic:1 trading:1 picked:1 year:1 makers:1 appear:2 bracing:1 firms:1 public:1 million:1 pursuit:1 offset:1 last:1 losses:1 credit:2 s:2 products:1 maker:1 major:1 ca:1 manage:1 8217:2 one:2 another:1 fees:1 kings:1 little:1 raise:1 initial:1 system:1 been:1 expected:1 themselves:1 markets:1 offering:1 pie:1 indicators:1 hold:1 than:1 up:3 n't:1 baby-formula:1 600:1 sales:1 single:1 have:3 finance:1 mountain:1 thing:1 equities:1 investment:1 highlighted:1 without:1 answer:1 week:1 's:2 may:1 hired:1 eight:1 such:1 building:1 bankers:2 client:1 so:1 volumes:1 banks:1
stock_BMY r_up	set:1 sales:1 valuable:2 market:1 competitor:1 $:1 would:1 decision:2 marketed:1 anticlotting:2 should:1 may:1 potentially:2 multibillion-dollar:1 recommend:1 expected:1 new:3 sway:1 pill:3 more:1 selling:1 's:3 7:1 government:2 drugs:2 after:1 but:2 approaches:2 world:1 than:1 panel:3 billion:1 whether:1 dangerous:2 signal:2 drug:1 --:1 which:1 2007:1 approve:1 called:1 prasugrel:1
stock_BMY r_up	exception:1 tough:1 get:1 company:1 chance:1 second:1 run:1 have:1 found:1 's:1 public:1
stock_BMY r_down	emerging:1 proposed:1 being:1 developed:1 major:1 follow:1 huge:1 unanimously:1 lead:1 sit:1 agency:1 anticlotting:1 recommended:1 which:2 pursuing:1 sidelines:1 might:2 picture:1 's:2 clearer:1 panel:1 acquisitions:1 companies:1 drug:2 approve:1 prasugrel:1
stock_BMY r_up	fourth-quarter:1 set:1 its:1 market:1 overshadow:1 three:1 event:1 earnings:1 test:1 week:2 his:1 's:3 company:1 unveil:1 expected:1 preparing:1 world:1 drugmaker:1 launch:1 --:1 companies:1 deals:1 future:1 faces:1 2009:1 vision:1 first:1
stock_BMY r_down	tap:1 ending:2 offerings:1 market:1 again:1 $:1 initial:1 long:1 public:1 drink:1 stock:1 week:1 million:1 's:2 spell:3 than:2 dry:3 four:1 debut:3 well:1 maker:3 deals:1 680:1 once:1
stock_BMY r_up	saying:1 deck:1 being:8 money:1 over:3 lack:3 quarters:1 four:1 session:1 through:1 shares:4 its:7 previous:1 24:9 25:1 $:14 surprises:2 had:1 advisories:2 lows:1 listing:1 fuel:1 8:9 weeks:8 indicating:1 gave:4 evening:1 hit:4 rose:3 government:1 spell:1 little:1 continued:3 name:1 --:2 trillion:1 debut:5 companies:1 herald:1 banking:3 security:1 week:1 billion:1 deal:1 crop:1 surrounding:3 college:4 faces:1 year:1 estimated:1 spin-off:1 out:8 deals:1 said:2 business:1 driving:1 since:4 diesel:1 comments:1 formula:4 public:8 specialist:1 welcome:4 parent:7 opening:3 million:6 unease:3 others:1 article:1 100:2 21:1 dry:1 organic:1 else:1 32:1 could:1 30:3 reports:1 range:1 buzz:1 maker:8 first:10 among:1 industrial:2 tone:1 raise:1 slipped:1 point:1 lending:1 private:1 system:3 offerings:1 least:1 another:1 support:1 market:11 use:1 details:3 create:1 initial:8 two:1 long:1 jump-start:4 much:1 expected:2 500:3 roundup:1 generating:1 plunge:4 offering:8 offer:1 company:6 but:2 priced:1 fund:2 bounce:1 10:4 keeping:1 12:8 largest:1 up:7 n't:1 future:1 were:5 following:2 trading:2 closing:1 steep:1 skittish:1 published:1 tap:1 flat:5 certain:1 share:2 fertilizers:1 dropped:1 seen:2 sells:1 gains:1 sell:3 again:1 mostly:1 4.3:1 2.75:1 1:1 potential:1 earnings:1 which:9 online:4 test:1 stock:8 gaining:1 begin:2 's:11 plans:1 price:2 drink:1 most:1 plan:3 stocks:1 data:1 renewable:1 ago:4 off:1 consumer:1 futures:11 well:1 shore:3 points:4 banks:1 latest:1 corporate:1 680:2 once:1
stock_BMY r_down	spun:1 all:1 since:4 rallies:2 being:1 global:1 infant:1 one:1 offerings:1 set:1 college:1 higher:1 have:1 changed:1 's:1 cold:1 its:2 market:2 out:1 million:1 thaw:2 parent:1 sentiment:1 been:2 initial:3 anticlotting:1 shares:1 good:1 signals:2 jump-start:1 much:1 don’t:1 which:1 online:1 wasteland:2 formula:2 weeks:1 public:3 stock:2 gaining:1 his:1 hit:1 offering:2 company:1 welcome:4 long:1 medicine:1 reason:1 part:1 fan:1 announce:1 hopes:1 article:1 you:1 those:1 $:1 ago:1 10:3 13:1 12:1 off:1 driving:1 rights:1 --:1 rival:1 debut:2 drug:1 agree:1 winter:1 hardest:1 720:1 published:1 gave:1 maker:3 experimental:1 first:3
stock_BMY r_down	summer:1 initial:1 managed:1 planning:1 's:2 its:1 since:1 been:1 only:1 formula:1 has:1 markets:2 public:2 stock:1 week:1 hit:1 offering:1 baby:1 day:1 last:1 up:1 maker:1
stock_BMY r_down	summer:1 initial:1 planning:1 's:2 its:1 since:1 been:1 only:1 formula:3 has:1 markets:2 public:2 stock:1 week:1 hit:1 offering:1 baby:1 day:1 last:2 success:2 up:1 maker:1
stock_BMY r_down	19:1 settlements:2 number:1 related:1 high:1 bring:1 rate:1 doubled:1 aggressive:1 makers:1 market:2 encouraged:1 litigation:1 these:1 copycat:1 has:1 patent:1 there:1 debate:1 increase:1 their:4 potentially:1 spiked:1 enjoying:1 more:1 them:1 good:1 get:1 but:1 lucrative:1 whether:1 coming:1 despite:1 2008:1 challenges:2 branded:1 success:2 versions:1 --:1 involved:1 companies:3 drug:2 generic:3 benefit:1 continue:1 products:1 push:1 efforts:2
stock_BMY r_down	s:2 8217:2
stock_BMY r_up	'':2 amp:2 ``:2
stock_BMY r_down	gauges:1 point:1 some:1 sales:1 one:1 year:3 watched:1 fear:1 its:2 even:1 index:1 documents:1 swaps:1 show:1 had:1 widely:1 volatility:1 cause:1 tell:1 outperforming:3 head:1 though:1 far:3 rise:1 psychiatric:1 link:1 doctors:1 such:2 credit-default:1 diabetes:1 physician:1 did:1 drug:1 n't:1 individuals:1 so:3 rears:1 investments:2
stock_BMY r_down	s:2 8217:2
stock_BMY r_down	broader:1 executive:1 focus:2 8217:2 trade:1 see:1 session:1 committee:1 follow:1 market:1 whose:1 said:1 negative:1 shares:1 delay:2 also:1 state:1 lured:1 tumbles:2 expected:1 new:1 economy:1 's:2 retrench:2 company:1 serve:1 part:1 operating:1 active:1 president:1 stocks:3 reaction:1 companies:1 drug:3 s:2 chief:1 testimony:1 south:1
stock_BMY r_up	move:1 broader:3 ground:1 giant:2 group:1 $:1 board:2 under:1 details:1 executive:3 his:1 risk:1 trouble:1 him:1 --:1 companies:1 development:2 committee:3 acid:1 said:1 anticlotting:1 3:2 unit:1 newly:2 shows:1 body:1 terms:1 million:1 agreement:1 following:1 along:2 atrial:1 study:1 drug:4 changes:2 block:1 named:1 market:3 pharmaceutical:1 two:2 strategy:1 fibrillation:1 type:1 duties:1 more:2 ``:2 stomach:1 sessions:1 company:3 formed:2 serve:1 part:2 '':2 join:2 up:1 patients:1 future:1 promoted:1 taking:1 heart:1 agent:1 disappointing:1 have:1 rally:2 increased:1 pay:1 also:1 chairman:1 several:1 gains:1 higher:1 week:1 used:1 's:1 collaboration:1 earlier:1 chart:1 falls:2 president:2 stocks:3 flutter:1 amid:1 allow:1 time:1 senior:1 spend:1
stock_BMY r_down	retracts:1 sales:1 warns:1 expects:3 quarters:1 '':3 rate:1 good:2 trading:2 elevated:1 broader:2 year:1 next:1 investment:1 declined:1 bankruptcy:2 pharmaceutical:1 fails:1 said:4 $:1 million:3 few:1 profit:3 rose:1 08:2 09:2 detail:1 comments:1 grow:1 failed:1 market:2 new:3 net:2 2007:1 low:1 ``:3 after:2 company:4 measures:2 possible:2 but:2 results:2 driven:1 reported:1 rise:2 fell:1 announce:2 background:1 fall:3 rollout:1 28.2:1 stocks:4 revealed:1 analyst:1 drugmaker:1 lower-than-expected:2 last:1 products:1 launch:1 stimulus:2 warned:1 double-digit:1 drug:1 --:2 range:1 continue:2 '08:2 afternoon:2 amid:1 through:1 2008:2 2009:5 33:3
stock_BMY r_up	unemployment:1 sigh:2 0.3:1 0.5:1 0.4:1 report:2 rate:1 numbers:2 broader:1 reached:1 saw:1 market:1 8.1:1 now:1 rose:1 better:2 also:1 expected:2 higher:2 edged:2 gains:1 payroll:2 but:1 early:3 said:1 wake:2 nearly:1 jobs:1 payrolls:2 stocks:4 than:2 advanced:1 off:1 lost:1 relief:2 were:2 action:2 climb:2
stock_BMY r_up	shed:1 almost:1 health-care:1 trading:1 market:1 pharmaceutical:1 $:2 reform:1 ways:1 3:1 potential:1 boost:1 midday:1 stock:2 expiring:1 's:2 efficiency:1 megamergers:1 despite:1 look:1 pressure:1 amid:1 industry:1 companies:1 up:2 drug:1 piling:1 costs:1 patents:1
stock_BMY r_up	private-sector:1 smaller:1 have:1 investors:1 turned:1 site:1 two:2 past:1 cost:1 embrace:1 drug:1 broader:3 during:1 treat:1 rally:3 next:1 its:1 market:3 1:1 debt:2 proposed:1 profit:1 mounting:1 review:1 outpacing:1 stocks:3 makers:1 fates:1 bailout:1 landscape:1 has:2 meeting:1 more:1 recipient:1 notice:1 buy:2 raising:1 risk:1 government:4 drugs:1 funds:1 questions:1 surges:2 consolidation:1 rise:1 protection:3 key:1 news:1 injection:1 now:1 surged:1 discuss:1 buying:1 panel:1 2:2 begun:1 posted:1 's:4 default:3 industry:1 months:2 companies:1 drive:1 against:3 $:2 --:1 costs:1 month:1 diabetes:1 47:2 tablets:1 2009:1 first:1
stock_BMY r_up	yearly:1 seven:1 drop:1 number:1 years:1 recording:1 2:1 lobbyists:1 active:1 2008:1 its:1 declined:1 first:1
stock_BMY r_up	troubled:1 's:2 prompted:1 veteran:1 long-awaited:1 near:1 hiring:1 finally:1 separation:1 run:1 speculation:1 has:1 unit:1
stock_BMY r_down	streak:1 biotech:1 1.2:1 into:1 move:1 0.7:1 year:1 edged:1 end:1 positive:1 while:1 comments:1 winning:1 their:1 territory:1 0.3:1 gaining:1 's:2 early:1 extending:1 modest:1 four-session:1 wake:1 stocks:1 advanced:1 made:1 last:1 broad-based:1 could:1 later:1 up:1 recession:1 chief:1 week:1 rose:1 action:1
stock_BMY r_down	index:1 broader:1 lead:2 reacts:1 had:1 0.4:1 shares:1 economic:1 market:1 sharply:1 fall:1 indicators:1 news:1 drugmakers:2 fallen:1 south:2
stock_BMY r_down	saying:1 benefits:1 bleeding:1 anticlotting:1 possible:1 drug:1 risks:1 backed:1 its:1 panel:1
stock_BMY r_up	join:2 help:1 government:1 have:1 reacts:1 debts:1 system:1 financial:1 stifled:1 plan:1 broader:3 toxic:1 rally:3 rid:1 stocks:3 's:1 lending:1 market:3
stock_BMY r_down	program:1 financial:1 help:1 soars:2 almost:1 ease:2 after:1 system:1 government:1 takeover:2 rid:1 market:1 broader:1 new:1 hopes:1 rally:1 speculation:2 stocks:3 day:1 retreat:1 assets:1
stock_BMY r_up	standout:1 significantly:1 lead:2 came:1 reacts:1 than:1 durable-goods:1 positively:1 broader:1 news:1 expected:1 gainers:3 orders:1 market:1 higher:1
stock_BMY r_up	few:1 heart:2 certain:2 agreed:1 probe:1 sign:1 sales:1 industry:1 past:1 medical:1 cost:2 drug:1 have:1 year:1 high-profile:1 recently:1 2.1:1 negotiations:1 relatively:1 compared:1 $:1 their:2 generic:1 pay:1 discussion:2 been:1 research:1 delay:1 brighter:2 version:1 cardiologists:2 between:1 clinical:1 meeting:3 into:1 more:1 move:1 's:2 needle:1 drugs:1 company:1 million:1 treatments:2 much:1 meetings:1 coming:2 article:1 one:1 beginning:2 shine:2 launch:1 whether:2 light:1 could:1 annual:1 disease:2 devices:1 worth:2 large:2 successes:1 settle:1 published:1 far:1 studies:1 spotlight:2
stock_BMY r_down	heart:1 set:1 proposed:1 trend:2 executive:1 sag:1 sales:1 billions:2 jump:1 see:1 shares:1 have:1 summit:1 recently:1 if:1 while:1 said:1 asthma:1 jobless:1 would:1 federal:1 anniversary:1 stocks:1 next:1 better:1 their:1 other:1 treat:1 which:1 under:1 expected:1 new:2 he:1 conditions:1 events:1 higher:1 rise:1 's:2 downward:2 attend:1 government:2 drugs:1 addition:1 arthritis:1 treatments:1 costs:1 heads:1 upgrade:1 cutting:1 they:1 progress:1 report:1 8.5:1 debt:1 loans:1 than:1 diabetes:2 20:1 received:1 breaks:2 developing:1 --:2 dollars:2 register:1 proposals:1 up:1 drug:1 standards:1 whether:1 chief:1 're:1 meet:1 overseas:1 rate:1 out:1 options:1 unsure:1
stock_BMY r_up	sector:1 clamp:1 all:1 risk:1 they:1 proposed:2 trend:3 developed:1 move:1 major:1 hearing:1 down:1 ask:1 rate:1 set:1 experts:1 aimed:1 have:1 vote:1 unsure:1 saw:1 event:1 panel:1 cardiovascular:2 conference:1 provided:1 respective:1 said:3 recently:1 devices:1 spending:1 data:1 administration:1 enough:1 shares:1 research:1 their:1 outside:1 clinical:2 low:1 executive:1 new:2 developers:1 higher:2 gaining:1 ``:1 health-care:1 's:2 plans:1 cardiology:1 drugs:1 published:1 treatments:1 break:2 whether:2 key:1 excess:1 regulatory:1 article:1 chief:1 cost-effectiveness:1 being:1 diabetes:4 relative:1 ahead:1 developing:1 --:3 determining:1 anticipate:1 companies:1 drug:3 standards:1 he:1 more:1 competitors:1 products:1 rule:1 amid:1 push:1 meet:1 downward:2 drugmakers:2 studies:1 medical:2 out:1
stock_BMY r_up	sector:2 shot:1 being:1 developed:1 results:1 stability:1 shares:3 its:3 cardiovascular:1 whose:1 $:1 candidate:2 much:1 sugar:1 versus:2 modestly:2 increased:1 eroded:1 long-acting:1 auto:1 early:1 advanced:1 loss:1 like:1 --:3 companies:1 found:3 reduced:2 financial:1 weight:1 people:2 bleeding:1 related:2 economic:1 trading:2 's:3 3rd:1 comments:1 version:1 new:3 turmoil:1 scientific:1 alone:2 ahead:1 attacks:1 study:5 climbed:1 drug:7 16th:1 trial:1 fell:1 leading:1 heartbeat:2 comment:1 major:1 60:1 diabetics:1 market:1 positive:2 anti-clotting:2 two:1 traction:1 2:1 rates:1 combined:1 type:1 more:2 drugs:1 released:1 controlling:1 gain:1 doctors:1 hopes:1 than:1 shoot:1 12:1 word:1 irregular:2 showed:1 meeting:1 up:4 were:2 industry:1 0.9:1 heart:1 annual:1 moved:1 0.7:1 have:1 partner:1 risk:3 also:1 interested:1 low:1 events:1 gains:1 product:1 edged:1 strokes:2 price:1 levels:1 blood:1 stocks:2 diabetes:4 acquisitions:1 lead:2 effective:1 6th:1 disease:2 points:1
stock_BMY r_up	sector:1 gaining:2 says:1 people:1 trend:2 manage:1 related:1 trade:1 active:1 session:1 trading:1 best:1 risk:1 whose:1 anticlotting:1 shares:1 class:1 score:1 combined:1 biggest:2 new:1 has:1 red:1 versus:1 modestly:1 's:4 gains:1 strokes:1 early:1 found:1 alone:1 languishes:1 stocks:2 seeing:1 potential:1 declining:2 buck:2 irregular:1 bulk:1 rival:1 study:1 companies:1 disease:1 drug:2 afternoon:1 heartbeat:1 downward:2 reduced:1
stock_BMY r_down	saying:2 raised:1 since:1 investors:1 heart:2 being:1 developed:1 share:2 site:1 8217:2 highly:1 states:1 second:1 broader:1 7.5:1 spinoff:2 close:1 estimated:2 its:4 market:3 n't:2 strong:1 end:1 $:5 decision:1 appear:2 top:2 initial:1 range:2 shares:3 member:1 company:1 going:1 sixth:1 diabetes:2 meeting:1 public:2 stock:2 development:1 gaming:2 product:2 offering:1 information:1 strokes:2 big:1 price:1 million:3 risks:2 drew:2 anticipated:1 120:2 additional:1 scores:1 backed:2 along:1 stocks:3 rebounds:2 panel:3 advance:3 16:2 attacks:2 wins:1 proposed:1 debut:4 drug:2 surge:2 priced:1 --:1 s:2 does:2 depositary:1 popular:1 increase:2 starting:1 support:1 first:1
stock_BMY r_up	thinner:1 false:1 deal:7 ground:1 says:1 into:1 executive:2 blood-thinning:1 related:1 '':1 not:1 selling:1 have:1 reached:1 statements:1 apparent:1 federal:2 its:1 market:1 gains:2 sell:4 settlement:1 competitor:1 sentiment:1 antidepressant:1 patent:1 cut:1 while:1 shares:1 access:1 clouding:1 charge:1 critical:1 role:2 collapse:1 under:1 2015:5 struck:1 has:3 until:4 stock:1 firm:2 rally:1 ``:1 his:1 's:1 said:1 government:2 drugs:1 turned:1 after:1 psychiatric:1 most:1 involving:1 blood:1 prices:1 news:1 competitive:1 stocks:3 former:1 undermine:1 lower:1 off:1 like:1 --:1 futures:1 guilty:2 according:1 drug:5 keep:1 generic:1 slide:3 continue:1 allow:2 popular:3 making:1 view:2 downgrade:1 maker:2 four-week:1 gain:1
stock_BMY r_down	help:1 investors:1 churning:1 disease:1 year:1 still:1 makers:1 out:1 considering:1 large:1 cut:1 $:1 trials:1 two:1 research:1 their:1 outside:2 clinical:1 which:1 under:1 new:1 announced:1 exploring:1 million:1 's:1 drugs:1 company:1 325:1 kind:1 treatments:1 pressure:1 financing:1 last:1 fund:1 receive:1 companies:1 up:1 drug:1 deals:1 while:1 costs:1 efforts:1 similar:1 experimental:1
stock_BMY r_down	acquisitions:1 do:1 seven:1 additional:1 independent:1 six:1 8217:2 stay:1 looking:1 re:2 drug:1 maker:1 seeks:1 partnerships:1
stock_BMY r_up	via:1 midsize:1 office:1 up:1 prices:1 say:1 economic:1 expect:1 flush:1 's:2 hospitals:1 pharmaceutical:1 doctor:1 there:1 pharmacy:1 going:1 health:2 between:1 you:2 paying:1 uptick:1 shopping:1 get:1 big:1 slump:1 but:1 pressure:1 they:1 despite:1 not:1 world:1 injection:1 difference:1 raising:1 care:2 acquisitions:1 prescription:2 companies:3 cash:1 drug:3 costs:1 're:1 pick:1 small:1 rein:1 executives:1
stock_BMY r_up	cancer:1 scrapes:1 sales:3 mutual-fund:1 manager:1 growth:1 lung:1 its:2 out:2 title:2 top:1 due:1 rolls:1 earnings:3 buys:2 expected:3 treatment:1 someone:1 first-quarter:1 early:1 part:1 report:3 frequently:1 post:1 strong:1 earn:2 bottom:1 antidepressant:1 barrel:1 higher:3 comes:1
stock_BMY r_down	says:1 prompted:1 revenue:2 over:1 dollar:1 sales:2 competition:1 maintain:1 margins:1 its:2 impact:1 gross:1 23:1 profit:2 rose:1 forecast:3 concerns:1 income:1 net:3 higher:1 rise:2 first-quarter:1 increased:1 maintains:2 but:3 drugmaker:1 stronger:1 foreign:1 generic:1 future:1 2009:1
stock_BMY r_up	because:1 proposed:1 period:1 years:1 drug:1 market:1 pharmaceutical:1 said:2 review:1 research:1 has:1 economy:1 firm:1 extended:1 's:2 than:1 diabetes:1 influential:1 could:1 companies:1 50:1 contract:1 deterioration:1 time:1 more:1 first:1
stock_BMY r_up	impact:1 both:1 first-quarter:1 currency:1 --:1 results:2 reports:1 due:1 expected:1 produce:1 mixed:1 report:2 part:1 foreign:1 earnings:1
stock_BMY r_down	inspire:1 revenue:1 stronger:1 dollar:1 sales:2 trade:1 active:1 see:1 growth:1 reports:4 need:1 's:1 margins:1 its:1 market:1 gross:1 raise:1 companies:1 profit:2 moderately:2 expectations:2 shares:2 makers:1 beat:1 stemming:1 earnings:2 capital:1 quarterly:1 outbreak:1 posted:1 issue:1 higher:3 modestly:1 selling:1 first-quarter:1 increased:1 whose:1 may:1 after:1 but:2 focus:4 slides:2 expected:1 part:1 shortfall:1 stifled:1 fall:2 report:1 stocks:1 drugmaker:1 both:1 short:1 improved:1 level:1 futures:1 flu:1 drug:2 more:1 session:1 swine:1 threat:1 rallies:2 following:1 stock:1 helps:1 dropped:1
stock_BMY r_down	roundup:1 saying:1 surprises:2 companies:1 reports:1 quarters:1 advisories:2 earnings:1 future:1 corporate:1 latest:1
stock_BMY r_up	over:1 back:1 one:1 say:1 through:1 market:1 investing:1 won’t:1 two:1 been:1 has:1 stock:2 cycle:1 bear:1 legendary:1 stocks:1 buying:2 he:1 well:1 88:3 cautiously:2 50:1
stock_BMY r_up	heart:1 says:1 risk:1 study:1 medicine:1 anticlotting:1 attack:1 pills:1 popular:1 increases:1 mixing:1 new:1 heartburn:1 |:1
stock_BMY r_down	stock:2 heart:2 medication:1 says:2 more:1 sign:1 back:3 trade:1 aiding:1 hopes:2 financial:2 economy:2 dropped:2 table:2 blockbuster:1 its:2 out:3 traders:2 shown:2 banks:2 rivals:1 generic:1 mounting:1 shares:2 crisis:2 better:3 pressures:1 run:2 earnings:1 survive:2 weeks:1 branded:1 pill:1 shows:1 after:4 's:2 gains:3 futures:2 advance:2 big:2 company:1 rise:1 took:2 focus:2 following:3 run-up:2 eight:1 gain:1 competing:1 report:1 news:1 worked:1 stocks:5 than:4 recent:2 pull:3 prospects:1 drop:2 off:2 effective:1 largely:2 study:2 latest:1 drug:4 morning:1 recession:2 trial:2 nine:1 mixed:3 climb:2 better-than-expected:1 profits:2 late-stage:1
stock_BMY r_down	biotech:3 trade:1 trading:1 ground:3 merger:1 shares:2 note:2 several:1 company:1 afternoon:1 's:1 gains:2 mostly:1 jumps:2 after:1 slides:2 jumping:1 gain:1 fall:1 stocks:2 while:1 analysts:3 praise:1 mixed:1 plunges:2
stock_BMY r_up	's:2 relationship:1 marketing:1 drug:1 bipolar:1 part:1 patient:1 have:1 become:1 has:1 important:1
stock_BMY r_down	biotech:1 emerging:1 get:1 handful:1 companies:1 encouraging:1 reports:1 treatments:1 tests:1 boost:1
stock_BMY r_up	's:2 prescriptions:1 agencies:1 slowing:1 scrutiny:1 state:1 growth:1 usage:1 intensify:1 children:1
stock_BMY r_up	both:1 them:1 help:1 generic-drug:1 portfolios:1 deals:1 their:1 announced:1 expand:1
stock_BMY r_down	billion:3 it’s:1 says:1 $:3 rights:3 planning:1 after:3 slides:2 yogurt:1 much:1 7:1 fall:1 world’s:1 largest:1 issue:3 maker:1
stock_BMY r_down	billion:1 again:2 unexpected:1 shopping:2 $:1 rights:3 4.2:1 behind:1 lurking:1 go:2 issue:3
stock_BMY r_up	biotech:1 run:1 license:1 cancer:1 drugs:1 positive:1 million:1 two:1 part:1 developments:1 140:1 experimental:1 $:1
stock_BMY r_up	sell:1 biotech:2 buyers:1 full:1 's:1 minority:1 reportedly:3 n't:1 could:1 stake:3 companies:1 deal:1 firm:1 action:1 flurry:1 takeover:1 been:2 have:1 talks:3 world:1 finding:1
stock_BMY r_up	over:1 soar:1 company:1 shares:1 drug:2 gain:1 taken:1 stoke:2 speculation:1 stocks:3 could:1 ground:1
stock_BMY r_up	gaining:2 moves:1 's:5 notable:1 include:1 market:1 biggest:2 making:1 stocks:2 declining:2 stock:1
stock_BMY r_down	seven:1 just:1 revenue:1 over:1 offset:1 emerging:1 dose:1 growth:1 pricing:1 home:1 research:2 its:1 market:1 pharmaceutical:1 said:1 group:1 doctor:1 review:1 anti-clotting:1 should:1 makers:1 pressures:1 new:1 markets:1 firm:1 's:1 stop:1 account:1 early:1 half:1 loss:1 lower:1 look:1 --:1 involved:1 study:1 companies:1 according:1 drug:2 patents:1 published:1 2009:3 studies:1 order:1 prasugrel:1
stock_BMY r_down	reactor:1 proposed:1 ninth:1 month:1 shake:1 children:4 staff:1 death:1 disorders:2 scheduled:1 worse:1 fate:1 get:1 auto:1 they:1 judge:1 treating:2 --:3 suppliers:1 large:1 indication:1 disorder:4 scanning:1 schizophrenia:3 close:1 makers:1 said:2 lead:1 nuclear:1 review:1 crucial:1 bipolar:4 risks:2 conference:1 restructuring:1 supplying:1 care:1 last:1 attacks:1 could:2 annual:1 analysts:1 adolescents:3 maker:1 shutdown:1 carry:2 market:1 bankruptcy:1 considering:1 additional:1 three:2 next:1 treat:4 way:1 ``:1 drugs:2 but:2 change:1 released:1 part:1 doctors:1 10:1 17:1 patients:2 can:1 were:2 situation:1 heart:1 adults:2 almost:1 delaying:1 ages:1 '':1 say:1 kidney:1 information:1 court:1 agency:1 week:1 product:1 's:5 again:1 applications:1 significant:2 such:1 weekend:1 approved:2 diabetes:1 dealers:1 effective:2 medical:1 disease:2 face:1 800:1 once:1
stock_BMY r_down	decidedly:1 heart:2 blood-thinner:1 because:1 ordered:1 convinced:1 sentence:1 being:1 into:2 testing:2 blood-thinning:1 idea:1 competition:1 topic:1 stroke:1 unlikely:1 proved:1 blockbuster:2 your:1 worry:1 increased:1 even:1 delay:1 said:2 but:1 has:1 patent:1 effort:1 away:1 write:1 attack:1 potential:2 way:2 plavix:1 2014:2 you:2 he:1 company:1 over:1 dispute:1 sell:1 disappointment:1 's:8 risk:2 pharmaceutical:1 successful:1 big:1 atop:1 problems:1 possible:2 lists:1 drugmaker:1 part:1 moving:2 paving:2 new:2 put:1 guys:1 class:1 diabetes:2 case:1 high:1 criminal:1 launch:2 --:1 many:1 medicines:1 companies:1 suffering:1 drug:5 n't:1 generic:1 patients:2 2006:1 can:1 aims:1 connected:1 more:1 book:3 late-stage:2
stock_BMY r_up	use:1 's:1 disorder:1 bipolar:1 schizophrenia:1 treat:1 backed:1 adolescents:1 children:1 panel:1
stock_BMY r_down	disclosure:1 's:2 members:1 show:1 medical:1 reports:1 financial:1 have:1 ties:1 industry:1 latest:1
stock_BMY r_down	11:1 health-care:1 members:1 million:2 holdings:1 30:1 27:1 have:1 $:2
stock_BMY r_down	hunt:1 mega:1 deal:1 there:1 business:1 newspaper:1 recent:1 another:1 report:1 sparking:1 speculation:1 works:1 pharma:1
stock_BMY r_down	all:1 because:1 sensitive:1 cancer:3 less:1 being:1 into:1 health-care:1 system:1 down:1 bring:1 actively:1 trading:2 want:1 3.1:1 years:1 patient:1 2.6:1 deeper:1 2.35:1 whose:2 needs:1 now:1 matter:1 prostate:1 make:1 six:1 two:2 shares:2 research:1 better:2 does:1 3:1 2:1 treatment:2 closed:1 factor:1 falling:2 before:1 illness:1 sliding:2 500:2 said:1 ago:1 ``:1 after:1 's:2 mid-stage:1 pharmaceutical:1 brings:1 company:1 knew:1 free:1 understanding:2 admits:1 appreciation:1 job:1 fell:1 enduring:1 news:1 stocks:2 surged:1 analyst:2 declining:2 he:2 gained:1 sure:1 his:2 '':1 --:1 taking:1 months:1 companies:2 disease:1 thought:1 trial:1 patients:2 session:1 diagnosed:1 behavior:1 after-hours:1 44:1
stock_BMY r_up	pact:1 seniors:1 help:1 exposed:1 industry:1 most:1 need:1 shows:1
stock_BMY r_up	into:2 some:1 growth:1 questions:1 successes:1 drugs:1 cut:1 generic:1 contributed:1 profitability:1 research:1 also:1 big:1 his:1 's:1 track:1 brings:1 problems:1 but:1 includes:1 preparing:1 longer-term:1 strong:1 whether:1 drug:1 spending:1 record:1 tenure:1 push:1 maker:1
stock_BMY r_up	application:1 adults:1 add-on:1 some:1 growth:1 questions:1 longer-term:1 successes:1 pharmaceutical:1 said:1 their:1 positive:1 contributed:1 profitability:1 also:1 2:1 treatment:1 marketing:1 type:1 his:1 's:1 track:1 brings:1 company:1 published:1 problems:1 but:1 includes:1 therapy:1 whether:1 article:1 strong:1 diabetes:1 received:1 --:1 record:1 tenure:1 opinion:1
stock_BMY r_down	use:1 just:1 cancer:1 drugs:1 into:1 months:1 question:1 called:1 prolong:1 patients:1 lives:1 published:1 article:1 widespread:1 weeks:1 expensive:1
stock_BMY r_down	advisory:1 just:1 cancer:1 limited:1 developed:1 into:1 say:1 cost:1 expensive:1 if:1 use:1 $:1 question:1 should:2 prolong:1 comparing:1 board:1 new:1 widespread:1 more:1 drugs:2 released:1 part:1 lives:1 they:1 authors:1 report:1 article:1 20,000:1 than:1 weeks:1 benefits:2 --:1 science:1 medicines:1 months:1 funded:1 according:1 called:1 n't:1 influential:1 published:1 studies:1 study:1
stock_BMY r_down	million:2 said:1 group:1 $:1 business:1 --:1 global:1 cash:1 acquired:1 23.2:1 generics:1 healthcare:1 branded:1 consideration:1 has:1
stock_BMY r_up	proved:1 show:1 had:1 primary:1 '':1 trading:1 its:1 said:2 anticlotting:1 day:1 better:1 besting:1 virtually:1 premarket:1 performance:2 unprecedented:1 achieve:1 ``:1 earlier:1 's:1 which:1 company:1 after:1 but:1 desired:1 than:1 endpoint:1 effective:1 did:2 plunged:1 drug:1 n't:2 trial:2 studies:1 latest:1
stock_BMY r_down	trend:1 into:1 number:1 replace:1 world-wide:1 market:2 appear:1 warfarin:1 their:1 poised:1 increasing:1 public:1 stock:1 business:1 omen:1 rights:1 could:1 companies:1 drug:1 bad:1 race:1 divest:1 piece:1 experimental:1
stock_BMY r_down	comment:1 thinner:1 shot:1 bleeding:1 blood-thinning:1 warning:1 tablets:2 carry:1 blockbuster:1 its:3 unit:1 sell:1 said:2 sodium:1 generic:1 long-awaited:1 two:1 label:1 which:1 marks:1 fatal:1 cause:1 equivalent:1 can:1 's:2 becoming:1 blood:1 significant:1 doctors:1 approval:1 strong:1 approved:1 received:1 has:2 launch:1 --:2 sometimes:1 drug:4 spokeswoman:1 while:1 prescribing:1 victory:1 time:1 hypertension:1 first:1
stock_BMY r_down	reactions:1 they:1 cancer:1 series:1 including:1 result:1 little:1 area:1 studying:1 research:1 cell:1 role:1 certain:1 pathway:1 play:1 key:1 term:1 --:1 many:1 inside:1 companies:1 n't:1 cancers:1 talk:1 promising:1 believed:1 called:1 researchers:1
stock_BMY r_up	reactions:1 key:1 gold:1 series:1 certain:1 cost:1 including:1 result:1 its:2 current:1 little:1 said:2 cancer:1 area:1 studying:1 review:2 anti-clotting:1 research:1 priority:2 application:2 role:1 disclosed:1 acetaminophen:1 new:3 many:1 pathway:1 more:1 play:1 's:2 company:1 promising:1 designated:2 standard:1 they:1 article:1 accepted:2 than:1 term:1 has:1 --:1 18:3 inside:1 cell:1 companies:2 drug:5 n't:1 cancers:1 talk:1 published:1 believed:1 called:1 researchers:1
stock_BMY r_up	prevent:1 gold:1 heart:1 betting:1 cost:1 premium:1 touting:1 anti-clotting:1 analyst:1 current:1 clinical:1 disclosed:1 new:1 insurers:1 more:2 's:3 ability:1 price:2 standard:1 updates:1 they:1 than:2 reaction:1 attacks:1 18:3 companies:1 drug:1 large:1 trial:1 patients:1 can:1 stock:1 justify:1
stock_BMY r_down	wo:1 medicines:1 n't:1 these:1 benefit:1 gene:1
stock_BMY r_up	comment:1 outlook:1 revenue:1 sales:2 disappointing:1 known:1 including:1 throughout:1 its:2 market:1 said:1 profit:1 shares:1 treatment:1 company:2 sent:1 stock:1 core:1 updated:1 's:1 price:1 but:1 driven:1 background:1 franchise:1 strong:2 second-quarter:1 volume:1 lower:1 --:1 31:3 climbed:1 were:1 dominating:1
stock_BMY r_up	prices:1 outlook:1 smaller:2 deal:1 give:1 sales:4 anti-clotting:1 agreed:1 focus:2 competition:1 trade:1 helped:1 currency:1 see:1 session:1 including:1 dropped:2 reports:1 pain:1 2.1:1 higher:4 its:3 full-year:1 whose:1 giant:1 $:1 profit:4 top:2 revenue:1 had:1 negative:1 shares:1 forecast:3 access:1 potential:1 earnings:2 expected:1 details:1 buy:1 's:4 increased:2 meanwhile:1 drugs:3 treatments:1 hurt:1 posts:2 most:1 host:1 reported:1 active:1 second-half:1 second-quarter:3 cancer:2 billion:1 lower:1 launch:1 19:2 rival:2 companies:1 trends:1 drug:3 antidepressant:1 generic:1 while:1 stock:1 profits:1 raises:3
stock_BMY r_up	seasonal:1 saying:1 background:1 less:1 being:1 agreed:3 focus:2 quarters:1 7.2:1 ended:1 session:5 economy:1 higher:9 cuts:3 unfavorable:1 1.95:1 its:6 ground:1 24:1 whose:5 giant:3 $:17 also:1 surprises:2 unemployment:1 had:3 expectations:3 than:1 revenue:1 add:1 advisories:2 treatment:1 cash:4 total:1 has:1 details:1 customer:2 return:2 holding:1 auto:1 rise:3 results:2 cheaper:1 early:1 increases:1 tanks:2 half:2 not:1 world:1 trade:1 continued:4 like:1 growing:2 several:1 impressive:1 --:3 companies:8 morning:1 1.85:1 slipping:2 predicted:1 defaults:2 after-hours:1 release:1 stock:8 likes:1 week:4 because:1 above:1 deal:4 acquired:1 headwinds:1 blood-thinning:1 competition:1 up:2 actively:4 trading:4 changed:1 2.3:1 2.2:2 2.1:7 makers:3 2.5:2 2.4:4 said:3 potential:1 profit:3 announces:1 exceeding:2 shares:6 18:1 access:2 future:1 closed:1 falling:2 bought:1 available:1 zeitgeist:1 were:3 weak:1 broker:1 costs:1 hours:1 reported:5 economists:1 active:1 news:1 100:2 strong:1 declining:2 jobless:1 gained:3 projected:1 benefits:2 ahead:1 industry:3 climbed:4 host:1 drug:9 34:2 products:2 context:1 rose:14 share:3 traded:2 maker:2 comment:1 seeing:1 raised:3 fresh:1 cancer:3 point:2 amid:1 into:1 each:1 increased:1 29:4 rising:2 65:1 winning:2 post:1 late:2 little:1 8.2:1 additional:1 analyst:1 double:1 top:3 due:2 per-share:1 their:1 2:2 rates:1 biggest:3 upbeat:2 500:8 more:1 firm:1 roundup:1 buy:5 form:2 drugs:3 season:3 company:1 worker:1 timing:1 expected:2 finished:2 transaction:1 gain:2 prices:2 last:2 second-quarter:4 those:1 case:1 10:2 grew:1 improved:2 17:1 16:3 science:1 faced:1 signed:1 while:7 cost:3 promising:2 following:1 3.2:1 other:1 acquisition:1 streak:2 biotech:1 medication:1 investors:1 give:2 almost:1 6.2:1 sales:7 helped:4 full-year:1 reports:2 close:1 partner:1 activity:4 margins:1 returned:4 information:1 5.3:1 mostly:2 generic:1 pay:1 able:1 41:1 shifts:1 concerns:2 earnings:13 which:2 outlook:1 layoffs:1 target:1 gamble:1 soar:2 gaining:2 wave:1 added:1 's:13 treatments:1 price:2 after:2 update:2 plenty:1 2.05:1 improving:1 stoke:2 stocks:9 billion:6 purchase:2 lower:3 30,000:1 largely:2 makes:1 futures:14 roughly:1 antidepressant:1 points:13 savvy:1 claims:2 2009:3 corporate:1 filing:1 profits:1 latest:2
stock_BMY r_up	unexpected:1 reject:1 cancer:1 certain:1 energy:1 retailer:2 cash:1 unexpectedly:1 battle:1 shares:3 another:3 tumultuous:1 years:1 reached:1 its:4 after:3 litigation:1 recession:2 group:1 opened:1 prove:2 patent:1 rose:1 stemming:1 three:1 send:1 health:1 plummeting:1 online:2 agreements:1 care:1 boost:3 over:1 stock:1 week:2 rise:1 's:1 resolve:1 again:1 million:1 slump:2 disclosed:1 chemicals:1 fell:1 authorities:1 approval:1 stocks:3 efforts:1 buying:1 $:1 ago:1 has:1 rejection:2 sectors:1 --:2 drop:1 up:1 drug:3 deals:2 wallet:1 settle:1 tech:1 footwear:1 '06:2 providing:1
stock_BMY r_down	money:1 250,000:1 executive:1 likes:1 pipelines:1 blockbuster:1 he:1 law:1 court:1 $:1 patent:1 had:1 upheld:1 take:1 strong:1 has:1 chairman:1 's:2 anti-clotting:1 but:1 pocket:1 chance:1 insider-trading:1 overturn:1 manufacturer:1 lower:1 did:1 drug:1 n't:1 chief:1 ruling:1 partnerships:1 asked:1 names:1
stock_BMY r_up	outlook:3 rise:3 says:1 scientific:1 cancer:1 linked:1 profit:3 journal:1 after:2 reports:1 one:1 helped:1 hikes:3 5:3 drug:1 controversial:1 income:1 quarterly:1 net:1 its:1 diabetes:1
stock_BMY r_up	drugs:1 purchase:1 discounts:1 government:2 --:1 bribing:1 whistleblower:1 intervene:1 n't:2 their:1 manager:1 pharmacy-benefits:1 has:1 lawsuit:1 price:1 declined:1 hiding:1
stock_BMY r_up	said:1 adults:1 business:1 --:1 2:3 treatment:1 healthcare:1 international:1 has:1 type:1 approved:1 diabetes:1
stock_BMY r_up	thinner:1 people:1 number:1 four:1 its:1 antidepressants:1 sell:1 said:1 generic:2 rose:1 version:1 4:2 percentage:1 has:1 blood:1 regulatory:1 approval:1 received:1 countries:1 --:1 taking:1 drug:1 did:1 so:1 maker:1
stock_BMY r_down	soon:1 wholesalers:1 shipping:1 begun:1 pills:1 said:2 had:1 makers:1 their:1 which:1 newly:1 available:1 after:1 they:1 press:1 approval:1 now:1 approved:1 diabetes:1 effective:1 31:1 drug:3 release:1 pharmacies:1
stock_BMY r_down	often:1 valuable:1 wrong:1 too:1 tactic:1 pursuing:1 waste:1 resources:1
stock_BMY r_up	has:1 ordered:1 patent:1 anti-clotting:1 drug:2 citing:1 questions:1 new:1 blockbuster:1 's:1
stock_BMY r_up	thinner:1 ordered:2 outstanding:1 anti-clotting:2 over:1 settlements:1 midnight:1 tendered:1 buy:1 deadline:2 been:1 questions:2 tender:1 partner:1 blockbuster:2 its:2 out:1 litigation:1 giant:1 said:1 end:1 8.7:1 patent:3 support:1 initial:1 had:1 two:1 shares:2 citing:2 low:1 9:1 2006:1 has:2 gave:1 extended:2 's:4 offer:1 long-running:1 shareholder:2 blood:1 new:2 judge:1 approval:1 --:1 amid:1 days:1 drug:6 a.m.:1 popular:1 efforts:1 dispute:1 maker:1
stock_BMY r_up	make:1 mining:1 finances:1 big:1 company:1 earlier:1 sales:1 easier:1 asset:1 somewhat:1 year:1 finding:1 progress:1 its:1 than:1 allowing:1
stock_BMY r_up	summer:1 cancer:1 heart:1 slim:1 according:1 likely:1 drug:2 have:1 rally:1 said:1 develop:1 working:1 writes:1 anticlotting:1 two:1 attack:1 test:1 more:1 good:1 's:2 offer:1 may:1 company:1 after:1 variation:2 diagnostic:2 but:1 others:1 services:1 than:1 those:1 look:1 --:2 taking:1 stroke:1 value:1 times:1 while:1 without:1 handful:1 published:1 gene:1 starting:1 study:1
stock_BMY r_down	heart:2 less:2 one:1 stroke:2 comments:1 have:2 confirms:2 likely:2 anticlotting:2 two:2 responds:2 research:2 attack:2 has:2 more:2 earlier:2 variation:6 authors:1 article:1 than:2 those:2 population:2 --:2 study:5 30:2 according:2 drug:2 times:2 while:2 without:2 published:3 gene:4 taking:2
stock_BMY r_down	profit:1 said:1 generic:1 32:1 rise:1 possible:1 drug:2 makers:1 reported:1 first-half:1 western:1 talks:1 net:1 alliances:1 maker:1
stock_BMY r_down	says:1 led:1 spending:1 companies:1 new:1 growth:1 '09:1 half:1 report:1 during:1 first:1
stock_BMY r_up	sector:2 pointing:5 being:1 developed:1 move:1 soon:1 trade:1 ended:2 session:1 6.3:1 6.2:1 whose:1 slow:1 rose:1 than:7 add:2 equity:1 holiday:2 do:2 oil-and-gas:2 risk:1 broadly:3 focus:2 suffering:1 try:1 nearly:1 lighter:1 fall:1 lost:1 stabilize:1 --:5 companies:1 facing:1 11.50:1 thinners:1 small:1 higher:2 deal:2 declines:1 heartburn:1 competition:1 actively:1 trading:1 close:1 pills:1 index:5 said:1 sentiment:5 patients:1 shares:4 routing:1 closed:2 new:2 falling:1 available:2 sinks:2 worries:1 base:1 put:1 100:2 could:1 according:1 drug:1 keep:1 amount:1 action:4 south:5 among:4 thinner:2 slipped:1 supply:1 lending:1 down:2 61:1 64:1 another:5 proved:1 market:1 working:1 least:1 attack:1 trigger:1 6:7 expected:5 markets:3 500:4 more:7 ``:1 drugs:1 gas:1 but:5 somewhat:1 prices:2 analyst:1 11:1 '':1 n't:4 while:2 were:7 study:1 heart:2 tap:1 1.3:1 0.3:1 0.4:1 metals:1 helped:1 highlighted:1 dropped:1 again:2 end:2 rout:4 warfarin:1 1:2 concerns:1 take:1 stock:7 week:2 oil:1 's:2 may:1 after:2 falls:1 fell:10 blood:3 plenty:2 pair:1 such:1 stocks:9 data:1 lower:6 tracking:1 effective:1 amid:1 futures:9 overnight:6 2003:1 workhorse:1 points:6 volumes:1 weigh:5 latest:2
stock_BMY r_up	's:1 over:1 drug:1 improvement:1 potential:1 time:1 maker:1
stock_BMY r_up	comment:1 shunned:2 inadequate:2 '':4 prices:2 throughout:1 its:2 best:2 again:2 shareholders:2 $:2 comments:1 current:2 fourth:1 stock:2 ``:4 's:2 interest:2 offer:2 sixth:1 company:1 million:2 approaches:2 takeover:2 background:1 not:2 analyst:1 additional:1 --:2 calling:2 information:1
stock_BMY r_up	shunned:1 interest:1 inadequate:1 '':2 prices:1 its:1 best:1 again:1 shareholders:1 $:1 statement:1 stock:1 ``:2 's:1 fourth:1 offer:1 million:1 seventh:1 approaches:1 takeover:1 not:1 --:1 calling:1 closing:1
stock_BMY r_up	reductions:1 produced:1 cuts:1 its:3 decade:1 terms:1 $:1 treatment:1 has:1 decades:1 staffing:1 ...:1 big:2 survival:1 nearly:3 probably:1 one:1 bringing:1 down:1 found:2 preceded:1 because:1 force:1 series:1 breakthrough:1 rate:1 year:1 pain:2 targets:1 best:1 wonder:1 giving:1 while:1 research:1 scientists:1 new:1 patient:1 scientific:1 pharma:2 both:1 many:1 could:1 months:1 drug:3 keep:1 trial:1 maker:1 first:2 among:1 cancer:2 two:1 brought:1 chronic:1 financial:1 market:1 eye:1 three:2 long:1 mark:1 genetic:1 clinical:2 care:1 life:1 elsewhere:1 drugs:1 award:1 sales:1 90:1 he:1 work:1 recession:1 patients:1 future:1 treated:1 industry:1 1.9:1 have:1 end:1 six:1 successful:1 which:1 out:1 five-year:1 's:4 plans:1 may:1 leukemia:1 whittle:1 most:1 diabetes:1 billion:1 medical:1 disease:1 relief:2
stock_BMY r_up	deal:1 presence:1 still:1 its:1 said:3 $:5 over-the-counter:3 company:1 markets:1 worth:3 buy:3 's:4 brand:1 million:3 demand:1 subsidiary:1 aiming:1 assets:3 --:2 boost:1 well:1 drug:3 products:1 growing:1
stock_BMY r_down	among:1 oncology:1 cancer:1 independent:1 rate:1 colon:1 its:1 conference:1 pharmaceutical:1 data:1 survival:1 division:1 's:3 company:1 key:1 weekend:1 --:1 study:1 drug:1 patients:1 learn:1 starting:1
stock_BMY r_up	biotech:2 examines:1 some:1 have:1 year:1 seem:1 targets:1 market:1 wonder:1 hold:1 six:1 their:1 finally:3 potential:1 acquirers:1 if:1 harrowing:1 recovered:3 gains:1 though:1 may:1 earlier:1 possible:1 fall:1 stocks:3 cliff:1 off:1
stock_BMY r_up	reinforce:1 our:1 finance:2 said:4 appear:2 pay:2 anti-clotting:2 health:2 details:1 progress:2 sluggish:2 ``:1 's:7 plans:2 convincing:2 but:2 new:2 volumes:1 data:1 analyst:2 reimbursement:1 prescription:1 drug:4 chief:2 9th:1 making:2 view:1 maker:2 latest:1
stock_BMY r_down	proved:1 cancer:7 results:1 three:1 lived:2 colon:3 its:1 seemed:1 pharmaceutical:2 compared:3 just:1 their:1 rose:1 detail:1 shares:3 failed:1 rates:1 combined:1 which:1 chemotherapy:2 company:3 sent:1 treatment:1 independent:2 earlier:1 's:1 said:2 survival:2 after:2 overall:1 extended:1 standard:1 fell:1 therapy:1 key:1 half:1 data:1 day:1 improve:1 longer:2 showed:3 --:2 study:4 months:2 median:1 up:1 drug:3 trial:1 patients:4 3.5:1 afternoon:1 rollercoaster:1 published:1 added:1
stock_BMY r_up	gathering:1 already:2 managers:1 investors:1 almost:1 energy:1 them:1 manager:1 economic:1 have:2 signs:1 portfolio:1 best:1 out:1 recession:1 industrials:1 recovery:1 puts:1 also:1 make:1 question:1 such:1 been:1 their:1 only:1 materials:1 candidates:1 too:1 which:1 gains:1 has:1 markets:1 grows:1 surprised:1 difficult:1 says:1 weighing:1 way:1 see:1 but:2 most:1 pricey:1 whether:1 healing:1 recent:1 become:1 not:2 during:1 stocks:1 he:1 tricky:1 lead:1 sectors:1 --:1 climbed:1 companies:1 50:1 iffy:1 face:1 n't:1 credit:1 benefit:1 growth:1 analysts:1 position:1 economy:1 bet:2 lows:1
stock_BMY r_down	another:1 investors:1 sign:1 offerings:1 have:1 find:1 footing:1 crisis:1 capital:1 newly:1 markets:1 stock:1 bonds:2 sold:2 after:1 year’s:1 debt:1 last:1 third:3 receptive:1 more:2 fresh:1 quarter:3
stock_BMY r_down	versus:1 found:1 study:1 drug:2 sugar:1 blood:1 measure:1 alone:1 new:1 reduced:1 experimental:1 diabetes:1
stock_BMY r_up	biotech:1 drug-sector:2 says:1 findings:1 undervalued:1 developed:1 four-year:1 up:1 phase:1 session:1 scheduled:1 been:1 have:1 measure:1 rally:1 sells:1 230:1 its:2 unit:1 25:2 now:1 pharma:1 shares:1 sugar:1 being:1 dapagliflozin:1 cooperation:1 medicine:1 new:1 diabetes:2 meeting:1 exercise:1 versus:1 's:1 mostly:1 company:1 million:2 jointly:1 met:1 said:1 blood:1 alone:1 article:1 100:1 stocks:1 data:1 present:1 $:4 posted:1 off:1 --:1 study:1 annual:1 quiet:3 drug:4 summary:1 published:1 trial:1 patients:1 maker:1 researchers:1 goals:1 rallies:2 action:2 found:1 first:1 reduced:1 experimental:2 otherwise:2
stock_BMY r_down	pharmaceutical:1 27:1 countries:1 --:1 marketing:1 company:2 has:1 granted:1 announced:1
stock_BMY r_up	marketing:1 granted:1 diabetes:1 drug:1 approval:1
stock_BMY r_up	giant:1 downgraded:1 drug:1
stock_BMY r_down	saying:1 force:5 cuts:2 move:2 sales:5 '':2 year:2 our:2 its:6 declined:1 size:1 25:6 said:5 antipsychotic:2 no:1 there:1 spokesman:4 reduction:1 better:2 has:2 evaluation:2 resources:2 ``:2 extended:2 jobs:1 proprietary:1 after:2 overall:1 job:2 cut:1 deployment:2 eliminated:2 earlier:2 pact:2 made:1 many:1 drug:5 calling:2 spokeswoman:1 so:1 were:1 increase:1 maker:4
stock_BMY r_up	sell:1 private-equity:1 company:1 itself:1 discussions:1 firms:1 data:1 advanced:1 care:1
stock_BMY r_up	private-equity:1 because:1 people:1 share:1 sign:1 jump:1 itself:1 discussions:1 sharp:1 saw:1 its:1 sell:1 said:1 profit:1 two-year:1 third-quarter:1 payments:1 one-quarter:1 details:1 firms:1 company:1 more:1 worldwide:1 royalties:1 's:1 business:1 familiar:1 price:1 lag:1 treatments:1 preparations:1 royalty:1 but:1 known:1 waking:1 data:1 advanced:1 care:1 discovered:1 --:1 slumber:1 climbed:1 flu:1 36:3 drug:1 matter:1 swine:1 receives:1 fresh:1 maker:1 latest:1
stock_BMY r_down	results:2 years:1 discovered:1 legal:2 year-earlier:3 its:5 $:1 graph:1 had:2 enjoying:1 around:1 continues:2 arsenal:1 increases:1 royalty:1 updates:1 background:1 not:1 world:1 governments:1 lost:1 --:1 payments:1 lose:2 set:2 financial:2 competition:1 challenges:2 profit:4 comments:1 enough:1 new:1 million:1 seventh:1 protection:1 offset:1 reaction:1 improved:2 recovering:1 climbed:1 36:3 drug:2 swine:1 receives:1 long-term:2 maker:2 comment:1 revenue:1 period:2 down:2 dominating:1 throughout:2 market:1 additional:1 best-selling:1 third-quarter:3 biggest:3 royalties:1 successful:1 company:2 but:3 known:1 analyst:1 jump:1 flu:1 while:2 share:1 sales:3 weighed:2 have:1 sharp:1 swung:3 saw:1 increased:2 information:1 patent:1 one-quarter:1 drugs:5 details:1 fourth:1 several:1 stock:1 's:5 may:1 price:2 lag:1 prepared:1 most:3 coming:1 charges:3 face:2 generic:1
stock_BMY r_down	sector:1 due:1 shed:1 figure:1 flat:1 companies:1 focus:2 marked:1 third-quarter:2 currency:1 see:1 massive:1 thanks:1 year:1 its:3 out:1 delay:2 wraps:1 trying:1 impacts:1 divestiture:1 spending:1 session:1 stake:1 negative:1 shares:2 looking:1 also:1 growth:1 earnings:1 year-ago:2 taken:1 territory:1 gains:1 more:1 do:1 expected:1 's:5 around:1 business:1 pharmaceutical:1 drugs:1 company:2 after:1 falls:2 most:1 fell:1 gain:3 despite:1 active:1 during:1 line:1 stocks:2 continued:1 trade:1 acquisitions:1 increased:1 quarter:1 last:1 whose:1 shift:2 drop:1 posts:1 sale:1 drug:2 morning:1 profit:3 slide:1 63:3 gears:2 2008:1 drops:2 core:1
stock_BMY r_down	roundup:1 saying:1 surprises:2 companies:1 reports:1 quarters:1 advisories:2 earnings:1 future:1 corporate:1 latest:1
stock_BMY r_down	operations:1 shares:1 year-earlier:1 its:3 26:1 1.15:1 antipsychotic:1 analyst:1 has:1 drug:3 increased:1 early:1 background:1 despite:1 continued:1 companies:1 reduced:1 thanks:1 growth:1 makers:2 declined:2 said:1 profit:1 comments:1 version:1 core:1 continuing:1 giant:1 reported:2 tripled:1 regulatory:2 approval:1 $:2 reaction:1 asset-sale:1 products:1 due:1 mixed:1 patents:1 stakes:1 major:2 thinner:1 revenue:1 spreading:1 period:1 third-quarter:4 down:1 63:3 conference:1 pharmaceutical:2 two:1 call:1 interest:1 more:1 health-care:1 way:1 drugs:1 company:2 validity:1 released:1 gain:1 filed:2 than:1 were:1 challenging:1 impacts:1 1.3:1 cents:1 0.2:1 sales:1 0.6:1 helped:1 currency:1 reports:1 bolstered:1 risk:1 sell:1 generic:1 application:1 other:1 earnings:3 animal:1 several:1 higher:2 's:6 minority:1 though:1 after:1 fell:2 blood:1 such:1 stocks:1 recent:1 purchase:1 sale:1 costs:1 filing:1
stock_BMY r_up	sleuth:2 financial:1 just:1 caused:1 exposes:2 used:1 statements:1 children:1 if:1 information:1 medications:1 much:1 winners:2 widely:1 new:1 you:1 worth:1 stock:1 company’s:1 selling:1 drugs:1 after:1 gain:1 not:1 hold:1 footnotes:1 buying:1 11:1 weeks:1 traps:2 pounds:1 19:1 youths:1 according:1 tell:1 published:1 study:1 obscure:1 average:1
stock_BMY r_down	heart:2 challenging:2 investors:1 developed:2 blood-thinning:2 one:1 blockbuster:1 top-performing:1 generic:1 faint:2 has:1 week:1 's:2 generic-drug:1 rejected:2 invested:1 but:1 letter:1 not:2 stocks:1 appeal:2 --:1 fully:1 drug:3 worried:1 patent:2 bad:1 maker:2 remains:1
stock_BMY r_up	10:1 guarded:1 assets:1 investors:1 ignored:1 short:1 dividends:1 stampede:1 back:1 optimism:1 one:1 healthy:1 have:1 buy:1 names:1 context:1 stocks:1 risky:1
stock_BMY r_up	private-equity:1 help:1 cancer:2 acquired:1 agreed:1 some:1 sales:1 year:1 $:1 would:1 23:1 jumped:1 leveraged:1 initial:1 shares:1 failed:1 treatment:1 largest:1 boost:1 4:1 firm:1 's:3 survival:1 after:1 overall:1 but:1 buyout:1 believe:1 data:1 advanced:1 improve:1 billion:1 transaction:1 --:1 could:1 drug:1 patients:1 study:1
stock_BMY r_up	exclusive:2 smaller:1 increasingly:1 developed:1 held:2 privately:2 have:1 reached:2 develop:2 $:4 1:4 their:1 treatment:2 firms:1 boost:1 more:2 development:1 billion:2 after:1 pipelines:1 string:1 company:2 arthritis:2 agreement:2 than:2 paying:2 rights:2 could:2 companies:1 drug:2 costs:1 failures:1 rheumatoid:2 result:2
stock_BMY r_down	financial:1 deal:1 companies:1 industries:1 pipelines:1 speed:1 its:2 conference:1 said:1 $:1 their:1 bolstered:1 1.75:1 chest:1 helps:1 between:1 fledgling:1 war:1 week:2 billion:1 's:1 company:1 infusion:1 debt:1 acquisitions:1 last:1 refinancing:1 pursue:1 reignite:1 bid:1 flow:1 cash:1 drug:2 keep:1 --:1 chief:1 continue:1 funded:1 biotechnology:1 maker:1 executives:1
stock_BMY r_up	wants:1 offerings:1 own:1 's:1 look:1 than:1 doing:1 even:1 drug:1 sign:1 labs:1 hiring:1 already:1 new:1 beyond:1 its:1 maker:1 more:1
stock_BMY r_up	1.4:2 1.5:2 1.6:2 deal:1 bankruptcies:1 can:1 all:1 related:1 jump:2 spinning:1 session:2 trading:3 broader:1 saw:1 its:7 market:1 gains:1 whose:2 gathers:1 busy:1 $:3 lead:3 rose:2 dispose:1 shares:5 6.5:1 much:1 split:4 interest:1 equity:1 biggest:1 out:1 remaining:1 500:2 higher:3 billion:3 swap:1 's:4 increased:2 business:4 drugs:1 company:1 after:1 unusual:1 acquisitions:1 focus:2 diversifying:1 1.15:2 moving:1 unit:2 giant:1 news:3 bid:1 stocks:5 day:1 drugmaker:1 gained:2 financing:1 valued:1 off:2 would:1 --:3 industry:1 climbed:2 companies:2 up:1 drug:3 morning:1 private:1 actively:2 so:1 announced:1 said:2 sets:1 stock:1 core:1 maker:1 mergers:1
stock_BMY r_down	all:2 using:1 its:1 rundown:1 whose:1 rose:1 should:1 late:1 warns:3 gains:2 combination:1 showing:1 nearly:1 half:1 world:1 1.33:1 --:3 medicines:1 companies:1 popular:1 stock:3 dip:1 right:1 tumble:2 heartburn:2 signs:2 some:1 growth:2 trading:1 year:2 said:2 gainers:1 avoid:1 while:1 shares:2 increase:1 closed:1 new:2 firms:2 therapies:1 succeed:1 active:1 news:1 declining:2 gained:1 attacks:1 taking:3 drug:1 afternoon:1 pick:1 action:1 studies:1 major:2 thinner:1 two:1 such:1 market:1 pharmaceutical:1 prove:1 positive:1 people:1 three:2 attack:1 biggest:2 energy:2 500:1 drugs:2 reduce:1 company:1 lift:1 gain:1 doctors:1 must:1 grew:1 patients:1 can:2 were:2 1.45:1 closing:2 heart:2 medication:1 against:2 risk:2 indexes:2 1.38:1 also:1 other:2 take:1 effectiveness:2 blunt:1 higher:1 gaining:2 's:10 may:2 boosted:2 highs:2 blood:1 robust:2 stocks:4 acquisitions:1 amid:1 daily:1 commodities:2 materials:2 decliners:1 paced:2
stock_BMY r_up	heart:1 said:1 's:1 risk:1 drugs:1 heartburn:1 some:1 may:1 attack:1 lift:1 effectiveness:1 blunt:1
stock_BMY r_up	health-care:1 estimates:1 sales:1 partly:1 makers:1 feared:1 pharmaceutical:1 cut:1 overhaul:1 rose:1 comfort:1 had:1 due:1 been:1 52-week:1 increasing:1 's:1 hit:1 wo:1 highs:1 stocks:1 investor:1 drug:2 n't:1 products:1 maker:1
stock_BMY r_up	business:1 's:1 drug:1 underestimating:1 maker:1
stock_BMY r_down	already:1 weight:4 reviewers:2 teenagers:1 effects:1 children:2 impact:2 specific:1 use:1 said:4 20:2 antipsychotic:3 review:2 agency:3 two:1 should:2 also:1 other:1 take:1 which:1 conduct:2 additional:2 include:1 more:2 wants:1 's:2 risk:1 warnings:1 drugs:6 effect:2 but:1 sales:1 warn:1 increases:1 12:1 know:1 approved:1 diabetes:1 billion:1 younger:1 kids:1 look:2 calls:1 --:1 medical:2 $:3 n't:1 patients:1 common:2 side:3 gain:4
stock_BMY r_up	biotech:1 there:1 just:1 session:1 speech:1 22:1 closed:1 rate:1 actively:1 trading:1 dropped:1 another:1 year:1 11,000:1 jobs:1 whose:1 cancer:1 group:1 $:3 4.3:1 rose:2 45:1 zigzags:2 two:1 shares:2 next:1 smallest:1 5:2 authorized:1 interest:1 6:2 rates:1 has:1 500:3 higher:2 modestly:1 ceiling:1 after:1 's:3 increased:1 index:1 drugs:1 price:1 rise:3 payroll:1 nonfarm:1 zigzag:1 30,000:2 job:1 fell:2 buyback:3 news:2 100:1 stocks:5 added:1 raise:1 billion:1 lower:1 grew:1 lost:1 ahead:1 38:1 --:1 could:1 futures:3 companies:1 board:1 years:1 points:9 climbed:1 sent:1 21:1 were:1 chairman:1 stock:2 traded:1 destruction:1 nearly:1
stock_BMY r_down	thinner:1 over:1 settlements:1 long-running:1 its:1 out:1 litigation:1 end:1 patent:1 final:1 dispute:1 's:1 shareholder:1 blood:1 judge:1 approval:1 --:1 drug:1 2006:1 popular:1 efforts:1 gave:1 maker:1
stock_BMY r_up	all:1 strengthening:2 adults:2 weight:2 division:1 blood:2 labels:2 have:1 such:1 children:2 cardiovascular:1 considering:2 information:1 said:3 antipsychotic:2 lead:1 top:2 agency:3 concerns:2 which:2 time:1 has:1 cause:1 over:1 glucose:1 impact:2 's:1 manufacturers:1 drugs:3 cholesterol:1 problems:1 psychiatric:1 warn:2 increases:1 compared:2 gain:2 they:1 article:1 diabetes:3 director:1 like:1 --:2 amid:2 could:2 official:2 stronger:2 side:1 levels:1 products:1 can:2 published:1 asked:1 effects:1
stock_BMY r_up	comment:1 raised:1 suitors:1 inadequate:1 into:1 emerging:2 healthcare:1 growth:1 rising:1 talks:1 tap:1 throughout:1 makers:1 pharmaceutical:1 said:1 potential:1 $:1 spending:1 alliances:1 there:1 other:2 details:1 interest:1 420:1 markets:1 seeks:1 board:1 slows:1 's:5 offer:1 company:3 million:1 but:1 rejected:1 background:1 continued:1 analyst:1 acquisitions:1 reaction:1 like:1 --:2 invited:1 larger:1 economies:1 drug:1 calling:1 pursue:1 continue:1 stressed:1 acquisition:1
stock_BMY r_up	outlook:1 just:1 ...:1 cents:1 share:1 down:1 trading:1 year:1 still:1 $:1 lackluster:1 per:1 next:1 1:1 earnings:1 which:1 presentation:1 company:1 today:1 fairly:1 ``:2 estimates:1 offered:1 midpoint:1 yesterday:1 investor:1 day:1 '':2 off:1 meeting:1 37:1 forecast:1 morning:1 sour:1 following:1
stock_BMY r_up	comment:1 default:1 serving:1 financial:2 rescue:1 inclusion:1 4:1 executive:1 year:1 retail-sales:1 helped:1 marginally:1 rising:1 shares:3 such:1 ailing:1 followed:1 10.5:1 declined:1 cream:1 widely:1 said:2 group:1 $:1 person:1 rose:2 veteran:1 5.7:1 due:1 ice:1 end:1 pharmaceuticals:1 acting:1 potential:1 advancing:1 which:1 soap:1 500:5 stock:1 gaining:1 49:1 added:2 's:3 premarket:1 futures:3 get:1 nod:2 familiar:1 company:3 rise:2 points:5 staving:1 65:1 higher:1 lift:1 key:1 brands:1 president:1 100:1 stocks:1 data:1 payment:1 he:1 billion:1 10:1 goods:1 off:1 name:1 vice:1 --:1 basis:1 leave:1 matter:1 chief:2 expire:1 replaced:1 officer:2 though:1 owns:1 push:1 bond:1 consumer:1 maker:1 came:1 joining:1
stock_BMY r_down	1.5:1 all:1 selection:1 arbitrage:1 investors:1 cents:4 both:1 share:2 raised:1 '':1 offer:1 individual:1 per:4 year:1 go:1 investment:1 11:1 shareholders:1 stocks:1 $:1 49:1 holdings:1 47:1 since:1 due:1 been:1 next:1 their:1 recommended:1 bonds:1 has:1 pending:1 stock:2 ...:2 ``:1 rise:1 's:1 payouts:1 exchange:1 company:1 after:1 quarter:2 short:1 dividend:1 careful:1 raising:2 payout:2 down:1 38:1 15:1 split-off:1 success:1 16:1 18:1 believes:1 record:1 today:1 12:1
stock_BMY r_up	named:2 later:1 dean:1 show:1 major:1 appoints:2 held:1 economic:1 including:1 changes:1 financial:1 market:1 string:1 said:1 no:1 housing:1 due:1 been:1 1:1 statement:1 expected:1 new:4 has:2 2010:1 stock:1 firm:1 's:3 gains:1 monetary:1 policy:1 prices:1 finance:2 appointed:1 school:1 join:1 40:1 --:1 starts:1 medical:2 futures:1 reports:1 chief:4 officer:2 following:1 position:1 consumer:1 spotlight:2 left:1
stock_BMY r_up	opinions:1 tendered:1 adopted:1 year:1 spinoff:2 its:3 giant:1 said:3 would:1 positive:1 shares:3 attracted:2 new:1 has:1 's:1 offer:2 marketing:1 million:2 but:1 early:1 part:2 nearly:2 accepted:1 recommending:1 granting:1 --:1 many:2 medicines:1 up:1 twice:2 were:1 following:1
stock_BMY r_up	set:1 autoimmune:1 cents:1 billions:1 years:1 high:1 seem:1 morning:1 drugs:1 develop:1 $:3 patent:1 rose:1 disease:1 43:1 next:1 few:1 5:3 pretty:1 9:1 announced:1 ...:1 million:1 may:1 company:2 after:1 possibility:1 protection:1 front:1 90:1 receive:1 boring:1 dollars:1 annual:1 steady:1 up:2 drug:2 maker:1 work:1 appealing:1 products:1 therapies:1 lose:1 revenues:2 reliable:1
stock_BMY r_down	focus:2 its:2 26:1 20:1 $:2 rose:1 quarterly:1 poised:2 pending:1 rise:1 expects:1 made:1 clutch:2 continue:3 common:1 activity:1 up:4 economic:2 3.2:3 our:2 85:1 said:2 contributed:1 increase:1 health:1 progress:1 boost:1 we:1 business:1 giant:1 dividend:1 100:1 strong:2 32:3 37:1 drug:1 question:1 down:1 upgrades:1 market:2 stocks:2 start:2 positive:2 legislation:1 cent:1 strategy:1 confident:1 poured:1 expected:2 500:2 ``:1 company:1 favorable:1 excellent:1 those:1 10:2 12:1 solid:1 cash:2 value:1 while:1 opens:2 were:3 investors:2 cents:1 cited:1 health-care:1 share:1 '':1 full-year:1 have:1 viewed:1 par:1 strength:1 4.3:1 corporation:1 1.28:1 insurers:1 holiday-shortened:2 stock:1 week:2 added:1 's:3 boosted:1 flows:1 firmer:2 data:2 payment:2 billion:1 futures:3 points:6 position:1
stock_BMY r_up	saying:2 stake:1 deal:2 0.8:1 cents:1 into:1 move:1 $:1 years:1 past:1 second:3 soars:2 reports:2 83:1 tender:1 rally:2 collaboration:1 its:2 result:1 giant:1 said:1 20:1 21:1 surprises:4 since:1 had:1 shares:3 advisories:4 earnings:2 which:1 largest:1 entered:1 has:2 sluggish:2 completed:1 higher:1 separated:1 modestly:1 small-cap:1 food:1 company:1 after:1 took:1 following:1 therapy:1 gain:2 ...:1 baby:1 news:1 stocks:5 day:3 stage:1 roundup:2 advance:1 off:1 split-off:1 stem-cell:1 solid:1 biotechs:1 future:2 companies:2 drug:1 public:1 2001:3 benchmarks:1 rallies:1 quarters:2 soar:1 corporate:2 maker:2 latest:2
stock_BMY r_up	slips:2 's:1 lead:3 dominated:1 --:1 funds:1 over:1 after-hours:1 late-trading:2 held:1 modest:1 session:1 trading:1 thin:1 broader:1 keeps:2 during:1 stocks:1 onto:1 market:1 exchange-traded:1
stock_BMY r_up	highly:1 '':3 80:1 thinks:1 based:1 $:1 candidate:1 writes:1 shares:1 its:1 note:1 attractive:1 worth:1 ...:1 ``:3 premium:1 food:1 earlier:1 month:1 analyst:1 could:1 clients:1 following:1 maker:1 acquisition:1
stock_BMY r_down	2000:2
stock_BMY r_down	biotech:1 drugs:1 agency:1 trend:1 early:1 may:1 call:1 too:1 2008:2 2009:2 approved:1 more:1
stock_BMY r_up	biotech:2 combination:1 rose:1 study:1 two:1 shares:1 includes:1 leads:2 candidates:1 therapy:1 drug:1 positive:1 early:1 new:1 stocks:3 higher:3
stock_BMY r_down	little:1 's:1 longer:1 no:1 scrappy:1 manufacturers:1 think:1 competitors:1 generics:1 big:1 heels:1 correct:1 pharma:1
stock_BMY r_up	blame:1 sometimes:1 last:1 said:1 may:1 --:1 jumped:1 brand-name:1 competition:1 years:1 lack:1 drugs:1 much:1 eight:1 tenfold:1 400:1 than:1 more:1
stock_BMY r_down	sometimes:1 lack:1 competition:1 years:1 said:1 antipsychotic:1 jumped:1 drugs:1 much:1 400:1 medicine:1 include:1 more:1 's:3 may:1 price:1 blame:1 increases:1 tenfold:1 eight:1 article:1 than:1 last:1 --:1 brand-name:1 drug:1 large:1 published:1
stock_BMY r_up	``:1 's:4 company:1 expectations:1 '':1 zero:1 growth:1 world:1 come:1
stock_BMY r_up	sector:2 biotech:1 smaller:1 health-care:1 likely:1 pharmaceutical:1 get:1 predictions:1 opportunities:1 writing:1 access:1 instead:1 checks:1 huge:1 drugs:1 brings:1 but:1 stay:1 focused:1 acquisitions:1 cautious:1 --:1 companies:1 large:1 remain:1 usual:1
stock_BMY r_down	millions:1 promises:1 because:1 slipped:2 being:1 health-care:1 share:1 seat:3 bring:1 initiative:1 election:3 's:7 special:3 fill:1 closer:1 traded:1 overhaul:1 additional:1 broad:1 hospital:2 managed-care:1 legislation:1 system:1 comments:1 passage:1 late:3 majority:1 won:3 compromise:1 market:1 downturn:1 insurers:1 health:1 final:1 opening:1 victory:1 threatens:1 led:1 mostly:1 though:1 after:5 eliminates:1 moving:1 members:1 prices:1 stocks:5 opened:1 health-plan:1 lower:1 viewed:1 --:2 amid:1 months:1 companies:2 rancor:1 analysts:1 were:1 mixed:1 higher:2 even:1 profits:1 risky:1
stock_BMY r_down	already:1 newest:1 health-care:1 some:1 another:1 need:1 targets:1 before:1 20:1 would:1 bullishness:1 since:1 research:1 their:1 add:1 health:1 pretty:1 so:1 week:1 's:3 gains:1 big:1 price:1 reach:1 new:1 stocks:2 care:1 roundup:1 --:1 upset:1 drug:1 order:1 resuming:1 analysts:2 were:1 quick:1 tall:1 pharmaceuticals:1 lofty:1
stock_BMY r_up	fourth-quarter:2 outlook:2 benefited:2 revenue:2 well:2 sales:2 related:2 bright:2 throughout:1 its:2 now:2 profit:2 rose:2 43:6 comments:1 seller:2 details:1 spike:2 biggest:2 company:5 royalties:2 's:4 combination:2 drugs:2 offered:2 therapy:2 background:1 rollout:2 article:1 strong:2 continued:2 --:2 amid:2 flu:2 pandemic:2 2010:6 swine:2 published:1
stock_BMY r_down	operations:1 being:1 over:3 executive:2 results:2 years:2 leads:2 planning:2 thanks:1 broader:1 cold:1 year-earlier:3 its:5 whose:2 giant:1 cut:3 $:8 candidate:1 29:1 analyst:1 better:1 according:1 quarterly:1 2.15:1 has:1 2010:3 earnings:3 ...:1 updated:1 hit:2 gains:2 focus:2 expects:3 early:2 increases:1 updates:1 background:1 fall:1 not:1 trade:1 day:1 loss:3 lost:1 excluding:1 drop:1 companies:2 've:1 slide:1 session:2 predicted:1 speculation:2 higher:1 related:1 2.25:1 because:1 financial:1 mental:3 ten:1 estimates:1 back:2 competition:1 see:1 actively:1 trading:2 year:3 morning:1 subject:1 said:4 profit:13 nature:1 below:1 per:1 3:1 sixth:1 falling:1 jobs:3 business:3 decline:2 hefty:1 continuing:1 water:1 reported:2 uneven:1 shifting:1 struggle:1 active:1 news:1 reporters:1 strong:1 beginning:1 improve:1 digits:1 pipeline:1 last:2 split-off:2 prior-year:1 36:1 drug:5 takeover:2 products:1 traded:1 maker:2 south:2 comment:1 fourth-quarter:8 adjusted:1 revenue:8 splitting:2 period:1 down:1 market:1 conference:1 pharmaceutical:1 swings:1 basis:1 8.9:1 best-selling:1 been:1 next:1 2:1 call:1 expected:2 percentage:1 500:1 ``:1 growth:1 some:2 company:3 gander:1 but:1 hurt:1 taken:1 gain:1 prices:2 improved:1 than:1 posted:3 '':1 15:1 worth:1 while:4 're:3 baby-formula:3 9th:1 acquisition:4 slid:1 illness:3 cents:1 share:2 sales:5 sale:1 weighed:3 dropped:1 swung:3 increased:1 huge:3 estimated:1 generic:1 47:1 shares:4 also:1 points:3 5:1 details:1 commentary:1 several:1 stock:2 's:9 plans:1 again:1 after:7 upon:2 treatments:3 fueled:3 fell:2 stocks:5 soared:1 recent:3 billion:2 lower:1 off:2 especially:1 four:1 charges:4 well:1 persistent:1 reports:1 chief:1 costs:1 sets:1
stock_BMY r_up	comment:1 saying:1 fourth-quarter:1 bleeding:1 42:1 quarters:1 '':1 unit:1 massive:1 reports:2 arise:1 its:2 boosts:2 use:2 said:2 $:1 bottom:1 profit:3 surprises:2 28:1 severe:1 p.m.:1 advisories:2 version:1 health:1 details:1 boosted:1 8:1 has:1 cause:1 earnings:1 billion:1 ``:1 's:2 drugs:1 sixth:1 company:1 corrected:1 but:1 regulators:1 death:1 liver:2 they:1 doctors:1 line:1 future:1 spinout:3 recent:1 roundup:1 received:1 rare:2 --:1 follows:1 age:1 companies:1 1/28:2 posts:1 patients:2 're:3 products:1 can:2 published:1 serious:1 corporate:1 other:1 latest:1
stock_BMY r_up	already:1 associated:1 some:1 '':1 extended:1 hypertension:1 news:1 said:1 headline:1 marketed:1 29:1 p.m.:2 version:1 treat:1 release:1 ``:1 used:1 drugs:1 reported:2 portal:1 liver:2 article:1 rare:1 --:1 warned:1 taking:1 drug:1 patients:1 published:1 disregard:1 serious:1 disorder:2
stock_BMY r_up	among:1 old:1 leaders:1 soon:1 years:1 likely:1 65:1 year:1 mandatory:1 pharmaceutical:1 retirement:1 there:1 age:1 2011:1 announced:1 more:1 his:1 's:1 reaching:1 could:1 continues:1 replacement:1 change:1 recent:1 industry:1 drug:2 turn:1 turnover:1 changes:1 maker:2 generational:1
stock_BMY r_down	financial:1 deal:1 year:1 its:1 giant:1 said:1 $:1 spending:1 bonuses:1 salaries:1 targets:1 also:1 3:1 much:1 employee:1 2012:1 affected:1 plans:1 wo:1 freezing:1 cut:1 although:1 billion:1 drug:1 n't:1 lowered:1
stock_BMY r_down	aided:1 heavy:1 being:1 doses:1 sales:1 trade:1 stealing:1 cost-cutting:1 pharmaceutical:1 federal:1 create:1 employee:1 firm:1 government:1 big:1 company:1 modest:1 gain:1 competing:1 former:1 attempt:1 secrets:1 companies:1 according:1 --:1 charged:1
stock_BMY r_up	use:1 said:1 's:1 state-run:1 cancer:1 --:1 recommend:1 two:1 one:1 regulator:1 drugs:1 unable:1 within:1 health-cost:1 expensive:1
stock_BMY r_up	pact:2 billion:1 license:1 $:3 deal:1 royalties:1 pay:1 treat:1 up:1 drug:3 arthritis:1 bln:2 used:1 reaches:1 ink:2 rheumatoid:1 1.25:3 before:1
stock_BMY r_up	fourth-quarter:1 north:2 weakened:1 ground:1 earnings:1 after:1 report:1 drug:2 leads:2 released:1 while:1 shares:1 lose:1 inch:1 stocks:3 higher:1
stock_BMY r_up	yearly:1 cut:1 plans:1 bonus:1 employees:1 some:1 workers:1 salaries:1 its:1 38:1 performance:1 freeze:1 targets:1
stock_BMY r_up	cancer:1 job:2 certain:1 agreed:1 partnership:2 strategic:1 '':1 second:2 discussions:2 250:1 blockbuster:1 its:6 if:1 tumbled:2 large:1 said:2 $:3 patent:1 pay:1 make:2 anti-clotting:1 other:2 treatment:2 which:1 has:2 tentatively:1 ``:1 after:2 company:2 million:1 rejected:1 explore:2 cut:2 key:1 apart:2 approved:1 recent:2 four:2 --:2 months:2 companies:1 sale:1 drug:2 n't:2 leading:2 claims:1 had:2 fallen:2 options:2 experimental:1
stock_BMY r_down	says:1 investors:3 cheap:1 expects:1 numbers:1 rally:1 market:1 if:1 even:1 stocks:3 best:2 viewed:1 trash:1 bets:2 buy:1 chance:1 strong:1 he:1 solid:2 many:1 companies:1 2009:1
stock_BMY r_down	associated:1 proposed:1 presence:1 risk:1 brain:1 owner:1 kidney:1 option:1 said:1 better:1 potentially:1 increased:1 undergoing:1 offered:1 but:1 possibly:1 infection:1 building:1 --:1 drug:1 patients:1 long-term:1 serious:1
stock_BMY r_down	advisory:1 proposed:1 experts:1 kidney:1 if:1 use:1 federal:1 question:1 rejecting:1 should:1 their:1 recommended:1 5:1 voted:1 new:1 transplant:1 's:1 undergoing:1 approval:1 approved:1 panel:2 13:1 --:1 medical:1 drug:2 keep:1 patients:2 asked:1
stock_BMY r_up	advisory:2 proposed:1 over:1 executive:1 focus:3 years:1 session:1 4:1 whose:1 should:1 voted:1 has:1 remaining:1 his:1 combination:1 during:1 strategic:1 treating:1 --:2 companies:1 officer:1 rheumatoid:1 consistent:1 successfully:1 past:1 trading:1 our:2 said:1 federal:2 commitments:1 shares:1 leader:1 announced:1 led:1 delivering:1 leadership:2 operating:1 active:1 approval:2 standard:1 panel:3 both:1 last:1 biopharma:1 drug:4 asked:1 among:1 named:1 cancer:1 into:1 replace:1 use:3 additional:1 question:1 statement:1 expected:1 meeting:1 patients:3 treatment:1 ``:1 worked:1 13:1 12:1 roles:1 transformation:1 while:1 next-generation:1 '':1 experts:1 kidney:2 if:1 information:1 recommended:3 5:1 chairman:1 used:1 's:9 undergoing:2 arthritis:1 prepared:1 president:1 approved:1 third:1 medical:1 disease:1 chief:2 senior:1 starting:1
stock_BMY r_down	over:1 global:1 focus:1 its:2 $:1 except:1 should:2 citing:1 treatment:2 executive:1 retire:2 government:1 nearly:2 new:1 austerity:3 bigger:2 maker’s:1 officer:2 shedding:2 pledge:1 some:1 economic:2 trading:1 year:1 's:1 makers:2 said:1 7:2 got:2 announced:1 million:1 contrarian:2 agreement:1 succeed:1 operating:2 upfront:1 article:1 100:1 unnamed:1 according:1 drug:3 keep:1 range:1 products:1 published:1 focused:1 slightly:1 named:1 backup:1 point:1 shed:2 marked:2 replace:2 down:1 weaker:1 names:2 news:1 labor:2 market:2 eye:1 due:2 strategy:2 their:1 500:1 4:2 flat:1 company:1 diversified:2 took:1 delivery:1 wake:1 case:1 four-year:2 rights:4 ouster:1 measures:3 while:2 officials:1 can:1 were:2 meet:1 more:4 futures:3 investors:2 totaling:1 turned:1 reports:1 develop:1 pay:3 40:1 tight:1 other:2 take:1 which:1 ensure:1 stock:2 pain:2 after:2 molecule:1 fell:3 president:2 data:2 billion:1 assets:2 effective:1 light:2 later:2 chief:2 points:2 tenure:2
stock_BMY r_up	saying:1 help:2 unemployment:2 insight:1 expects:3 quarters:1 exclusivity:3 its:8 before:1 impact:1 candidate:1 surprises:2 had:1 failed:1 advisories:2 details:2 2010:3 2013:8 gave:1 focus:2 anticipated:2 five:2 updates:1 background:1 fall:3 years:1 loss:5 --:4 companies:1 banking:2 financial:1 estimated:1 subject:2 said:2 new:2 business:1 opening:1 seventh:1 protection:3 key:1 offset:2 losing:1 news:4 beginning:1 roundup:2 10th:1 incoming:1 launch:2 drug:7 trial:1 maker:2 experimental:1 first:1 comment:1 bell:1 regulatory:2 approval:2 throughout:1 market:3 pharmaceutical:1 additional:1 anti-clotting:3 due:3 clinical:1 expected:3 plunge:1 drugs:5 company:1 than:3 13:3 future:1 2012:2 prospect:2 sees:3 reports:1 blockbuster:1 compared:1 patent:3 breaking:1 also:2 other:2 earnings:5 9:3 '13:2 stock:1 product:2 's:1 price:1 after:2 levels:3 lower:3 disease:1 claims:2 corporate:1 latest:1
stock_BMY r_up	index:2 upgrade:1 's:2 pushes:2 biotech:3 drugmakers:1 among:1 shares:1 while:1 marks:1 action:1 rally:3 stocks:1 boosts:1 higher:2
stock_BMY r_down	1.4:1 150:1 named:1 executive:1 one:1 '':1 incentive:1 its:2 if:1 said:1 based:1 $:3 eligible:1 addition:1 pay:1 since:1 remain:1 been:1 discretionary:1 chairman:1 performance:2 has:1 board:1 week:1 ``:1 his:2 's:2 bonus:1 payment:1 million:1 award:1 early:1 base:2 operating:1 goals:1 regulatory:1 last:1 opportunity:1 2006:1 he:1 salary:3 directors:1 incoming:1 target:1 receive:1 annual:2 drug:1 filing:1 chief:2 succeed:1 plus:1 officer:1 more:1 maker:1
stock_BMY r_up	bets:1 good:1 get:1 whether:1 drug:1 makers:1 acquired:1 not:1 4:2 they:1 small:1 investment:1
stock_BMY r_down	medication:4 ordered:1 some:4 warning:6 through:1 says:1 risk:1 information:1 additional:1 top:1 marketed:1 anti-clotting:4 label:1 does:4 toughest:1 product:3 added:3 's:2 boxed:4 sixth:1 most:1 doctors:4 appears:1 --:3 work:4 well:4 drug:1 n't:4 patients:4 10th:1
stock_BMY r_up	major:1 said:1 bleeding:1 study:1 warfarin:1 episodes:1 drug:1 replace:1 their:1 investigational:1 2:1 treatment:1 compared:1 reduced:1
stock_BMY r_up	down:1 said:1 assets:1 scrap:1 value:1 its:2 write:1 putting:1 agreements:1 have:1 probably:1 breach:1 dividend:1 forcing:1 lenders:1 maker:1 second-half:1
stock_BMY r_down	profitable:1 has:1 his:1 crash:1 mostly:1 superbear:1 since:1 cash:1 been:1 hibernating:2 still:2 before:1
stock_BMY r_up	sector:1 major:1 almost:1 health-care:3 all:1 helped:1 trading:1 controversial:1 rally:1 makers:1 passes:2 strong:1 rose:1 buying:1 passed:1 earnings:1 after:3 pharmaceutical:1 rise:2 but:1 most:1 historic:1 coverage:1 stocks:2 day:1 expand:1 10:2 broad-based:1 bill:3 afternoon:1 health-insurance:1
stock_BMY r_up	another:1 dual:1 presence:1 health-care:1 eyeing:1 drug:1 council:1 turning:1 debate:1 management:1 tablet:1 reform:2 responsibilities:1 1:3 also:1 only:1 potential:1 local:1 announced:1 executive:1 weighing:1 combination:1 company:1 but:1 here:1 members:1 not:1 approval:1 expand:1 he:1 acquisitions:1 effective:1 --:1 companies:1 transferred:1 's:4 leaving:1 their:2 efforts:1 maker:1
stock_BMY r_up	blood-thinner:1 thinner:1 presence:1 paid:1 certain:1 blood:1 blockbuster:2 eyeing:1 officials:1 battle:1 weighing:1 unaffected:1 debate:1 market:1 speak:1 considering:1 fronts:1 said:1 adds:1 reform:2 generic:2 travel:1 detail:1 its:1 also:1 only:1 potential:1 health:1 copies:1 way:1 capital:1 decade-long:1 care:1 's:1 price:1 scored:1 turning:1 plans:1 government:1 drugs:2 some:1 company:1 but:1 curbing:1 here:2 not:1 changing:1 expand:1 he:1 acquisitions:1 off:1 --:2 recall:1 keep:1 their:1 victories:1 efforts:1 two:1 recommended:1
stock_BMY r_down	among:1 settlement:1 proposed:1 antitrust:1 generic:1 thinner:1 inexpensive:1 blockbuster:1 copies:1 dismissed:1 other:1 2006:1 drug:1 retailers:1 filed:1 judge:1 pharmacies:1 has:1 lawsuit:1 makers:1 blood:1
stock_BMY r_down	prevent:1 used:1 clots:1 drug:1 application:1 step:1 important:1 treatment:1 filed:1 new:1 has:1 blood:1
stock_BMY r_up	said:1 they:1 combat:1 --:1 drug:1 market:1 have:1 new:1 launched:1 diabetes:1
stock_BMY r_down	needs:1 patent:1 off:1 wo:1 replace:1 n't:1 drugs:1 protection:1 bloodletting:1 coming:1 probably:1 blockbuster:1 more:1
stock_BMY r_up	lowest:1 ratings:1 highest:1 months:1 far:2 companies:2 average:1 half:1 outperformed:2 three:1 much:1 made:1 so:2 year:3 during:1 has:2 quality:3 writes:1 first:1
stock_BMY r_up	financial:1 over:1 '':1 elected:1 year:1 its:1 basis:1 veteran:1 since:1 p.m.:1 acting:1 version:1 role:1 has:1 correct:1 ``:1 company:1 beginning:1 he:1 third:1 follows:1 chief:1 officer:1 action:1 served:1 maker:1
stock_BMY r_down	large:1 because:1 longer:1 no:1 --:1 deals:1 company:1 within:1 looking:1 diagnostics:1 ready:1 expand:1 he:1
stock_BMY r_down	core:1 sales:2 further:1 treatments:2 drove:1 its:2 said:1 profit:1 45:1 looking:1 details:1 boost:1 earnings:1 royalties:1 first-quarter:1 combination:1 though:1 drugs:1 's:1 but:1 forecasts:1 leapt:1 demand:1 continued:1 both:1 short:1 getting:1 --:1 drug:1 fell:1 more:1 maker:1
stock_BMY r_up	's:4 granting:1 extension:1 --:1 recommended:1 indication:1
stock_BMY r_up	's:1 rose:1 company:1 51:1 n't:2 earnings:1 season:1 flu:1 quarter:1 cites:1 first:1
stock_BMY r_up	saying:1 over:2 top:1 expects:2 quarters:1 session:4 comments:1 broader:1 cuts:1 its:13 before:1 impact:4 whose:4 giant:1 cut:1 overhaul:12 $:6 surprises:2 expectations:1 citing:1 advisories:2 400:1 5:1 weeks:1 2011:2 2010:5 details:1 giants:1 hit:3 rescue:1 government:1 results:1 focus:4 made:1 nearly:1 report:1 trade:2 day:2 bank:1 treating:3 boost:1 collective:1 posts:1 trimmed:2 underlying:4 after-hours:1 rising:2 2.20:1 stock:4 lifted:1 because:1 financial:4 companies:9 some:3 actively:4 trading:2 first-quarter:5 best:2 provided:1 said:7 lead:4 reform:2 profit:5 jumped:2 since:2 shares:4 forecast:5 health:3 closed:1 new:3 net:1 conditions:1 24:1 recently:3 business:5 opening:1 300:1 million:4 offset:4 news:1 strong:2 beginning:1 care:1 roundup:2 reflect:3 package:1 certainty:1 months:1 36:1 reports:2 surge:1 became:3 rose:7 share:3 maker:5 among:2 adjusted:1 industrial:1 cancer:3 bell:1 number:1 negative:1 63:1 viruses:3 market:4 600:1 pharmaceutical:1 manufacturing:1 would:4 one-day:1 1.3:1 two:1 biggest:1 500:5 more:1 north:2 drugs:3 reduce:2 company:4 peers:1 but:1 expected:5 lift:2 gain:1 line:3 he:1 12:1 15:2 17:1 16:11 double:1 up:2 while:1 future:1 were:2 already:1 similar:1 taking:1 1.4:1 heart:3 climbed:5 1.1:2 give:2 cents:3 health-care:6 moved:1 sales:7 helped:1 full-year:2 drug:7 have:1 12th:1 rally:5 moves:1 gains:1 health-related:1 strength:4 make:1 breaking:1 40:1 also:5 costs:4 stemming:3 earnings:7 which:2 9:1 outlook:1 '11:2 higher:6 added:4 's:13 may:1 driven:1 levels:1 improving:1 stocks:10 recent:1 lower:3 bottom:3 disease:3 points:10 relief:1 push:2 800:1 corporate:1 latest:4
stock_BMY r_down	among:1 blood-thinner:1 help:1 cancer:1 higher:1 companies:1 share:1 results:1 full-year:1 economic:1 shares:1 climbing:1 ready:1 first-quarter:1 throughout:1 its:2 market:1 hit:1 now:1 eye:1 signal:1 consumers:1 their:1 profit:2 moves:1 costs:1 comments:1 end:1 also:2 offers:1 details:1 which:1 biggest:2 new:1 developers:1 company:1 hope:1 earnings:3 gaining:2 after:1 's:4 jumps:2 drugs:2 boosted:1 price:1 continues:1 notable:1 sales:4 posts:1 drug:1 modest:1 lowered:1 therapy:1 low:1 despite:1 approval:1 forecasts:1 prostate:1 soared:1 recovery:1 sending:1 stocks:2 driven:1 bid:1 blockbuster:1 16:1 --:1 makes:1 could:1 factors:1 appearance:1 up:1 fewer:1 spend:1 declining:2 charges:1 patients:1 maker:1 products:1 those:1 making:1 stock:1 similar:1 other:1 surge:2
stock_BMY r_down	help:1 cancer:2 3.1:1 article:1 controlled:1 close:1 find:1 $:1 immune:1 data:2 since:1 had:1 system:1 been:1 approved:1 late:1 also:1 attack:1 offers:1 provider:1 new:2 firms:1 developers:1 therapies:1 more:1 's:3 get:1 drugs:1 but:1 therapy:1 approval:2 trying:1 prostate:1 class:1 buying:1 billion:1 publisher:1 --:1 could:1 work:1 disease:1 patients:1 2006:1 hope:1 published:1 financial-market:1 similar:1 asked:1 stimulating:1 first:1
stock_BMY r_up	sector:1 giants:1 trend:3 cash:1 not:1 reports:1 have:1 first-quarter:1 its:3 market:1 pharmaceutical:1 said:1 date:1 $:5 expiration:1 45:1 had:1 shares:1 does:1 3:3 program:1 9.8:1 earnings:1 has:1 board:1 gaining:1 added:1 's:2 capitalization:1 first:1 early:1 nearly:1 repurchase:1 end:1 common:1 billion:3 break:3 quarter:1 up:1 drug:2 securities:1 authorized:1 activity:1 downward:3 stock:1 maker:1 better-than-expected:1
stock_BMY r_down	stocks:1 only:1 reform:1 some:1 up:1 shares:1 ended:1 3:2 attractive:1 making:1 has:1 quality:1 more:1
stock_BMY r_down	competitive:1 '':1 not:1 been:1 gauge:1 numbers:1 its:1 market:1 payoff:1 $:1 sentiment:1 personal:1 had:1 three:1 hepatitis:1 3:1 treatment:1 weeks:1 worth:1 fare:1 ``:1 watching:1 million:1 key:1 coming:1 report:1 data:1 reward:1 --:1 median:1 n't:2 whistleblowers:1 cost:1 late-stage:1 studies:1 first:1
stock_BMY r_up	cancer-drug:1 all:1 report:1 its:1 25:1 $:7 late:1 4:1 has:3 good:1 judge:2 now:1 --:2 shy:1 twice:1 respond:1 says:1 lawyer:1 vacate:1 increase:1 does:1 new:1 notice:1 million:4 takeover:1 snapped:1 manufacturer:1 faith:1 prescription:1 hostile:2 brand-name:1 against:2 motion:1 illicit:2 connection:2 maker:1 comment:1 retired:2 apply:1 ring:2 bitten:1 her:3 top:1 6:2 9.7:2 launching:1 more:4 ``:2 buy:1 allegedly:2 offer:1 drugs:1 immediate:1 insider-trading:2 effort:1 than:4 behalf:1 made:1 appearance:1 up:1 n't:1 file:1 '':2 have:1 saw:1 clearly:1 court:1 no:1 granted:1 5:2 which:1 finding:1 's:1 price:1 after:3 award:2 end:1 judgment:1 billion:1 attempt:1 failing:1 having:1 2009:2 order:3 profits:2 once:1
stock_BMY r_down	opinions:1 results:1 interim:1 including:1 portfolio:1 its:3 previous:1 adding:1 $:1 treatment:2 include:1 gave:1 therapy:1 using:1 advanced:1 --:3 medicines:1 companies:1 authorized:1 rheumatoid:1 16th:1 shedding:1 alfa:1 acquired:1 makers:1 2.4:1 plays:1 critical:1 new:1 moderate:1 therapies:1 reported:1 key:2 active:1 beginning:1 pipeline:1 ahead:2 study:2 drug:2 extensions:1 options:1 among:2 already:1 cancer:3 indications:1 one:1 hoard:1 lung:1 conference:2 additional:1 positive:1 been:1 treat:1 more:3 drugs:2 specialty:1 released:3 part:1 favorable:1 focusing:1 than:2 has:1 cash:1 aims:1 patients:1 were:2 inhibitor:1 acquisition:1 investors:2 proceeds:1 information:1 immune:1 role:1 build:1 out:1 product:1 blocks:1 4,000:2 arthritis:1 molecule:1 applications:1 moving:2 billion:1 assets:1 severe:1 regulating:1 biotechnology:2 responded:1
stock_BMY r_down	bets:1 index:1 ``:1 just:1 heavily:1 big:2 taking:1 countries:1 companies:1 '':1 few:1 other:1 dominated:1 those:1 banks:1 themselves:1 really:1 markets:1 find:1 buying:1 stock:1
stock_BMY r_down	background:1 people:1 results:1 strain:1 news:1 throughout:1 its:1 information:1 additional:1 three:1 1:1 treatment:1 weeks:1 form:1 showing:1 after:1 hours:1 reported:1 virus:1 key:1 included:1 using:1 strong:1 $:1 13:1 12:1 success:1 most:1 --:1 study:1 up:1 drug:1 patients:1 common:1 were:1 first:1 studies:1 late-stage:1
stock_BMY r_up	fashion:2 '':2 needs:1 visiting:1 their:1 add:1 book:1 new:1 has:1 do:1 ``:2 's:2 means:1 food:1 nothing:1 austerity:1 term:1 look:2 rage:2 --:1 plain:1 budget:1 recession:1 planned:1 latest:2 wine:1
stock_BMY r_down	week:1 off:1 conferences:1 opposite:1 opening:1 show:1 pair:1 electronics:1 technology:1 sides:1 kick:1
stock_BMY r_down	major:1 cancer:2 give:1 results:1 watched:1 develop:1 investors:1 trials:1 two:1 clinical:1 health:2 which:1 expected:1 new:1 meeting:2 's:1 scientific:1 attend:1 treatments:1 chance:1 nearly:1 closely:1 doctors:1 beginning:1 present:1 professionals:1 medical:1 annual:1 drug:1 efforts:1 30,000:1 maker:1
stock_BMY r_down	extended:1 gains:2 woes:2 offer:1 merger:2 time:1 share:1 $:1 shares:1 second:1 tumbles:3 tender:1 news:1 2.20:1 has:1 its:2 acquirer:1 intended:1
stock_BMY r_down	firm:1 oncology:1 later:1 cancer:2 some:1 indications:1 indicates:1 promise:1 open:1 its:1 said:1 pharma:1 research:1 forms:1 start:1 which:1 new:2 meeting:1 shows:1 week:1 's:1 releases:1 drugs:1 confusion:1 company:2 equals:1 treatments:1 key:1 press:1 such:1 data:3 analyst:1 improve:1 sound:1 both:1 pipeline:1 rare:1 effective:1 --:1 markets:1 medicines:1 annual:1 drug:1 prior:1 plus:2 common:1 promising:1 release:1 fresh:1 experimental:1
stock_BMY r_up	sharply:1 over:2 global:1 weekend:2 focus:2 month:1 against:1 session:2 including:1 6.2:1 7.5:1 battle:1 7.9:1 its:2 before:1 24:1 whose:4 giant:1 group:4 pharma:2 immune:1 rose:4 flash:1 expectations:1 revenue:1 citing:1 transformed:1 attractive:2 premarket:1 has:2 hit:1 increased:1 combination:1 government:1 advances:1 survival:3 rise:1 background:1 effects:1 they:2 during:1 one:1 continued:1 advanced:2 treating:1 lost:1 --:3 drop:2 companies:4 miracle:1 did:2 though:2 team:1 worries:2 simply:1 higher:1 prior:1 side:1 view:1 system:1 application:1 financial:1 people:2 skin:3 estimates:1 growth:1 trading:3 'flash:2 year:1 fail:2 edged:1 heavy:1 out:2 even:1 index:1 said:2 extend:2 jumped:1 marketed:2 patients:5 shares:6 research:1 current:1 3:3 volatile:1 above:1 new:2 newly:1 beating:1 body:1 ends:2 business:1 opening:1 after-hours:1 notable:1 broker:1 constructive:1 reported:2 ovarian:1 enhance:1 losses:1 news:2 leukemia:2 debt:1 meaningful:1 downgraded:1 $:3 gained:1 received:1 pipeline:2 last:1 sustainability:1 study:3 changed:1 36:1 drug:8 trial:1 'd:2 economic:1 diagnosed:1 published:4 mixed:1 studies:1 experimental:1 designed:1 upgraded:2 among:2 daunting:1 slipped:1 bell:1 each:1 treatment:1 futures:4 catalysts:1 chronic:1 5.25:1 rising:1 adding:1 another:1 article:3 100:1 market:1 better:1 cancer:8 industrials:1 1.2:1 8.9:1 positive:1 sovereign:1 throw:1 2:1 come:1 low:2 clinical:2 recent:2 markets:1 war:1 500:4 more:2 lung:1 roundup:1 ``:6 buy:3 form:2 slumping:1 drugs:3 treat:2 company:2 nonfarm:1 but:2 neutral:3 short:1 lows:1 newer:1 chemotherapy:4 improved:1 approval:1 payrolls:1 than:1 11:1 13:1 grew:1 effective:1 showed:2 up:2 n't:2 below:3 actively:3 cancers:1 were:6 following:1 margin:1 called:2 obstacles:1 1.4:1 0.8:1 later:1 sees:1 have:1 investors:1 certain:4 disease:1 '':6 continues:1 dropped:1 file:1 crash:3 worry:1 tumbled:1 melanoma:1 recovery:1 suggests:1 superior:1 things:1 breaking:1 4.8:1 while:1 also:1 potential:1 potentially:1 take:1 finding:2 stock:2 profile:1 added:3 's:13 plans:1 colon:4 separate:1 track:1 after:4 treatments:4 action:1 fell:4 two:1 plenty:1 previous:1 risk/reward:2 stocks:7 data:2 approved:2 involving:2 euro:2 lower:1 found:1 kept:1 treats:1 surprising:2 slightly:1 sometimes:1 drive:1 severe:1 points:8 upside:2 deadly:1 decliners:1 years:1 researchers:2
stock_BMY r_up	upgraded:1 rating:1 all:1 sees:2 major:1 drug:1 rally:1 market:1 skin-cancer:1 rundown:1 gainers:1 rose:1 shares:3 their:1 biggest:2 stock:1 gaining:2 buy:1 's:3 results:1 wake:1 stocks:2 declining:2 daily:1 trial:1 upside:2 analysts:1 positive:1 decliners:1
stock_BMY r_up	heart:1 because:1 irregular:1 superior:1 far:1 suggest:1 drug:1 early:1 trial:1 clinical:1 stopped:1 rhythm:1 so:1 data:1 experimental:1
stock_BMY r_up	sector:3 help:1 issued:1 over:3 lack:1 focus:2 risk:1 6.7:1 ended:2 session:4 questions:1 fear:2 7.9:1 its:1 whose:3 26:1 $:2 zone:1 rose:3 point:1 had:1 chipmakers:1 signals:3 production:1 late:1 8:1 giants:1 increased:1 views:1 rattled:1 rise:1 results:2 nearly:2 they:1 despite:1 report:1 during:1 day:1 --:3 resurface:1 medicines:1 drop:7 companies:6 morning:4 16:2 after-hours:1 higher:5 reduced:2 shed:2 woes:1 people:1 declines:2 back:1 past:2 3.7:1 second:3 actively:3 trading:7 measure:2 edged:1 81:1 2.6:1 2.5:1 out:3 recently:1 sentiment:3 blue-chip:2 since:2 shares:5 increase:1 health:1 buoyed:1 closed:1 surprise:2 fall:2 hurt:1 boost:2 red:2 bought:1 earlier:2 led:2 25:1 0.9:2 news:1 debt:2 half:1 gained:2 both:3 39:1 2.8:1 irregular:1 losses:2 modest:1 drug:2 7:1 trial:3 analysts:1 mixed:7 retail:8 first:2 1.5:1 among:1 major:3 slipped:7 clinical:3 unexpectedly:1 encouraging:2 two:2 down:1 market:3 pharmaceutical:2 manufacturing:1 online-video:1 spending:2 positive:1 prompting:1 negative:1 been:1 their:1 2:1 biggest:1 upbeat:2 recent:2 500:5 firm:1 0.2:2 posting:2 benchmark:2 but:3 0.4:2 finished:1 lift:2 gain:2 midst:1 plants:1 high:2 12:2 look:1 showed:1 developing:1 straight:1 up:7 while:4 economic:1 transparency:1 were:9 1.4:2 0.8:2 investors:6 1.3:3 0.3:1 health-care:3 sales:6 500,000:2 disappointing:3 stroke:1 dropped:7 surge:1 technology:1 autism:1 gains:5 end:3 recovery:1 paring:2 45:1 4.8:1 indexes:3 note:2 costs:1 declined:1 test:1 encouraged:1 stock:7 week:5 's:15 components:1 though:1 54,000:1 price:1 after:7 helped:4 fell:5 genetics:1 stocks:10 data:5 pulled:1 euro:1 51:3 consumers:1 amid:3 futures:7 steady:1 looked:1 points:20 finishes:1 consumer:7 left:1
stock_BMY r_up	slid:1 n't:1 years:1 ended:1 session:2 trading:2 partner:1 its:1 points:5 whose:2 said:1 20:1 provide:1 rose:2 support:1 three:1 shares:2 next:1 2:1 agreements:2 9:1 clinical:1 has:1 500:2 higher:1 development:1 full:1 's:2 25:1 disclosed:1 but:1 fell:1 70:1 stocks:2 gained:1 pipeline:1 studies:1 climbed:1 companies:3 signed:1 deals:1 actively:2 researchers:1 were:1 mixed:1 traded:1 terms:1
stock_BMY r_up	biotech:1 ``:1 closed:1 business:1 question:1 vexing:1 seems:1 up:1 private:1 sign:1 '':1 exit:1 have:1 hung:1 investors:1 route:1 market:1
stock_BMY r_up	futures:8 industrials:1 results:2 50:1 ended:2 6.5:1 extended:1 through:2 its:2 4.5:1 strong:2 televised:2 sentiment:2 weaker:1 continue:1 treatment:1 7:1 9.5:1 developing:1 500:4 stock:2 oil:2 's:2 gains:2 earlier:1 nationally:2 new:1 possible:1 helping:2 fell:6 200-day:2 cleaning:2 they:1 address:2 improving:2 based:1 100:2 stocks:2 data:3 arthritis:1 break:2 manufacturing:2 spill:2 average:2 losses:1 bellwether:2 up:2 trial:1 points:6 31:1 stabilizing:2 said:1 were:1 moving:2 toward:2 rheumatoid:1 spotlight:2
stock_BMY r_down	1.1:1 over:2 move:2 moved:1 currency:2 actively:2 trading:2 66:1 whose:2 rose:1 shares:2 1:2 5:2 enthusiasm:2 500:2 higher:2 's:4 fell:2 reversal:2 climbing:1 stocks:4 session:2 ahead:1 16:4 climbed:1 companies:2 up:2 points:3 traded:2 late-day:2
stock_BMY r_up	actively:1 whose:1 lower:1 's:1 session:1 companies:1 shares:1 fell:2 trading:1 dropped:1 closed:1 after-hours:1 stocks:1 500:1 points:3
stock_BMY r_up	treating:1 control:1 said:1 's:3 option:1 also:1 --:1 inadequate:1 could:1 early-stage:1 drug:2 sugar:1 considered:1 patients:1 researchers:1 blood:1 have:1 new:2 dapagliflozin:1 late-stage:1 diabetes:2
stock_BMY r_up	30:1 could:1 stocks:1 pop:1 doubts:1
stock_BMY r_down	adviser:2 30-year:1 set:1 's:1 1980:2 mostly:2 since:2 cash:2 anniversary:1 newsletter:1 looks:1 three:1 best-performing:1 become:1 gets:1 decades:1 its:1 celebrate:1 last:1
stock_BMY r_down	another:1 scheme:3 results:3 second:1 have:1 reached:3 blockbuster:1 makers:1 patent:1 avoid:3 anti-clotting:1 alleged:3 legal:1 pump:3 agreements:1 generics:1 under:3 has:1 's:3 which:3 denied:1 prosecution:3 they:3 former:3 manufacturer:1 criminal:3 request:1 up:3 drug:5 victory:1 maker:3 executives:3
stock_BMY r_down	among:1 pressured:1 --:1 weak:1 health-care:1 companies:1 rate:1 pricing:1 pressures:1 macroeconomic:1 conditions:1 trading:1 midday:1 were:1 worries:1 stocks:1 continued:1 500:1 weakest:1
stock_BMY r_up	prevent:1 adults:1 cancer:1 give:1 agreed:1 discovered:2 chronic:2 human:1 said:1 review:1 two:1 priority:1 treatment:1 scientists:1 newly:1 has:1 announced:1 can:1 leukemia:1 they:1 phase:1 90:1 believe:1 known:1 antibodies:3 cells:1 identified:1 drug:1 strains:1 diagnosed:1 have:1
stock_BMY r_down	1.4:1 limited:1 set:1 investors:1 loan:1 trade:1 buoyed:1 flexibility:1 actively:1 caution:1 dropped:1 year:2 portfolio:1 session:1 after-hours:1 open:1 its:3 declined:1 weekly:1 whose:1 giant:1 5.3:1 funding:1 $:1 quality:1 equities:1 speculative:1 shares:1 4.25:1 their:1 citing:1 5:1 best:1 biggest:1 territory:1 500:1 earnings:2 week:2 junk:1 's:3 posting:1 upcoming:1 ratings:1 season:2 company:1 -2:2 expected:1 fell:2 nearly:2 finance:1 100:1 highly:1 downgraded:1 futures:2 gained:1 lower:1 last:1 look:1 ahead:1 30:1 companies:1 optimism:1 credit:1 severe:1 points:3 deterioration:1 rose:1 following:1 trading:1 gain:1
stock_BMY r_down	billion:1 1.6:1 his:1 's:1 significant:1 offer:1 --:1 defend:1 continuing:1 fellow:1 shareholder:1 opposition:1 organization:1 company:1 $:1
stock_BMY r_up	all:1 says:1 show:1 may:1 earnings:1 strong:1
stock_BMY r_up	financial:1 jobless:1 despite:1 number:1 leads:1 active:1 see:1 economic:1 trading:3 pricing:1 second-quarter:1 decline:1 rally:2 price:1 issues:1 weekly:1 setbacks:1 increase:1 abroad:1 stocks:2 end:1 recovery:1 hunting:1 5.7:3 profit:1 swift:1 blue-chip:1 bonds:1 expectations:1 been:1 forecast:1 better:1 pressures:1 those:1 which:1 income:2 expected:1 net:1 has:1 2010:1 momentum:1 higher:2 rise:1 north:1 offer:1 earnings:2 company:1 after:1 watch:2 sales:1 early:1 reported:2 increases:1 gain:2 offset:1 hopes:1 now:1 data:3 than:1 bank:1 recent:1 faced:1 helped:1 whose:1 surprising:1 dents:1 reignite:1 16:3 companies:1 drug:1 shares:1 session:1 yields:1 afternoon:2 though:1 activity:1 claims:1 slightly:2 maker:1 latest:2
stock_BMY r_down	all:2 results:2 month:1 four:2 hopes:2 session:2 comments:1 its:7 weekly:1 25:6 cut:2 21:1 zone:1 rose:5 workers:1 had:2 expectations:2 second-quarter:4 failed:2 continued:2 suite:2 2010:6 hope:1 tests:1 affected:1 increased:1 combination:2 meanwhile:1 rebound:1 rise:1 increases:1 background:1 despite:3 not:1 disappointed:2 materialize:1 gloom:2 --:2 follows:1 fewer:1 release:1 stock:2 better-than-expected:2 shedding:2 estimates:2 rate:1 economic:5 pricing:1 year:2 3.8:1 encouraged:1 shrug:1 said:2 mood:1 3rd:1 profit:7 shares:1 increase:1 pressures:1 drug:2 net:1 previous:3 boost:2 core:2 after:1 weak:1 reported:2 job:1 them:1 offset:1 losing:2 100:2 strong:2 swift:2 abroad:1 gained:2 benefits:1 30:2 108:1 against:1 a.m.:1 published:1 slightly:1 maker:3 adjusted:1 industrial:1 followed:2 revenue:2 ground:2 number:1 throughout:1 decline:1 story:1 jobless:2 beginning:1 initial:1 due:1 per-share:1 grow:2 expected:1 markets:1 500:2 more:2 ``:4 drugs:2 share:1 reversed:1 corrected:1 lower:1 but:4 favorable:1 demand:2 91:1 last:1 surged:3 than:1 helped:2 uncertain:2 showed:1 16:3 second:2 89:1 were:1 unusually:2 balance:1 losses:2 1.1:2 investors:1 outstanding:1 bigger-than-expected:1 health-care:1 tax:1 sales:5 reignited:2 expenses:3 '':3 dropped:2 orders:1 recovery:2 5.7:6 glimmers:1 fears:1 detail:1 also:2 concerns:2 earnings:4 which:1 income:1 outlook:2 company:3 higher:1 week:1 added:1 's:7 though:1 may:1 price:2 testimony:2 treatments:4 helping:1 macroeconomic:1 stocks:1 data:5 eighth:1 euro:1 rallied:2 stress:1 off:1 charges:1 futures:6 points:8 components:2 time:2 banks:1 claims:2 corporate:2 filing:1 meet:2
stock_BMY r_up	website:2 do:1 effectiveness:2 's:2 proposed:2 outside:1 positive:1 review:2 anticlotting:2 patients:1 drug:2 should:1 only:1 questioned:2 developed:2 posted:2 data:1 its:2 if:1
stock_BMY r_down	prevent:1 proposed:2 heart:1 being:1 developed:2 taking:2 its:1 market:1 cardiovascular:1 use:1 compared:1 syndrome:1 anticlotting:2 benefit:1 clinical:1 international:1 has:1 brand:1 product:1 's:2 seeking:1 company:2 problems:1 despite:2 backed:2 approval:1 data:1 concerns:2 those:1 panel:2 effectiveness:1 name:1 showed:1 16:1 --:1 study:1 drug:2 leader:1 attacks:1 patients:2 diagnosed:1 other:1
stock_BMY r_up	sees:1 prompting:1 human:1 find:1 pharmaceutical:1 giant:1 trials:1 catalysts:1 been:1 new:1 several:1 's:3 big:1 acquire:1 shareholders:1 pressure:1 they:1 license:1 tested:1 medicines:1 barely:1 companies:2 drug:1 've:1 n't:2 products:1 biotechnology:1 reward:1 experimental:1
stock_BMY r_up	medication:1 prompting:1 process:1 tested:1 supplement:1 human:1 find:1 pharmaceutical:1 ingredients:1 trials:1 been:1 suit:1 new:1 wants:1 's:2 involuntary:1 big:1 acquire:1 pressure:1 effects:1 they:1 scary:1 license:1 clarify:1 medicines:1 barely:1 companies:2 've:1 n't:2 products:1 biotechnology:1 identifies:1 side:1 experimental:1
stock_BMY r_up	essentially:1 success:1 --:1 curing:1 three:1 drug:1 reported:1 second:1 treatment:1 key:1 using:1 72:1 studies:1 patients:1 late-stage:1
stock_BMY r_down	major:1 cancer:1 give:1 previously:1 agreed:1 focus:1 one:1 have:1 skin:1 its:1 use:1 said:1 melanoma:2 exists:1 no:1 provide:1 review:3 priority:1 treatment:4 has:1 offer:1 drugs:1 advances:1 given:1 advanced:1 received:1 drug:1 patients:1 experimental:1
stock_BMY r_down	give:1 agreed:1 health-care:1 its:1 priority:1 said:1 melanoma:1 ease:1 two:1 tai:1 access:1 treatment:1 symptoms:1 tidbits:1 more:1 may:1 news:1 bit:1 advanced:1 fibromyalgia:1 anxious:1 review:1 experimental:1
stock_BMY r_up	consider:2 investors:1 dividend-paying:2 names:1 have:2 busy:1 offer:1 been:1 safety:2 you:1 bored:1 frustrated:1 more:1 roster:2 dividends:1 stop:1 depths:1 flown:1 strategists:1 stocks:2 paying:1 both:1 healthy:1 well:1 leave:1 yields:2 can:1 plumbing:1 stock:1 bond:1
stock_BMY r_down	6:2 use:2 six:1 's:4 said:1 --:1 certain:1 agency:1 treatments:1 recommending:1 recommended:1 cost:1 statement:1 healthcare:1 rheumatoid:1 arthritis:1
stock_BMY r_down	prevent:1 major:1 heart:1 blood-thinning:1 emerging:1 competition:1 month:1 any:1 market:1 pharmaceutical:1 said:1 review:1 placing:1 next:1 potentially:1 interest:1 new:1 firms:1 type:1 generics:1 get:1 strokes:1 company:2 renewed:1 significant:1 despite:1 seeing:1 those:1 panel:1 acquisitions:1 rhythms:1 irregular:1 --:2 markets:1 companies:1 drug:3 n't:1 patients:1 having:1 experimental:1 first:1
stock_BMY r_up	outlook:1 expirations:1 patent:1 big:1 negative:1 drug:1 maker:1 facing:1 noting:1 including:1 two:1 significant:1 lowered:1 sellers:1 its:1 best:1 2012:1
stock_BMY r_down	thinner:6 say:1 drug:1 its:3 dysfunction:1 use:3 ads:1 no:1 question:3 two:1 rivals:1 genetic:3 potential:3 boon:3 test:3 new:3 before:1 boost:1 million:1 erectile:1 blood:6 using:3 50:1 value:3 long-term:3 studies:4 guide:3
stock_BMY r_up	pointing:1 less:1 global:1 years:1 session:1 behind:1 still:1 consumer-confidence:2 whose:2 26:1 20:1 $:2 rose:6 expectations:2 than:1 equity:1 fuel:1 hope:2 earnings:1 eventually:1 seized:1 seeking:1 rise:1 early:1 day:2 medicines:1 companies:2 race:1 activity:1 stock:1 round:1 better-than-expected:2 exceed:1 slower:1 cash:1 see:1 economic:3 trading:2 year:1 home:1 out:1 provided:2 said:1 future:1 shares:2 3:2 bracing:1 reading:2 strategist:1 bought:1 we:1 million:1 along:1 strong:1 could:1 climbed:2 37:1 36:1 climb:1 traded:1 experimental:1 first:1 raised:1 thinner:1 revenue:1 replace:1 market:2 decline:1 confidence:2 insider:1 housing:1 two:2 few:1 2:1 glimmer:2 500:2 more:1 chug:1 direction:1 enough:1 drugs:1 company:2 wiping:1 prices:1 insiders:1 altered:1 second-quarter:1 up:2 pace:1 actively:2 can:1 were:1 balance:1 purchases:1 investors:2 modestly:1 almost:1 flush:1 1.8:1 ``:1 slowing:2 '':1 develop:1 recovery:3 48:1 tentative:1 index:1 warfarin:1 1:1 economy:1 higher:1 gaining:1 added:1 's:2 though:1 boosted:1 blood:1 sheets:1 improving:1 stocks:4 data:2 billion:1 longer:1 corporate:1 thought:1 chief:1 points:9 consumer:2
stock_BMY r_up	among:2 exceed:2 thinner:2 deal:1 revenue:2 almost:1 session:1 global:2 0.4:1 replace:2 ended:1 actively:1 trading:1 shares:1 year:2 years:1 reached:1 1:1 eked:2 insurance:1 market:4 out:2 provided:2 replacements:1 develop:2 proceed:1 asks:1 rose:1 warfarin:3 two:3 tiny:2 research:1 cell:1 insider:1 potential:1 5:1 stock:1 fuel:2 insiders:1 500:1 conclusion:2 eventually:2 whose:1 drugs:2 company:1 million:1 points:3 stem:1 slipped:1 after-hours:1 blood:2 purchases:1 judge:1 20:2 line:1 month:2 than:1 $:3 billion:2 advance:2 stocks:1 bruising:2 dialysis:1 hike:1 medicines:2 climbed:1 companies:1 up:1 gainers:2 more:1 race:2 allow:1 5.9:1 mixed:1 bought:1 could:2 experimental:2 first:1
stock_BMY r_up	shot:1 up:1 cents:1 agreed:1 year:1 share:1 focus:2 trade:1 down:1 see:1 session:1 9.75:1 close:1 's:6 84:1 whose:1 $:5 pay:1 shares:3 closed:1 expected:1 has:1 price:1 stock:1 premium:1 7:1 83:1 company:1 after:2 hours:2 active:1 17:1 companies:1 cash:1 rose:1 biotechnology:1 closing:1
stock_BMY r_up	operations:1 consider:2 agreed:3 move:1 trade:2 mild:1 session:2 hepatitis:1 portfolio:1 life-sciences:1 children:1 whose:2 26:1 group:1 $:9 purchased:1 rose:3 29:1 late:2 other:1 parents:1 4:1 quarterly:1 has:1 diseases:1 rise:1 wave:1 five:1 nearly:1 they:1 judge:1 school:1 cognitive:1 real-estate:1 --:2 gender:1 drop:1 companies:3 morning:1 economy:1 heading:1 rents:1 likely:1 actively:2 trading:2 measure:1 82:1 surgery:1 investment:1 said:1 mortgage:1 profitability:1 shares:4 its:4 cell:1 leap:1 7:1 new:1 increasing:1 infrastructure:1 led:1 wo:1 million:4 stem:1 pressure:1 let:1 key:1 alone:1 news:1 rises:2 properties:1 trusts:1 roundup:1 pipeline:1 kids:1 receive:1 many:1 could:1 share:1 traded:2 maker:1 outlook:1 revenue:2 private:1 67:1 pharmaceutical:1 area:1 spending:1 leading:1 surges:2 there:1 been:1 their:1 735:4 proposal:1 gained:2 500:2 firm:2 publishes:1 buy:1 drugs:1 funds:1 company:3 differences:1 agrees:1 hurt:1 lift:1 posted:1 16:1 vacancies:1 up:2 n't:1 ruling:1 college:1 steep:1 bet:1 biotech:1 1.1:1 investors:1 1.3:1 strengthen:1 chip:1 moved:2 general:1 have:1 9.75:1 lifts:1 sell:1 ratings:1 'll:1 agreeing:1 pay:2 stake:1 small-capitalization:1 1:1 points:4 impairment:1 higher:4 week:1 acquire:2 's:3 though:1 after:3 stay:1 most:1 stocks:6 billion:1 lower:1 off:1 tenants:1 2000:2 materials:1 goodbye:1 biotechnology:2
stock_BMY r_up	stock:1 among:1 investors:1 people:1 share:1 years:1 schizophrenia:1 cost:1 shares:1 9.75:1 led:1 aged:1 fell:1 said:1 $:1 lead:2 spending:1 rose:1 moves:1 small-capitalization:1 their:1 treatment:1 biggest:2 new:1 proposal:1 effectiveness:2 more:1 gaining:2 product:1 infrastructure:1 's:5 soar:1 drugs:2 84:1 company:1 acquire:1 notable:1 market:1 lift:1 news:1 stocks:7 data:1 declining:2 15:1 17:1 --:1 could:1 companies:1 regulator:1 while:1 materials:1 healthcare:1 making:1 higher:1 asked:1 bet:1
stock_BMY r_down	comment:1 prevent:1 followed:2 biotech:1 cited:2 appropriate:1 warning:2 follow:1 sees:1 establish:1 fifth:1 said:1 $:1 generic:1 agency:2 opportunities:1 written:1 5:1 violations:4 company:2 website:2 plant:4 's:3 rules:2 outlined:2 designed:1 letter:4 contamination:1 manufacturing:2 procedures:1 buying:1 posted:2 billion:1 assets:1 --:2 starting:1 industry:1 30:2 drug:2 n't:1 did:1 manages:1 products:1 were:2 inspection:2
stock_BMY r_up	thinner:1 have:1 its:2 market:1 said:2 would:1 confident:1 remains:1 decision:1 there:1 three:1 than:1 application:2 more:1 scheduled:1 product:1 finish:1 's:5 company:1 but:1 regulators:1 blood:1 key:1 review:1 approval:1 now:1 needed:1 16:2 --:1 study:1 months:1 drug:1 rather:1 time:1 postponed:1 maker:1 experimental:1
stock_BMY r_up	deal:1 share:1 strategic:1 '':1 premium:1 relationships:1 said:1 adds:1 comments:1 ``:1 's:1 contracts:1 hefty:1 negotiating:1 prices:1 dividend:1 strong:1 valuation:1 organizations:1 pipeline:1 --:1 drug:1 spokeswoman:1 enter:1 making:1 maker:1 justify:1
stock_BMY r_up	operations:1 limited:1 show:1 developed:1 executive:1 results:2 years:1 its:1 adding:1 revenue:1 had:1 controls:1 sugar:1 candidates:1 treatment:2 various:1 has:1 versus:1 good:1 increased:1 measurement:1 primary:1 every:1 they:1 now:1 governments:1 --:3 experiencing:1 companies:1 yield:2 did:1 steps:1 common:1 each:1 found:1 reduced:1 national:1 searching:1 competition:1 past:1 gaps:1 pricing:1 measure:1 close:1 targets:1 out:2 said:3 consistently:1 3:1 health:1 new:1 told:1 conference:1 commercial:1 standard:2 met:1 alone:1 come:1 pressure:1 many:1 study:1 drug:5 leaving:1 trial:1 products:1 studies:1 experimental:1 late-stage:2 point:1 previously:1 number:1 one:1 regulatory:1 market:1 everybody:1 given:1 positive:1 two:1 their:2 clinical:1 pains:1 biggest:1 recent:1 today:2 glucose:1 ``:1 slumping:1 took:1 scrutiny:1 lowered:1 than:1 10:2 showed:1 vice:1 budget:1 n't:1 were:1 strategies:1 more:1 dapagliflozin:1 investors:1 year:1 '':1 single:1 itself:1 have:1 any:1 respective:1 generic:1 makers:3 note:1 potential:1 take:1 finding:1 's:2 price:1 levels:1 blood:3 president:1 stocks:1 diabetes:2 happening:1 programs:1 senior:1
stock_BMY r_down	prevent:1 major:1 heart:1 being:1 move:1 blood-thinning:1 replace:1 likely:1 hit:1 establish:1 market:2 closer:1 pharmaceutical:1 warfarin:1 increasingly:1 recommended:1 new:2 type:1 relationships:1 's:2 get:1 strokes:1 moved:1 company:1 wave:1 small:1 blood:1 pool:1 panel:1 organizations:1 rhythms:1 irregular:1 --:1 shaking:1 industry:1 companies:1 up:1 drug:2 large:1 patients:1 place:1 thinners:1 long-term:1 approve:1 first:2
stock_BMY r_up	paying:1 's:1 unauthorized:1 lead:1 illegal:1 doctors:1 drug:1 promoting:1 take:1 kickbacks:1 uses:1 trying:1 lawsuit:1 unit:1 improperly:1
stock_BMY r_down	'':3 ``:3 said:3 force:3 plans:3 maker:1 months:3 agile:3 create:3 work:3 reduce:3 costs:3 next:3 six:3 3:9 cut:3 6:2 organization:3 its:3 more:3
stock_BMY r_down	rating:1 just:1 chances:1 move:1 mainly:1 focus:1 ending:1 session:2 economist:1 its:1 before:1 had:1 sugar:1 better:1 being:1 treatment:1 equity:1 pill:1 good:1 cruising:1 risk:1 domestic:1 bid:1 rise:1 results:1 fall:1 not:1 month:1 net:1 treating:1 1400:2 showing:1 level:1 --:2 shy:2 consensus:1 bad:1 continue:1 treated:1 release:1 found:1 speculation:1 upward:1 says:2 decliner:1 declines:1 some:1 existing:1 economic:2 home:2 calendar:1 investment:1 revisions:1 closes:1 said:2 blue-chip:1 looking:1 participants:1 capital:1 new:4 falling:1 previous:1 business:2 aircraft:1 key:1 boosting:1 regulatory:1 approval:1 100:3 panel:1 climate:1 goods:3 ahead:1 many:1 study:1 trades:1 quiet:1 drug:4 survey:2 gainer:1 mixed:2 opinion:1 durable:2 late-stage:1 comment:1 already:1 followed:1 into:1 one:1 downgrade:1 away:1 reached:1 along:1 market:3 given:1 positive:1 caught:1 direction:1 due:1 been:1 their:1 2:1 low:1 biggest:2 upbeat:1 diabetes:1 meeting:1 final:1 more:1 ``:1 estimates:1 but:4 forward:1 expected:1 part:1 adult:1 focusing:1 than:2 homes:1 look:1 these:1 patients:3 growth:1 following:3 piece:1 similar:1 dapagliflozin:1 0.9:1 heart:1 ordered:1 investors:4 1.3:1 sales:3 '':1 close:1 partner:1 orders:4 strength:1 4.1:1 syndrome:1 no:1 things:1 recommended:1 instead:1 out:1 events:1 higher:1 's:11 index:1 may:1 effect:1 forecasts:1 driven:1 extending:1 blood:1 coming:1 positives:1 data:5 upwards:1 short:1 largely:1 downbeat:1 overshadowed:1 so:1 having:1 prevention:1 latest:1
stock_BMY r_down	strengthen:1 results:1 '':3 portfolio:1 need:1 's:1 buyout:1 agrees:1 said:2 melanoma:1 $:1 would:1 trial:1 positive:1 immunotherapy:1 its:1 whom:1 does:1 come:1 treatment:1 mid-stage:1 has:1 more:1 ``:3 patient:1 survival:1 million:1 midst:1 data:2 showed:1 --:1 n't:1 collect:1 acquisition:1 works:1 experimental:1
stock_BMY r_up	beautiful:1 investors:1 ``:1 soon:1 charts:1 '':1 not:1 through:2 crash:1 find:1 market:1 out:1 happens:1 better:1 now:1 just:1 lots:1 interesting:1 flash:1 except:1 been:1 yet:1 traders:1 few:1 hot:1 does:1 pretty:1 expected:1 has:1 day:1 ...:2 we:1 buy:1 's:2 easy:1 high-frequency:1 any:1 nobody:1 here:1 game:1 understand:1 report:3 picking:1 stocks:1 than:1 sound:1 pull:1 essentially:1 promising:1 potato:1 official:1 favorite:1 leaving:1 n't:2 're:1 due:1 fundamental:1 pick:1 starting:1
stock_BMY r_down	saying:1 billion:1 biotech:1 share:1 sales:1 slap:1 cash:1 trading:1 directly:1 69:1 seem:1 speed:1 makers:1 shareholders:1 bribes:1 $:2 variety:1 ways:1 looking:1 their:1 call:1 take:1 goes:2 dividends:1 finding:1 firms:1 boost:1 firm’s:1 500:2 analysts:1 high-speed:1 ...:1 we:2 earlier:1 offer:1 approvals:1 bid:1 after:1 fat:1 site:1 pursuit:2 report:1 lap:1 paying:1 hostile:3 anything:1 launches:1 could:1 up:2 drug:3 gobbling:1 victory:1 release:1 overseas:1 18.5:1 maker:1 related:1 investigators:1
stock_BMY r_up	590:2 just:1 ca:1 probe:1 sales:2 one:1 sight:1 peddle:1 speed:2 makers:3 bribes:2 $:2 variety:2 ways:3 wares:1 find:1 looking:2 their:1 enough:1 approvals:2 deal:1 legally:1 weeks:1 care:1 might:1 final:1 's:1 may:1 big:1 dealings:1 news:1 recent:1 paying:2 organizations:1 boost:2 could:2 drug:5 n't:1 thinking:1 overseas:3 investigators:2
stock_BMY r_up	comment:2 thinner:1 deal:1 certain:1 over:1 move:2 share:1 strategy:2 competition:2 years:2 '':2 including:2 reviewing:2 combining:1 facing:2 blockbuster:1 pills:1 unit:2 pharmaceutical:4 said:2 details:1 analyst:1 generic:2 review:2 overblown:1 been:2 its:8 drugs:2 other:2 systems:2 new:2 has:2 company:3 heartburn:1 combined:2 ``:2 risk:1 business:2 may:1 some:2 price:1 possible:2 adjusting:2 part:2 blood:1 background:1 coming:2 timing:2 financial-market:2 declining:1 improved:2 --:2 conditions:2 study:1 companies:3 sale:2 throughout:1 large:2 suggests:1 regular:2 many:2 businesses:2 speculation:1 makes:2 options:2 came:2
stock_BMY r_up	sector:1 biotech:1 smaller:1 certain:1 over:1 thinner:1 including:2 committee:2 combining:1 blockbuster:1 pills:1 special:2 fears:1 overblown:1 board:2 new:1 gets:1 heartburn:1 's:4 risk:1 get:1 may:1 evaluate:2 company:2 formed:2 blood:1 cough:1 booster:1 interaction:1 study:2 sale:2 drug:1 suggests:1 eases:1 options:2
stock_BMY r_down	biotech:1 600:1 0.2:1 up:2 sleeping:1 hit:1 its:2 issues:1 index:1 compared:1 long:1 snag:1 hampered:1 potential:1 health:1 which:1 biggest:1 safety:1 include:1 pill:1 higher:1 independent:2 's:2 plans:1 company:2 preference:1 report:1 strategic:1 surged:1 care:1 11:1 has:1 last:1 --:1 could:1 sale:1 remain:1 stressed:1 following:1 stock:1 dip:1 drawing:1
stock_BMY r_up	saying:1 revenue:1 existing:1 7.1:1 moved:2 sales:1 third-quarter:1 actively:2 trading:2 licensing:1 partner:1 reached:1 7.8:1 made:1 2.5:1 whose:2 management:1 $:5 rose:2 1.3:1 projected:1 shares:2 payments:1 much:1 agreements:1 collaboration:1 500:2 higher:2 deals:1 royalties:1 contracts:1 some:1 company:2 million:1 workforce:1 565:1 4.6:1 somewhat:1 automated:1 timing:1 stocks:2 expectations:1 stage:1 session:2 12:1 impacted:1 could:1 climbed:2 companies:2 up:2 specific:1 below:1 points:6 plus:1 analysts:1 milestones:1 biotechnology:1 traded:2 other:1 result:1
stock_BMY r_down	development:1 pharmaceutical:1 because:1 chasing:1 inefficient:1 may:1 should:1 companies:1 research:1 deals:1 their:1 note:1 own:1 take:1 changing:1 become:1 has:1
stock_BMY r_up	'better:1 hunt:1 20:3 pickers:1 bonds:1 continues:1 list:1 gander:1 yield:1 say:1 have:1 dividend:1 stocks:1 than:1 stock:1
stock_BMY r_down	comment:1 prevent:1 boosted:1 since:1 heart:1 beginning:1 heartburn:1 year:1 blood-thinning:1 sales:2 replace:1 warning:1 projections:1 exceeded:1 throughout:1 its:5 reduced:1 move:1 bought:1 4.7:3 total:1 $:2 million:1 profit:1 rose:1 plans:1 revenue:1 warfarin:1 third-quarter:1 shares:2 while:1 also:1 anticlotting:1 details:1 which:1 income:1 performance:1 net:1 price:1 stock:3 reiterate:1 used:1 's:4 widely:1 strokes:1 estimates:1 company:2 1.55:1 treatments:1 outstanding:1 said:1 plan:1 background:1 repurchase:1 taking:2 strong:1 bringing:1 approved:2 common:1 billion:2 10:1 rhythms:1 irregular:1 avoid:1 --:1 should:1 could:1 drug:5 2010:1 patients:2 ongoing:1 massive:1 quarter:1 maker:1
stock_BMY r_up	prevent:1 heart:1 violation:1 blood-thinning:1 blockbuster:1 $:3 federal:1 pay:1 anticlotting:1 should:1 damages:1 selling:1 's:2 strokes:1 million:1 judge:1 approved:1 ruled:1 patent:1 rhythms:1 irregular:1 versions:1 drug:3 generic:1 patients:1 2006:1
stock_BMY r_up	heart:2 experienced:1 thinner:1 have:1 advisory:1 bleeding:1 brain:1 stroke:2 cost:1 committee:1 wider:1 its:1 whose:1 use:2 said:1 generic:1 guidance:1 people:1 attack:3 been:1 recommended:1 draft:1 final:1 independent:1 recommends:1 's:3 risk:1 blood:1 now:1 condition:1 name:1 --:1 disease:1 regulator:1 patients:1 diagnosed:1 called:1 prevention:1
stock_BMY r_up	investors:1 bell:1 move:1 focus:1 session:1 trading:1 numbers:1 have:1 its:2 use:1 stocks:1 cancer:1 eagerly:1 preventing:1 spread:1 potential:1 denosumab:1 quarterly:1 new:1 drug:1 more:1 do:1 's:2 after:1 but:1 results:1 expected:1 key:1 during:1 anticipated:1 data:1 regarding:1 look:1 --:1 reports:1 bone:1
stock_BMY r_down	dollar:1 focus:2 through:1 boosts:1 bell:1 expectations:2 2010:1 earnings:4 good:1 string:1 early:1 know:1 despite:1 report:2 companies:1 fewer:3 large:1 race:1 small:1 quarter:1 posts:2 estimates:1 growth:1 year:3 declined:2 out:1 adds:1 profit:5 opening:1 exceeding:2 shares:4 forecast:1 increase:3 after:1 pharmaceutical:2 continuing:1 blue-chips:1 news:1 beginning:1 reaction:1 recovering:1 battling:1 changed:1 against:1 s:1 analysts:1 slightly:2 maker:3 among:2 revenue:2 into:1 decline:1 little:1 third-quarter:3 per-share:4 reduction:1 stock:2 flat:3 some:1 wake:1 analyst:1 posted:1 ahead:1 economic:1 were:3 spotlight:1 losses:1 outstanding:4 sales:3 drug:3 have:1 allowed:2 need:1 take:1 fourth:1 performance:1 you:1 revision:1 's:4 though:3 price:2 earlier:3 disappointments:1 fell:1 stocks:1 data:2 lower:5 short:1 third:1 fallen:1 costs:3
stock_BMY r_up	roundup:1 saying:1 surprises:2 companies:1 reports:1 quarters:1 advisories:2 earnings:1 future:1 corporate:1 latest:1
stock_BMY r_up	broader:2 cancer:1 sign:1 notice:1 replace:1 chronic:4 hepatitis:1 verge:1 such:1 treatments:1 help:1 pharmaceutical:1 use:1 investors:1 positive:1 granted:2 had:2 been:2 research:1 looking:1 failed:1 finally:1 other:1 treatment:2 which:1 advances:1 new:1 dividends:1 has:1 boost:1 today:1 treat:3 product:2 used:2 's:3 around:1 aging:1 drugs:1 big:1 highs:1 after:2 leukemia:5 but:1 blockbusters:1 drug:3 allowing:2 phase:1 approval:3 now:1 come:1 approved:2 getting:1 --:2 industry:1 hitting:1 against:1 n't:1 information:1 diagnosed:1 fresh:1 starting:1 could:1 first:1
stock_BMY r_down	weight:1 deaths:1 over:1 replace:1 against:1 least:1 verge:1 total:1 debate:1 pharmaceutical:1 been:1 makers:1 looking:1 which:1 big:1 new:1 has:1 boost:1 advances:1 aging:1 drugs:1 cholera:1 treatments:1 blockbusters:1 hepatitis:2 getting:1 industry:1 drug:1 soda:1 bet:1 research:1
stock_BMY r_up	deals:1 right:1 says:2 sail:1 no:1 should:1 executive:1 day:1 n't:2 chief:1 ignore:1 call:1 officer:1 transformative:1 yes:1 boss:1 's:1 until:1 he:1
stock_BMY r_down	projections:1 pipeline:1 big:1 third-quarter:1 call:1 earnings:1 generics:1 10-year:1 new:1 its:2 today:1 gave:1
stock_BMY r_down	control:1 emerging:1 futures:1 picture:1 investors:1 less:1 back:1 awaited:1 elections:1 date:1 session:2 trading:2 pushing:1 edged:1 open:1 its:1 declined:1 whose:2 needs:1 said:1 melanoma:1 won:1 22:1 application:1 rose:1 dramatic:1 point:2 treatment:1 shares:2 finish:1 1.50:1 points:6 fashion:1 months:1 meeting:1 gained:1 500:3 stock:1 flat:1 voters:1 added:1 's:5 index:2 company:1 after:1 but:1 early:1 fell:1 review:1 not:1 decision:1 100:1 stocks:2 than:1 change:1 additional:1 11:2 hours:1 lower:1 15:1 license:1 lost:2 midterm:1 climbed:1 companies:2 up:1 actively:2 3.5:1 three:1 time:1 mixed:1 outcome:1 traded:2 maker:1
stock_BMY r_up	doldrums:2 even:2 's:4 results:2 enough:2 cure:2 election:2 not:2 stocks:2 might:2
stock_BMY r_down	doldrums:1 even:1 cure:1 said:1 's:2 adults:1 --:1 might:1 company:1 results:1 election:1 enough:1 2:3 treatment:1 not:1 stocks:1 type:1 approved:1 diabetes:1
stock_BMY r_down	heart:1 said:1 they:1 drugs:1 certain:1 medical:1 effectiveness:1 should:1 may:1 patients:1 concerns:1 decrease:1 groups:1 despite:1 heartburn:1 still:1 treated:1 taking:1
stock_BMY r_down	still:2 scanning:1 thinner:1 they:1 heart:3 being:1 certain:3 heartburn:2 doctors:1 some:1 '':1 say:1 decrease:2 together:1 year:1 okay:1 should:2 research:1 risk:2 said:2 mix:1 treated:3 avoid:1 p.m.:1 increase:1 drugs:6 version:1 which:1 8:1 bleeding:1 effectiveness:2 correct:1 ``:1 's:2 plans:1 may:3 blunted:1 class:1 after:1 seventh:1 lower:1 effects:1 groups:3 despite:2 stomach:2 such:1 concerns:2 care:1 suggested:1 discourage:1 last:1 --:1 follows:1 medical:3 attacks:1 urged:1 turn:1 patients:3 prescribing:1 could:1 preventive:1 inhibitor:1 makes:1 taking:1 blood:1
stock_BMY r_up	billion:2 set:2 's:4 raise:2 exchange:2 could:2 up:2 drug:2 approved:2 early:2 planned:2 which:2 listing:2 maker:2 $:2
stock_BMY r_down	handing:1 's:1 antipsychotic:1 federal:1 validity:1 patent:1 upheld:1 legal:1 judge:1 blockbuster:1 drug:1 victory:1
stock_BMY r_down	comment:2 biotech:1 stalked:1 being:1 share:1 ``:1 '':1 course:1 have:1 recently:1 buffeted:1 its:1 market:1 unusual:1 said:1 adds:1 jumped:1 had:1 been:1 participants:2 other:1 declined:1 statement:1 largest:1 ordinary:1 company:3 dialogue:2 's:2 business:1 without:1 price:1 after:1 took:2 step:1 regular:2 background:1 rumors:1 part:1 bid:1 announcing:1 --:1 amid:1 industry:2 until:1 takeover:1 analysts:1 speculation:2
stock_BMY r_down	all:1 ended:1 against:1 have:1 rally:1 makers:1 said:1 syndrome:1 no:1 trials:1 anti-clotting:1 improvement:1 apixaban:1 new:1 gets:1 hormone:1 rules:1 after:1 therapy:1 they:1 timing:1 approval:1 meaningful:1 advanced:1 recent:1 showed:1 drug:2 patients:2 changes:1
stock_BMY r_down	lifted:1 financial:3 generation:1 flow:1 move:1 outlook:2 '':1 through:1 further:1 our:1 its:3 ratings:1 said:1 agency:1 policy:1 moderate:1 reflects:2 revision:1 profile:2 ``:1 's:3 company:2 measures:1 expectation:1 strong:1 continued:1 analyst:1 improve:2 term:1 stronger:1 cash:1 credit:1 near:1 continue:1 view:1
stock_BMY r_down	often:1 some:2 disease:2 planning:2 said:2 top:2 agency:2 costs:1 5:1 treat:1 slash:2 more:1 's:2 goes:1 but:1 hand:2 prices:2 artery:2 12:2 19:2 average:2 maximum:2 economic:2 retail:2 starting:2 medicines:2
stock_BMY r_up	respond:1 enjoy:1 do:1 schizophrenia:1 cost:1 aged:1 children:1 n't:2 should:1 recommended:1 stock:1 remedies:1 badly:1 's:7 company:1 react:1 cutting-edge:1 not:1 along:1 15:1 like:1 17:1 --:1 trades:1 drug:2 regulator:1 growth:1 mature:1 its:1
stock_BMY r_up	saying:1 accepted:1 previously:1 42:1 results:1 one:1 four:1 tendered:2 tender:1 250:1 2.6:1 maturing:1 giant:1 said:2 $:6 had:4 exceeding:1 been:2 its:1 note:1 500:1 series:2 final:1 announced:1 gave:1 750:2 offer:3 company:2 million:4 involving:1 nearly:1 debt:3 billion:2 purchase:1 made:1 1.09:1 cap:1 worth:1 --:2 expiration:1
stock_BMY r_down	comment:1 set:2 background:1 proposed:1 backing:2 there:4 fund:1 results:1 manager:1 thinner:3 comments:1 year:3 based:1 its:6 2.4:7 whose:1 said:5 end:2 $:7 would:3 decision:1 generic:1 make:1 initial:3 shares:1 late:2 also:1 much:1 treatment:1 premarket:3 under:1 deal:1 has:3 public:3 exercise:1 closed:1 's:8 which:3 offering:3 provided:1 food:3 marketing:4 price:3 after:2 pharmaceutical:1 priced:1 expected:1 regulators:3 blood:3 gets:1 between:1 approval:4 analyst:1 name:2 billion:4 received:3 lower:2 valued:2 tablet:1 won:2 --:3 country:3 grant:1 up:1 drug:5 worth:1 whether:1 range:2 tentative:1 green:1 came:1 evaluating:1 light:1 marketed:1 share:1 maker:4 experimental:3
stock_BMY r_up	comment:1 biotech:1 background:1 do:1 executive:1 '':1 want:1 type:1 any:1 n't:2 said:2 would:1 event:1 interested:1 wants:1 details:1 which:2 largest:1 sidelines:1 2011:1 2012:1 firm:1 independent:1 ``:1 's:3 company:2 here:1 stay:1 produce:1 shareholder:1 although:1 peers:1 --:1 deals:1 industry:1 headquarters:1 large:1 chief:1 discussing:1 could:1 block:1 partnerships:1
stock_BMY r_up	heart:1 key:1 some:1 expiring:1 its:1 group:1 crucial:1 which:1 test:1 new:1 scheduled:1 product:1 's:3 regulators:1 decide:1 offset:1 hopes:1 pipeline:1 --:1 medicines:1 drug:1 whether:1 faces:1 approve:1 patents:1
stock_BMY r_up	saying:1 another:1 extra:1 cents:1 oversubscribed:1 move:1 share:1 focus:1 trade:1 put:1 see:1 cost:1 been:2 have:2 3.1:1 its:4 whose:1 giant:1 said:1 $:1 topped:1 ways:1 since:1 third-quarter:1 shares:1 looking:1 way:1 quarterly:1 slightly:1 offer:1 flat:1 penny:1 increased:1 sitting:1 boosted:1 company:1 million:1 watch:1 use:1 but:1 sales:1 expected:1 fell:1 they:1 active:1 dividend:1 month:1 expectations:1 payout:1 2009:1 17:1 33:1 boost:1 companies:1 cash:2 drug:1 recession:1 profit:1 session:1 were:1 following:1 quarter:1 similar:1 spend:1
stock_BMY r_up	rating:1 over:1 dollar:1 session:2 its:2 whose:2 zone:1 rose:1 8:1 returned:2 showing:1 inflation:2 despite:1 advanced:1 lost:1 --:1 warned:1 companies:2 morning:1 worries:2 higher:1 euro-zone:1 3.6:1 actively:2 trading:2 makers:2 declined:1 index:1 blue-chip:1 since:1 shares:2 new:2 conditions:1 creating:2 drug:2 downgrade:1 100:1 manufacturing:2 gained:1 improved:1 ahead:1 33:1 climbed:2 against:1 credit:1 mixed:1 traded:2 major:2 slipped:1 point:1 into:2 down:1 forefront:1 debt:1 remains:1 there:2 tame:1 rivals:1 markets:2 500:3 more:2 posting:1 drugs:2 0.4:1 highest:1 11:1 kind:2 up:1 value:1 while:4 making:2 closing:1 spotlight:1 moved:2 1.9:1 dropped:2 diseases:2 ratings:1 4.6:1 48:1 agency:1 also:1 stock:2 oil:1 's:3 may:1 after:1 fast-growing:2 fell:2 stocks:2 data:2 euro:1 futures:5 points:8 push:2 2008:1
stock_BMY r_down	comment:1 heart:2 revenue:1 win:1 delaying:1 blood-thinning:1 another:1 approval:1 its:1 impact:1 again:1 needs:1 said:1 adds:1 patent:1 decision:1 exposed:1 failed:1 new:4 suffered:1 has:1 more:1 expiring:1 blow:1 product:1 's:5 information:1 some:1 company:1 after:1 most:1 regulators:1 protection:1 key:3 offset:1 losing:1 group:1 wanted:1 pipeline:1 --:1 medicines:1 drug:5 whether:1 products:1 study:1 approve:1 maker:1 patents:1
stock_BMY r_up	do:1 we:3 swans:1 's:2 ugly:1 predict:1 writes:1 but:1 forecasts:1 n't:2 next:1 ducklings:1 five:1 know:1 year:1 need:1 ca:1 face:1 2011:1 birds:1 today:1
stock_BMY r_down	development:3 named:2 financial:1 they:1 biotech:1 reductions:2 national:1 direction:1 joined:1 '':2 remarks:1 gaps:1 pricing:1 have:1 year:1 close:1 moves:1 its:1 help:1 conference:1 said:2 much:1 lead:1 also:1 remains:1 pay:1 since:1 future:1 negative:1 been:1 research:2 may:1 company:3 former:1 going:1 health:1 under:1 webcast:1 new:1 heavier:1 2011:1 leader:1 empty:1 told:1 available:1 ``:2 finding:1 's:2 drugs:1 price:1 results:1 scientist:1 pressure:2 restructuring:1 important:1 significant:1 organization:1 prices:2 post:1 hurt:1 investor:1 than:1 past:1 changes:1 has:1 prescription:1 programs:1 we:1 corporate:1 could:1 budget:1 drug:1 --:1 recently:1 continue:1 '09:2 situation:1 efforts:1 2009:1 head:2 challenge:1 rebates:1 result:1
stock_BMY r_down	fourth-quarter:1 set:1 session:3 0.8:1 companies:3 sixth:1 1.8:1 2.9:1 actively:3 trading:4 dropped:5 losses:1 close:1 open:1 declined:2 whose:3 giant:1 4.6:2 slipped:1 5.6:1 blue-chip:1 42:1 shares:3 ahead:1 earnings:1 closed:1 declines:1 markets:2 500:4 stock:2 week:2 11:1 's:3 index:2 season:1 after:1 but:1 sentiment:1 following:1 75:1 fell:1 last:1 100:1 stocks:3 posted:1 gained:2 lower:2 off:1 aluminum:1 lost:3 40:1 straight:1 futures:3 37:1 points:12 kick:1 after-hours:1 mixed:1 finishing:1 higher:1 traded:2 souring:1
stock_BMY r_up	standing:1 's:2 business:1 health-care:1 companies:1 their:1 audiences:1 strategies:1
stock_BMY r_down	biotech:1 people:1 over:1 years:1 high:1 culture:1 massive:1 dividend:1 go:1 's:1 cold:1 whose:1 use:1 productivity:1 pharma:1 long:1 research:2 equipment:1 winners:1 electrical:1 inject:1 new:1 has:1 pal:1 into:1 stock:1 development:1 head:1 his:1 terms:1 index:1 company:1 usually:1 groups:1 hopes:1 such:1 data:1 recent:1 short:1 --:3 tricks:1 put:1 up:1 2010:2 can:2 small:1
stock_BMY r_down	because:1 set:1 over:1 years:1 likely:1 smaller:1 tablets:1 cuts:1 explosive:1 next:1 makers:1 pharmaceutical:2 offering:1 lead:1 make:1 opportunities:1 grow:1 few:1 concerns:1 growth:1 policy:1 firms:1 local:1 outweigh:2 's:3 risk:2 efficacy:1 may:2 big:1 price:1 million:1 overseas:1 flurry:1 recalled:1 although:1 bumpy:1 affect:1 hypertension:1 manufacturing:1 problem:1 acquisitions:1 both:1 piles:1 industry:3 could:2 cash:1 drug:5 other:1 path:1 renew:1 overpay:1 64:1 diversify:1 reward:2 changes:1 spend:1 say:1
stock_BMY r_up	screen:1 but:1 much:1 today:1 carnage:1 red:1
stock_BMY r_up	opinions:1 said:1 granting:1 --:1 positive:1 medicines:1 recommending:1 adopted:1 marketing:1 following:1 new:1
stock_BMY r_down	operations:1 interests:1 says:1 penny:1 some:1 group:1 '':1 have:1 innovative:1 shareholders:1 cut:1 'll:1 $:1 patent:1 deeply:1 fix:1 been:1 strategy:1 rivals:1 4:1 which:1 new:1 has:1 discovery:1 development:1 ``:1 his:2 's:3 earnings:1 but:1 like:1 met:1 every:1 offset:1 during:1 hurt:1 those:1 he:1 billion:1 brought:1 search:1 last:1 products:1 --:3 many:1 annual:1 budget:1 drug:1 patients:1 ensure:1 failures:1 husband:1
stock_BMY r_up	extra:2 them:2 said:3 's:4 additional:1 months:3 --:1 there:1 granted:3 six:3 companies:1 blood-thinner:2 drug:1 blockbuster:1 their:3 anticlotting:1 exclusivity:1 has:1 market:3
stock_BMY r_down	fourth-quarter:1 medication:1 financial:1 people:1 well:1 global:1 share:1 focus:1 trade:1 risks:1 n't:1 see:1 session:1 drug:3 big-cap:1 blockbuster:1 find:1 industries:1 whose:1 needs:1 said:1 antipsychotic:1 flux:1 ways:2 providers:1 outside:1 shares:1 research:1 recommended:1 tape:1 treatment:1 way:1 capital:1 expected:1 new:1 firms:1 too:1 development:1 do:1 's:3 greater:1 pharmaceutical:1 read:1 watch:1 react:1 pharma:1 they:1 health-cost:1 active:1 along:1 years:1 than:1 change:2 must:2 15:1 sectors:1 17:1 --:3 industry:2 companies:1 schizophrenia:1 reports:1 regulator:1 aged:1 funded:1 heart:1
stock_BMY r_up	12000:4 all:1 3.75:1 issued:1 over:2 move:1 find:1 years:2 higher:2 year-earlier:3 its:1 weekly:2 overhaul:1 rose:8 expectations:1 citing:1 2011:3 details:1 division:1 effects:1 --:1 morning:1 large:3 quarter:1 heavy:1 related:1 economic:3 trading:3 year:1 inflated:3 dives:2 2.5:1 said:4 profit:3 forecast:1 above:1 schedule:1 reported:1 address:2 downgrade:2 dividend:1 100:2 debt:2 last:1 getting:1 reports:1 range:1 fell:3 massive:1 graph:1 mixed:1 narrow:1 slightly:3 maker:2 south:1 first:3 comment:1 fourth-quarter:3 12,000:1 period:3 awaited:2 sovereign:2 along:1 market:1 jobless:2 basis:2 positive:2 housing:2 due:1 year-ago:3 today:1 flat:1 direction:1 0.2:1 company:2 6:1 wake:2 gain:9 sharply:1 94:7 those:2 15:1 recall:1 plunged:3 while:5 louder:1 500:2 evaluating:1 were:2 closing:1 spotlight:2 biotech:1 associated:1 investors:2 health-care:1 0.5:1 sales:3 drug:5 slip:2 again:2 pay:1 began:1 topped:2 also:2 points:6 earnings:8 struggling:1 roll:1 stock:2 product:1 's:4 4th:1 two:2 such:3 stocks:3 data:5 lower:1 short:2 deluge:1 largely:1 6th:1 futures:2 divestiture:3 costs:1 experimental:1 time:2 claims:2 corporate:1 left:1
stock_BMY r_down	saying:1 1300:1 being:1 supported:1 dollar:1 quarters:1 comments:1 still:1 its:1 blow:1 surprises:2 had:1 advisories:2 suffered:2 has:1 pill:1 day:1 --:1 companies:1 speculation:1 higher:2 unexpected:1 series:1 jump:1 second:1 fail:2 close:1 said:2 adds:1 shares:1 misses:1 safety:1 medicine:1 setbacks:1 ends:1 drug:1 takeover:3 refuses:1 news:1 roundup:1 trader:1 months:1 12000:2 trial:1 analysts:1 grounds:1 into:1 hurdle:1 been:1 hardly:1 500:1 ``:2 company:1 but:3 stick:1 '':2 target:1 below:1 future:1 biotech:1 turned:1 sleeping:1 helped:1 reports:1 have:1 recover:1 viewed:1 blockbuster:1 rumors:1 traders:1 potential:1 earnings:1 which:3 largest:1 stock:1 development:2 hurdles:2 's:2 after:1 hair:1 stocks:1 recent:1 clear:2 edge:1 first:1 corporate:1 latest:2
stock_BMY r_down	his:1 ordered:1 deceiving:1 sentence:1 government:1 write:1 part:1 judge:1 book:1
stock_BMY r_up	take:1 purchases:1 runs:1 his:1 's:1 another:1 doctor:1 company:1 health-care:1 bottom:1 shares:2 month:1 insider:1 too:1 sharply:1 last:1 line:1 out:1 bite:1 bought:1
stock_BMY r_up	two:1 major:2 illness:2 another:1 cancer:1 people:1 series:1 doubt:1 number:1 competition:1 replace:1 clot:1 regulatory:1 because:1 including:1 lung-cancer:2 reports:1 recommendation:1 patient:2 throughout:1 market:1 halt:1 setbacks:1 pharmaceutical:2 different:2 one:1 based:1 cast:1 generic:1 revenue:1 due:2 same:2 research:1 current:1 their:1 investigational:1 clinical:2 safety:1 details:1 new:1 themselves:4 stock:1 's:6 continue:1 drugs:2 sixth:1 clots:3 halted:1 blood:3 background:1 cures:2 prices:1 world:2 future:1 concerns:3 advanced:1 panel:1 received:1 lost:1 bring:1 follows:1 enrollment:3 companies:2 drug:6 trial:4 prescribing:2 stopped:2 diagnosed:2 have:1 following:1 lung:1 efforts:1 first:1 studies:1 could:1 experimental:2 updates:1
stock_BMY r_up	leaders:1 investors:1 lines:1 billions:1 against:1 bottom:1 two:1 research:1 better:1 returns:1 5:2 biggest:1 new:1 2011:3 divergent:1 week:1 's:1 could:1 deliver:1 treatments:1 pressure:1 balancing:1 they:1 world:1 made:1 like:1 boost:1 dollars:1 companies:2 drug:2 choices:1 spend:1
stock_BMY r_up	saying:2 consider:1 executive:2 against:1 human:1 battle:2 shrugged:2 its:2 overhaul:2 should:1 better:1 version:1 4:1 boardroom:2 has:1 sent:1 divergent:1 bid:1 pave:2 balancing:1 they:1 world:1 hedge:1 investor:4 --:3 fully:2 companies:1 follows:1 leaders:1 election:1 investment:1 lead:2 research:1 asking:1 new:1 correct:1 attention:1 deliver:1 drew:2 pressure:1 takeover:3 group:1 received:1 could:4 comment:1 leadership:1 a.m.:1 antibody:2 top:2 experimental:1 criticism:2 cancer:1 billions:1 unit:1 5th:1 two:1 returns:1 2:1 interest:1 biggest:1 launching:2 more:1 firm:6 ``:1 way:2 company:5 fund:2 hopes:2 surged:1 than:1 made:1 board:3 choices:1 remain:2 called:2 shakeup:2 biotech:6 investors:1 backing:2 '':1 pushed:1 drug:3 no:1 dollars:1 also:1 chairman:3 largest:6 week:1 independent:3 's:15 after:1 resign:1 shareholder:1 letter:1 brass:2 off:2 amid:1 sale:3 chief:2 spend:1
stock_BMY r_up	firm:2 biotech:1 renewed:1 's:4 challenging:1 has:1 --:1 received:1 its:1 offer:1 takeover:1 call:1 board:1 largest:1 no:1 shake-up:1 strategy:1 investment:1
stock_BMY r_up	deal:1 sales:1 due:1 beyond:1 blow:1 huge:1 patent:1 best-selling:1 two:1 pharmacy:1 2012:3 hit:1 expirations:1 drugs:1 wave:1 kicking:1 fall:1 world:1 10:1 off:1 versions:1 shelves:1 drug:1 generic:1
stock_BMY r_up	control:1 biotech:1 smaller:1 depart:1 deal:2 then:1 acquired:1 hard:2 deals:1 challenges:1 ended:2 expect:1 another:1 hit:1 makers:1 risk:1 pharmaceutical:1 said:1 $:1 specialty-drug:1 avoid:1 had:1 system:1 long:2 tend:1 finally:2 assets:1 attractive:1 lot:1 new:1 has:2 might:1 week:1 meets:1 full:1 's:4 tried:1 purchasing:1 track:1 got:1 company:1 but:3 following:1 part:2 pitfalls:1 biotechnology:1 frequently:1 courtship:2 now:2 chatter:1 those:1 like:1 billion:1 made:1 talent:1 look:1 these:1 project:1 --:1 work:2 companies:1 large:1 record:1 future:1 marriage:2 acquisition:3 mixed:1 making:2 2009:1 its:1 comes:2
stock_BMY r_up	``:1 16:1 remains:1 corrected:1 had:1 site:1 '':1 version:1 closed:1 published:1 follows:1 11th:1 open:1 operation:1 pm:1
stock_BMY r_up	heavy:1 pharmaceutical:1 prospects:1 sector:1 bears:1 over:1 bulls:1 activity:1
stock_BMY r_down	calls:1 could:1 drug:1 surge:1 key:1 approves:1 if:1
stock_BMY r_up	symptoms:1 already:1 started:1 outperform:1 showing:1 health-care:1 n't:2 're:1 they:1 stocks:1 top:1 market:1
stock_BMY r_down	67:1 sales:1 setback:1 rate:1 35:1 year:1 little:1 $:3 writes:1 40:1 between:1 shrink:1 development:1 's:1 big:1 drug:2 base:1 diabetes:1 billion:3 could:1 policyholders:1 face:1 hikes:1 faces:1 worries:1
stock_BMY r_down	billion:1 contested:1 last:1 $:1 sales:1 according:1 blockers:1 accounted:1 year:1 8.4:1
stock_BMY r_up	firm:1 major:1 's:1 six:1 redefine:1 should:1 accelerated:1 board:2 members:1 new:1 naming:1 strategy:1 efforts:1 shakeup:1
stock_BMY r_up	brain:1 soaring:1 trading:3 animal-health:1 close:1 shines:2 open:1 its:1 before:1 4.1:1 power:1 damage:1 shares:1 call:1 treatment:1 shows:1 ...:1 's:2 combination:1 drugs:1 price:1 after:1 news:1 repairing:1 off:1 effective:1 drug-stock:1 study:1 up:1 reports:1 prescribing:1 following:1 rising:1 multiple-sclerosis:1 came:1
stock_BMY r_down	sector:1 one-year:1 right:1 help:1 propel:1 modestly:1 past:1 have:1 year:1 close:1 overhaul:1 $:3 anniversary:1 indexes:1 health:2 has:1 events:1 stock:1 ...:1 we:2 oil:3 's:2 big:1 after:1 hits:2 'd:3 end:2 stocks:2 104:3 care:2 lower:3 look:1 bill:1 three-session:1 surge:1 barrel:3 treated:1
stock_BMY r_up	firm:1 product:1 medication:1 return:1 rights:1 amid:1 agreed:1 pipeline:1 investigational:1 review:1 partner:1 's:1 its:1
stock_BMY r_up	promises:2 financial:1 cancer:2 results:1 drug:1 skin:2 shines:2 melanoma:2 rocket:1 fight:2 prolong:2 treatment:2 quarterly:1 boost:2 higher:2 form:2 after:1 lives:2 significant:2 approval:2 stocks:2 received:2 turns:1 against:2 patients:2 edge:2 time:2 maker:1 first:2
stock_BMY r_down	n't:1 sue:1 prescription:1 pharmaceutical:1 drugs:1 large:1 ca:1 health-care:1 companies:1 allegations:1 county:1 facilities:1 overcharged:1 they:1 public:1 ruled:1
stock_BMY r_up	major:1 brakes:1 price:1 companies:1 drug:1 increases:1 pressing:1 including:1 groups:1 put:1 religious:1
stock_BMY r_up	development:1 blue:2 great:1 spinoffs:2 ripe:2 get:1 drugs:1 chips:2 could:1 shareholder:1 value:1 2:2 businesses:1 can:1 way:1 enhance:1 boost:1 writes:1 nice:1
stock_BMY r_up	rating:1 benefits:1 retailer:1 drug:1 pharmacy:1 manager:1 shares:1 gives:1
stock_BMY r_down	all:1 prescriptions:1 drugs:1 make:1 up:1 according:1 now:1 78:1
stock_BMY r_up	saying:1 help:2 results:4 quarters:1 including:6 cuts:1 portfolio:2 its:11 $:2 surprises:2 expectations:2 advisories:2 has:2 take:1 updated:1 beat:2 big:1 watch:2 sellers:2 background:1 despite:1 report:1 years:2 chips:1 lost:2 --:1 companies:3 facing:1 lose:2 better-than-expected:1 shed:2 slower:1 some:1 competition:3 challenges:1 growth:4 projections:1 year:2 2.3:2 's:7 out:1 blue:1 said:1 lead:2 profit:1 anticlotting:3 comments:1 formula:2 bolster:2 noise:1 seventh:1 protection:2 offset:2 backed:1 beginning:3 stage:1 roundup:1 reaction:1 successes:2 drug:8 spending:1 afternoon:1 analysts:2 rose:4 south:2 benefited:2 features:1 revenue:2 three:1 names:1 conference:1 pharmaceutical:4 addition:1 leading:1 top:3 due:1 next:2 call:1 more:1 billion:2 drugs:4 company:4 baby:2 analyst:1 center:1 include:1 up:2 33:10 future:1 were:1 making:1 acquisition:2 biotech:3 health-care:1 sales:5 helped:1 full-year:1 hypertension:1 reports:2 proceeds:2 again:1 generic:3 make:2 other:3 earnings:6 which:2 new:2 stock:1 used:2 first-quarter:4 price:2 looming:1 helping:2 such:3 stocks:3 recent:2 acquisitions:2 assets:2 third:1 later:1 commodities:1 patent:2 2009:2 corporate:1 came:3 latest:3
stock_BMY r_down	limited:1 financial:1 sticks:1 previously:1 sales:1 competition:1 growth:1 year:1 its:2 said:1 profit:4 forecast:1 1:1 quarterly:3 2011:1 higher:2 first-quarter:1 drugs:1 earlier:1 but:1 acquisition-related:1 tripled:1 lower:1 reports:3 generic:1 while:1 costs:1
stock_BMY r_up	said:1 's:1 prompted:1 trades:1 health-care:1 companies:1 50:1 than:1 cancel:1 bad:1 evening:1 trading:1 4:3 exchanges:1 basket:1 brokerage:1 stocks:1 order:1 after-hours:1 more:1
stock_BMY r_down	remedies:1 increase:1 ``:1 asthma:1 16:2 warns:1 equal:1 '':1 merging:1 health:1 rates:1 open:1 its:1 unit:1
stock_BMY r_down	saying:1 certain:1 health-care:1 sign:1 high:1 cost:1 another:1 arm:1 expensive:1 said:1 group:1 pay:1 system:1 should:1 their:2 outweighs:1 's:1 drugs:1 leukemia:1 opposition:1 prices:1 benefits:1 drug:1 n't:1 patients:1 growing:1
stock_BMY r_up	do:1 recommends:1 's:2 cancer:1 prevent:1 cost-effectiveness:1 leukemia:1 against:1 n't:1 been:1 certain:1 subpoenaed:1 says:1 seem:1 prostate:1 panel:1
stock_BMY r_down	buy:1 recently:1 something:1 earnings:1 button:1 since:1 expectations:1 been:1 month:1 tear:1 analysts:1 beat:1 last:1 has:1 stock:1
stock_BMY r_up	good:1 's:1 less:1 drugs:1 make:1 companies:1 drug:1 treatment:1 same:1 news:1 makes:1 those:1
stock_BMY r_down	initial:2 up:1 cents:1 nutritional:2 product:2 2nd:1 '':1 10,000:6 his:1 been:2 have:1 year:1 's:5 its:2 24:2 $:6 since:4 shares:10 version:1 chairman:2 formula:2 has:2 correct:1 week:2 spiked:1 ``:1 buy:3 recently:1 offering:2 sixth:3 company:6 iconic:2 sold:2 baby:2 spree:2 buying:2 21:1 purchase:3 last:2 like:2 17:2 --:2 follows:1 spent:3 public:2 products:2 each:2 2009:2 traded:1 maker:2 block:3
stock_BMY r_down	watch:2 trade:1 active:1 see:1 session:1 expected:1
stock_BMY r_down	blue:1 open:1 ahead:1 sit:1 had:1 watch:2 been:1 one:1 screens:1 radar:1 anticipated:1 chips:1 than:1 investors’:1 more:1
stock_BMY r_down	annual:1 cancer:1 one:1 four:1 growth:1 scientific:1 death:1 ovarian:1 clinical:1 online:1 new:1 include:1 meeting:1 more:1 evening:1 return:1 4,000:1 upcoming:1 notable:1 delayed:1 slated:1 early:1 most:1 compared:1 nearly:1 found:1 article:1 data:1 than:1 women:1 study:1 months:1 companies:1 drug:1 tumor:1 trial:1 published:2 serious:1 placebo:1 studies:1 experimental:1
stock_BMY r_down	body:1 thinner:1 adults:1 cancer:2 people:2 backing:1 skin:1 year:1 treatment:1 recommending:1 have:2 approval:1 surgery:1 its:1 said:2 melanoma:3 granting:1 positive:1 live:1 adopted:1 also:1 recommended:1 spread:1 health:1 helps:1 which:1 new:1 has:1 type:1 treat:1 hip:1 hard:1 's:3 intended:1 marketing:1 clots:1 regulators:2 opinions:1 blood:2 knee:1 approved:1 advanced:2 received:2 longer:1 --:2 parts:1 drug:2 other:1 prior:1 patients:1 diagnosed:1 each:1 therapy:1 once:1 called:1 prevention:1 replacement:1
stock_BMY r_down	major:1 renewed:1 follows:2 over:1 fears:1 drug:1 loses:1 debt:1 trading:1 market:3 broader:3 fall:1 ground:1 crisis:1 makers:1 south:2 afternoon:1
stock_BMY r_up	...:2 his:1 crash:2 just:2 no:2 optimistic:1 least:1 standards:1 editor:1 sees:2 yet:2 relatively:1
stock_BMY r_up	later:1 cancer:2 people:1 focus:1 one:1 '':1 skin:1 melanoma:1 attend:1 conferences:1 deadly:1 version:1 largest:1 more:1 week:1 ``:1 's:2 form:1 corrected:1 world:1 than:1 11:1 17th:1 name:1 --:1 follows:1 annual:1 drug:1 a.m.:1 published:1 30,000:1 called:1
stock_BMY r_down	control:1 later:1 ago:1 cancer:2 people:1 attend:1 certain:1 focus:1 one:2 down:1 medical:1 see:1 trading:1 shares:1 skin:1 pills:1 4,000:1 melanoma:2 $:1 conferences:1 privacy:1 leading:1 two:1 40:1 released:1 3:1 willing:1 safety:1 way:1 provider:1 clinical:1 weeks:1 meeting:2 more:2 week:1 200:3 ``:1 handful:1 's:1 bolt-on:1 form:1 published:1 notable:1 early:1 deadly:1 were:1 acquisitions:1 birth:1 services:1 article:1 stocks:1 revealed:1 than:3 those:1 billion:1 '':1 lower:1 largest:1 world:1 most:1 --:2 could:1 annual:1 discussed:1 reports:1 called:1 sensitive:1 points:1 afternoon:1 pay:1 including:1 climb:1 30,000:1 studies:3 economically:1
stock_BMY r_down	control:1 cancer:1 agreed:1 high:1 ended:1 specific:1 melanoma:1 review:1 increase:1 their:1 genetic:1 safety:1 do:1 used:1 risk:1 combination:1 drugs:2 pressure:1 blood:1 class:1 treating:1 --:2 medicines:1 work:1 n't:3 patients:1 study:1
stock_BMY r_down	investors:1 deaths:1 reported:1 testing:1 potent:1 rising:1 shares:1 year:1 winds:1 research:1 seek:1 tomorrow:1 even:1 better:1 use:2 cancer:3 been:1 its:1 increase:2 their:1 returns:1 concerns:1 treat:2 expected:2 surprise:1 you:1 has:1 meeting:1 into:1 more:1 development:1 do:1 begin:1 move:1 's:2 far:1 company:1 earlier:2 notable:1 update:1 treatments:1 most:1 fell:1 effects:1 plenty:1 17:1 developing:1 --:2 could:1 companies:2 up:1 drug:3 side:1 investment:1 so:1 buzz:1 stages:1 think:1
stock_BMY r_up	19.5:1 smaller:1 cancer:4 deaths:2 beginning:1 among:1 argues:1 promise:1 same:1 prostate-cancer:1 measure:1 types:1 multiple:1 11th:1 hospitals:1 its:1 booming:1 use:1 designed:1 keen:1 prostate:1 there:1 shares:1 should:1 six:1 clinical:1 study:1 details:1 annual:1 new:2 effectiveness:2 markets:1 company:1 shows:1 do:1 's:8 business:1 price:1 time:1 update:1 reported:1 pricey:1 fell:1 updates:1 rising:1 despite:1 evidence:1 data:2 concerns:1 advanced:1 treating:1 kind:1 benefits:1 look:1 showed:2 getting:1 --:1 meeting:1 region:1 countries:1 companies:1 drug:5 trial:1 patients:1 were:1 military:1 stock:1 side:1 effects:1
stock_BMY r_down	plant:2 said:2 last:2 corrective:2 satisfied:2 drug:2 took:2 drew:2 regulators:2 resolve:2 actions:2 letter:2 year:2 manufacturing:2 warning:2 maker:2
stock_BMY r_up	now:1 because:1 prompt:1 they:1 cancer:4 focus:2 system:2 cure:1 seen:1 resilience:1 help:1 accepted:1 immune:2 provide:1 overcoming:1 fight:2 increase:1 field:1 treatment:1 which:1 widespread:1 increasing:1 more:1 body:1 eventually:1 's:3 any:1 form:1 may:1 approvals:1 resistance:1 solution:1 immunotherapies:1 key:2 using:1 validate:1 hold:2 effort:1 harnessing:1 has:1 --:4 could:1 larger:1 disease:2 their:1 successes:1 part:1 can:1 long-term:2 become:1
stock_BMY r_up	cancer:3 some:1 curb:1 patient:1 reducing:1 medications:1 develop:1 hospital:1 system:1 fight:1 immune:1 permanently:1 treatment:1 suit:1 hold:1 immunity:1 body:1 's:1 form:1 may:1 keeping:1 key:1 specialists:1 believe:1 spur:1 harnessing:1 scrambling:1 38:2
stock_BMY r_down	sell:2 prevent:2 rejection:2 brand:2 drug:2 maker:2 patients:2 treatment:2 which:2 under:2 's:6 receiving:2 approved:2 kidney:2
stock_BMY r_up	sector:1 over:1 trade:1 session:1 including:1 legal:1 before:1 25:1 revenue:1 had:1 has:1 watch:1 despite:1 lost:1 --:1 follows:2 companies:1 morning:1 lose:1 worries:1 round:1 better-than-expected:1 shed:1 set:1 economic:1 declined:1 index:1 shares:1 3:2 version:2 7:1 opening:1 protection:1 100:2 debt:1 reaction:2 many:1 31:1 drug:1 side:2 fell:1 approaching:1 fallen:1 bell:1 billions:1 down:1 been:1 open:1 crisis:1 story:2 fast:1 long:1 pharmaceuticals:1 chugging:1 recent:1 markets:1 500:1 allergic:2 ``:3 drugs:1 corrected:2 expected:1 13:1 made:1 hour:1 versions:1 while:2 actively:1 were:1 toward:1 similar:1 dollars:1 0.3:1 '':3 sap:1 patent:1 5:3 's:4 effect:2 most:1 involving:1 46:1 stocks:2 data:2 cliff:2 lower:1 whose:1 onto:1 futures:3 generic:1 points:4
stock_BMY r_up	edition:1 2011:1 17:1
stock_BMY r_up	midpoint:2 global:2 dollar:1 results:2 trade:2 against:1 6.4:1 coli:1 prospects:1 its:6 weekly:1 24:1 adding:1 cut:2 group:1 hint:2 premarket:1 equity:1 fuel:1 has:1 2011:2 risk:2 get:2 3.65:2 weakness:1 rise:4 watch:2 early:1 putting:2 additional:2 fall:2 report:1 austerity:1 day:2 lost:2 56:1 companies:5 session:4 testing:1 round:3 better-than-expected:1 heavy:1 prompted:1 signs:2 second:2 actively:4 trading:3 year:2 further:1 declined:4 out:1 closes:1 said:1 stands:1 pressured:2 profit:1 patients:1 shares:5 forecast:2 medicine:1 new:1 boost:2 reporting:1 core:1 after:5 jobs:1 sinks:2 whose:4 continuing:1 attention:1 notable:1 standard:1 drug:2 no:2 key:1 analyzed:1 news:2 spark:1 declining:2 jobless:5 hits:2 2.8:2 irregular:1 losses:3 reports:2 paring:1 heartbeat:1 blood:3 among:3 outlook:3 thinner:3 projection:2 point:1 into:1 down:2 shun:1 3.2:2 weak:1 another:1 reached:2 100:2 pouring:1 8.5:1 investors:3 their:1 positive:1 faltering:1 larger-than-expected:1 start:2 doubt:1 biggest:2 bonds:1 territory:1 500:5 more:1 selling:1 efficacy:1 funds:1 offered:2 slump:1 39:1 but:3 expected:2 lowered:2 wake:1 goals:1 than:1 showed:1 rival:1 likely:1 late-stage:1 while:2 growth:10 were:1 following:1 making:1 steep:1 spotlight:2 1.4:1 slid:3 1.1:1 1.2:1 1.3:1 slowing:2 strain:1 stroke:1 caution:2 dropped:2 spooked:1 moves:1 again:1 respective:1 easing:2 5.5:1 trial:2 government:1 preventing:1 concerns:1 5:1 stock:8 gaining:2 draw:1 used:1 's:10 index:3 strokes:1 earlier:1 extending:1 fell:7 plan:3 quantitative:2 authorities:1 such:1 stocks:11 data:3 euro:1 lower:2 downbeat:1 futures:8 disease:1 traditional:1 points:8 time:2 claims:5 once:1 latest:2
stock_BMY r_down	blood-thinner:1 thinner:1 says:1 session:1 true:1 ``:1 slid:1 3.6:1 ended:1 actively:1 trading:1 shakes:2 whose:1 '':1 rose:1 shares:1 pharmaceuticals:1 new:1 500:1 all:1 good:1 's:1 apixaban:1 big:1 but:1 results:1 release:1 fell:1 moving:1 blood:1 key:1 news:1 stocks:4 come:1 analyst:1 gained:1 60:1 lost:1 18:1 study:4 companies:1 drug:1 points:3 after-hours:1 mixed:1 dream:1 late-stage:1
stock_BMY r_down	control:1 week:1 weight:1 developed:1 results:1 colors:1 coli:1 headlines:1 out:1 votes:1 said:2 takes:1 incomes:1 spending:3 positive:1 had:1 two:1 sugar:1 their:1 investigational:1 pivotal:1 earnings:1 certain:1 new:1 type:1 higher:1 scheduled:1 lowering:1 draw:1 parliament:1 controlled:1 company:1 attention:1 watch:2 but:1 scrutiny:1 early:1 blood:1 they:1 compound:1 front:1 sustained:1 austerity:1 data:1 developments:1 diabetes:3 infections:1 effective:1 tobacco:1 --:1 study:1 later:2 well:1 rate:1 drug:2 turn:1 patients:2 consumer:2 spotlight:2 latest:1
stock_BMY r_up	heart:1 use:1 said:1 's:1 --:1 watchdog:1 drug:1 backing:1 won:1 key:1 healthcare:1 new:1 has:1 cost-effectiveness:1 its:1
stock_BMY r_up	prevent:1 clots:1 drug:1 blood:1 new:1 approved:1
stock_BMY r_up	restructure:1 global:1 divestitures:4 including:2 spinoff:1 follow:1 aggressive:2 its:6 giant:2 20:1 pharma:1 graph:1 treatment:1 pursuing:2 include:1 worth:1 appointment:1 novel:1 updates:2 background:1 spinoffs:2 --:3 each:1 businesses:3 result:2 animal-health:3 portfolio:2 said:2 review:2 research:1 new:1 announced:2 business:2 agreement:1 members:1 group:1 beginning:1 $:1 could:2 analysts:1 efforts:1 onto:2 options:3 road:1 cancer:1 strategic:2 down:1 throughout:2 unit:3 pharmaceutical:1 management:1 additional:2 two:1 2:2 more:4 nutrition:4 diversified:2 but:2 part:1 multi-month:1 hold:2 those:1 troubled:1 up:1 n't:2 drops:2 hoping:2 investors:2 exploring:3 health-care:2 sales:2 disappointing:2 say:1 organizational:1 proceeds:1 potential:1 details:3 which:1 units:2 stock:2 development:3 's:4 generic-drug:2 transactions:1 may:1 price:2 segment:1 structure:1 billion:1 disappointment:2 third:1 antibody:1 sale:1 consumer:2
stock_BMY r_down	agency:1 all:1 short:1 20:1 just:1 drugs:1 top:1 year:1 according:1 2010:1 one:1 far:1 so:1 new:1 total:1 's:2 has:1 approved:1 official:1
stock_BMY r_up	's:3 antipsychotics:1 warnings:1 drugs:1 older:1 powerful:1 elderly:1 patients:2 treat:1 using:1 risks:1
stock_BMY r_up	strongly:1 reforms:1 some:1 hit:1 crisis:1 concern:1 said:1 mounting:1 sovereign:1 interview:1 head:1 regional:1 's:2 pose:1 but:1 despite:1 debt:1 payment:1 severely:1 countries:1 --:1 region:1 performing:1 drug:1 healthcare:1 growing:1 maker:1
stock_BMY r_up	comment:1 cancer:4 certain:1 warns:1 fee-for-service:1 vary:1 years:1 pricing:1 have:3 skin:3 march:1 alternative:1 its:3 said:3 melanoma:4 system:1 deadly:3 immunotherapy:1 fight:1 immune:1 5:1 treat:3 under:1 new:3 type:3 brand:1 body:1 's:2 sold:1 20:1 most:3 regulators:3 mesh:1 uses:1 approval:2 approved:4 name:1 --:5 drug:6 patients:3 late-stage:4
stock_BMY r_down	investors:1 one:2 '':1 decisions:2 any:1 braces:2 highest:1 title:1 patent:1 crucial:2 two:2 reliance:2 few:2 version:1 new:2 increasing:2 correct:1 week:3 ``:1 's:4 watching:1 company:1 looming:1 announcements:1 its:1 regulators:2 key:2 coming:2 2:5 2nd:1 exposure:1 has:1 assets:2 --:2 follows:1 medicines:2 so:1 drug:3 regulator:1 products:1 makes:2 maker:3
stock_BMY r_down	week:1 's:3 scientific:1 showcase:1 drugs:1 companies:1 disease:1 diagnostic:1 their:1 investigational:1 imaging:1 tools:1 makers:1 developments:1 latest:1
stock_BMY r_up	advisory:1 being:1 developed:1 drug:2 before:1 information:1 said:1 federal:1 marketed:1 should:1 needed:1 concerns:1 safety:1 voted:1 certain:1 new:1 panel:1 type:1 more:1 's:2 slow:1 address:1 diabetes:1 reverse:1 --:1 disease:1 against:1 n't:2 s:1 called:1 aimed:1
stock_BMY r_up	advisory:4 help:1 proposed:2 saying:1 being:3 developed:3 results:1 competitive:1 including:2 its:3 before:4 votes:2 antipsychotic:1 28:3 should:4 investigational:1 pre-market:2 voted:6 under:2 pill:1 eventually:1 gains:3 rise:1 possible:2 early:1 if:1 compound:1 name:2 --:6 medicines:1 companies:1 thinners:1 deadline:3 toughest:1 discussing:1 diabetes-drug:1 because:1 says:1 bleeding:1 some:1 second:1 doses:2 thinks:1 provided:1 said:4 lead:2 federal:4 decision:2 marketed:4 anticlotting:1 outside:1 safety:5 above:1 new:7 risks:3 after:1 sold:1 pressure:1 lucrative:1 key:1 offset:1 news:1 100:1 panel:7 30:3 drug:13 action:1 studies:2 discontinued:1 patents:1 comment:1 groups:1 cancer:2 address:6 highly:1 restrict:1 approval:1 market:1 pharmaceutical:1 additional:3 best-selling:1 support:2 question:1 two:1 needed:4 rates:1 too:1 upbeat:1 type:6 more:4 expiring:1 reduce:1 company:4 wake:1 liver:2 known:1 those:1 high:1 developing:1 whether:2 meeting:1 told:1 submitted:1 n't:4 substantial:1 nine:1 can:3 were:2 called:1 dapagliflozin:4 biotech:1 certain:4 share:1 evidence:1 disappointing:1 stroke:1 warning:1 against:8 boxed:1 capture:1 generic:1 divided:2 six:1 also:1 concerns:4 earnings:1 effectiveness:2 brand:1 higher:1 product:2 used:1 's:12 information:5 football:1 falls:1 blood:1 stocks:1 data:1 approved:2 diabetes:6 3rd:1 asked:1 chief:1 practices:1 banks:1 starting:1 investments:1 prevention:1
stock_BMY r_up	shot:1 enter:1 increasingly:1 agreed:1 competitive:1 drug-price:1 held:1 manager:1 thinner:1 including:1 its:5 fifth:1 group:3 $:4 merger:1 rose:1 sale:3 charge:1 helps:1 has:2 over:1 hope:1 eventually:1 good:1 increased:1 rebound:1 boxed:1 background:1 world:5 highly:1 bringing:1 bank:1 --:11 companies:1 facing:1 thinners:1 through:1 toughest:1 noted:1 because:1 deal:1 bleeding:1 told:1 pricing:2 bigger:1 slew:1 index:1 said:1 adds:1 jumped:2 anticlotting:1 increase:1 discounts:1 won:1 safety:1 goes:1 medicine:1 new:3 receiving:1 across:1 risks:2 opening:1 million:1 rebates:1 pressure:2 regulators:4 focused:1 key:3 approval:2 100:1 rises:1 thinks:1 prescription:1 could:1 firing:1 drug:9 bow:1 focusing:1 planned:1 lucrative:1 comment:1 already:1 feel:1 clout:2 one:1 privately:1 news:1 carry:1 market:6 pharmaceutical:3 would:1 top:2 anti-clotting:2 finally:1 been:1 their:1 much:1 pharmacy-benefits:1 biggest:1 buy:1 much-needed:1 drugs:5 company:3 negotiating:1 lift:2 sharply:1 prices:1 analyst:1 behalf:1 pull:1 rival:1 clients:1 up:1 pill:1 while:1 can:2 promising:1 greater:1 30:3 share:1 overnight:2 high:1 stroke:1 warning:1 have:2 negotiations:1 expirations:1 capture:1 patent:1 makers:3 also:1 concerns:1 largest:3 if:1 higher:1 gaining:1 used:1 's:16 may:1 after:4 most:1 levels:1 blood:2 stocks:1 29.1:1 approved:3 billion:1 purchase:1 disease:1 chief:1 relief:3 475:1 prevention:1
stock_BMY r_down	fourth-quarter:1 agreed:1 global:1 results:1 trade:2 held:1 session:2 businesses:1 headlines:1 its:5 whose:2 27:1 $:5 rose:1 guidance:1 facility:1 expectations:1 second-quarter:1 copies:1 quarterly:1 has:1 indicating:1 customers:1 weakness:2 watch:2 redbox:1 early:1 continued:2 companies:2 fewer:1 large:1 after-hours:1 sign:1 actively:2 trading:1 250:1 declined:1 addition:1 said:1 profit:1 jumped:1 away:1 crucial:1 shares:2 new:1 net:1 boost:1 business:2 million:2 leadership:1 operating:1 offset:1 snapped:1 change:1 ate:1 inexpensive:1 prior:1 range:1 products:1 analysts:1 focused:1 software:2 among:1 secure:1 revenue:1 one:1 privately:1 another:1 narrowed:1 pharmaceutical:1 much:1 remains:1 system:1 2:1 low:1 expected:2 lingering:1 buy:1 company:3 but:1 sales:2 laptops:1 demand:1 than:1 buying:1 announcing:1 batch:1 while:1 toward:1 30:2 figure:1 up:1 turned:1 0.4:1 technology:1 end:1 credit:1 six:1 topped:1 1:1 other:1 earnings:1 income:1 stock:1 week:1 's:10 475:3 buyback:1 includes:1 applications:1 plan:1 stocks:1 segment:1 fiscal:1 lower:1 corporate:1 later:1 disease:1 enterprise:1 position:1 consumer:1 latest:1
stock_BMY r_down	less:1 sales:1 including:1 7.4:1 market:1 dominates:1 $:1 would:1 provide:1 contains:1 only:1 potential:1 role:1 treatment:4 which:1 2010:1 new:1 pill:1 product:1 full:1 's:1 option:1 mostly:1 combination:1 treatments:1 but:1 effects:1 coming:1 data:1 billion:1 regimen:2 working:1 third:1 developing:1 --:4 disease:1 drug:1 maker:1 continue:1 quarter:1 side:1 came:1
stock_BMY r_down	less:2 results:1 including:1 7.4:1 spinoff:1 its:3 $:1 rose:1 expectations:1 analyst:1 only:1 compelling:1 treatment:4 role:1 2011:2 2010:1 which:1 combination:1 effects:1 --:7 benefit:1 continue:1 quarter:2 side:1 heavy:1 because:1 growth:1 projections:2 exceeded:1 11th:1 dominates:1 profit:1 health:1 new:2 boost:1 full:1 business:1 exchange:2 backed:1 article:1 strong:1 beginning:1 reaction:1 working:1 drug:2 foreign:2 published:1 changes:1 maker:2 first:1 market:1 would:1 contains:1 option:1 mostly:1 drugs:1 company:1 but:1 scrutiny:1 second-quarter:1 regimen:2 developing:1 bill:1 pill:1 while:1 leaning:1 toward:1 tax:1 sales:4 sale:1 provide:1 4.8:3 potential:1 potentially:1 details:1 animal:1 gets:1 stock:1 product:2 's:3 price:1 treatments:1 viewing:1 coming:1 data:1 billion:1 third:1 antitrust:1 disease:1 came:1
stock_BMY r_up	limited:2 fixated:1 gold:1 treasurys:1 over:3 trade:2 including:1 talks:1 debt-ceiling:1 its:1 before:1 cut:1 20:1 $:4 rose:3 point:1 3:1 should:1 equity:1 stalemate:2 suffered:2 might:2 pending:1 started:1 ...:1 premium:2 gains:1 government:2 continues:1 worst:2 nearly:3 they:1 not:1 2:1 years:1 chips:2 day:3 --:3 small:1 deadline:2 stock:2 nigh:1 reduce:1 bounce:2 sign:1 aims:1 sight:1 our:1 happen:1 slew:1 blue:2 said:5 draws:1 profit:1 remain:1 participants:1 deficit:1 above:1 crude:1 limit:2 strategist:1 email:1 recently:1 slight:1 wrangling:1 sold:1 deliver:1 reported:1 restructuring:1 although:2 100:2 debt:4 21:1 gained:2 hits:1 months:2 drug:1 drama:1 products:1 action:1 maker:1 thinner:2 tone:1 revenue:1 2,000:1 down:1 another:1 decline:1 little:1 jobless:2 remains:2 top:1 two:2 their:2 1.50:1 much:1 compromise:1 passed:1 branded:1 markets:1 500:2 more:1 ``:2 drugs:1 becoming:1 but:2 priced:1 signaling:2 believe:1 second-quarter:1 posted:1 10:1 anxiety:1 14:1 rival:1 budget:1 value:1 while:3 ongoing:2 hope:1 were:2 called:1 soars:1 1.8:1 sales:2 '':1 something:1 home:1 seen:1 risk:1 4.5:1 confirmed:1 rout:2 get:2 also:1 potential:2 earnings:3 which:1 higher:4 narrowly:1 's:10 plans:1 price:3 after:2 includes:1 reflect:1 mixed:1 running:1 fell:1 blood:2 strategists:2 stocks:1 approved:1 lower:2 charges:1 futures:6 points:5 upside:2 claims:2
stock_BMY r_down	roundup:1 saying:1 surprises:2 companies:1 reports:1 quarters:1 advisories:2 earnings:1 future:1 corporate:1 latest:1
stock_BMY r_down	size:2 harm:2 says:2 formerly:2 headed:2 acquired:2 companies:2 within:2 named:2 one:2 pops:1 n't:2 including:2 debt-ceiling:2 sees:2 headlines:1 throughout:2 acquisitive:2 if:2 pharmaceutical:2 little:2 deal:1 all:2 three:2 concerns:2 details:2 interview:2 new:2 has:2 surprised:2 profile:1 product:2 executive:4 's:2 parent:2 wrangling:2 company:2 formed:2 watch:2 back:1 early:1 small:2 regional:1 background:2 benefits:2 major:1 years:2 bank:1 aggressively:2 incoming:2 name:1 limits:2 --:10 could:2 borrowing:2 up:1 doubled:2 large:2 chief:2 does:1 team:2 push:2 head:2 once:2
stock_BMY r_down	disclosure:2 emerging:1 because:1 slower:2 questions:2 cancer:1 progressing:2 over:1 demand:1 sales:2 competition:1 years:1 '':1 brain:1 prostate-cancer:1 growth:1 raises:1 have:1 's:8 appetite:2 its:2 issues:1 before:1 even:1 current:2 slow:1 raised:1 silent:1 pay:1 initial:2 question:1 research:1 symptoms:1 enough:1 expensive:2 expected:2 new:1 decades:1 price:2 physicians:1 ``:1 used:1 explosion:1 blames:1 stresses:1 bolsters:1 treatments:2 methods:1 small:1 pricey:1 them:1 but:1 others:1 phase:1 prostate:1 than:2 begins:1 reimbursement:1 short:1 surprising:2 limits:1 getting:1 --:4 disease:1 drug:3 finances:1 patients:1 practices:1 diagnosed:1 time:1 report:1 distribution:1 view:1
stock_BMY r_up	's:2 created:1 medical:1 lab:1 stem:1 premiums:1 devices:1 fall:1 cells:1 2012:1
stock_BMY r_down	adults:1 one:1 second:1 2.5:1 combines:1 said:2 $:1 single:1 three:1 treatment:3 new:2 has:1 pill:2 reflects:1 's:1 complete:1 company:1 after:1 hours:1 medications:1 therapy:3 approved:1 those:1 regimen:1 --:2 up:1 drug:1 patients:1 were:1 vision:1
stock_BMY r_up	system:1 bolstering:1 proved:1 adults:1 cancer:1 flow:1 powerful:1 surprisingly:1 three:1 foods:1 against:1 have:1 's:2 headlines:1 strategy:1 2.5:1 one:1 combines:1 said:2 genetics:1 $:1 second:1 immune:1 pet:1 positive:1 make:1 single:1 treatment:3 forecast:1 also:1 earnings:1 genetically:1 new:3 dominate:1 advanced:1 pill:3 reflects:1 stock:1 multiple:1 complete:1 form:1 broader:1 company:1 after:1 watch:2 leukemia:1 but:1 early:1 explored:1 therapy:3 buyback:1 news:1 salmonella:1 cleared:1 implications:1 approved:1 developments:1 hours:1 regimen:1 has:1 fighting:1 --:2 study:1 sclerosis:1 up:1 drug:1 patients:1 those:1 medications:1 were:1 small:1 corporate:1 could:1 vision:1
stock_BMY r_up	signals:1 promises:1 speedy:1 targeted:1 tumors:1 genetic:1 prolong:1 such:1 patients:1 won:1 lives:1 treatment:1 approval:1 regulators:1 new:1 enthusiasm:1 shrink:1 therapies:1 skin-cancer:1
stock_BMY r_down	conviction:1 would:1 show:1 market’s:2 writes:1 drop:2 share:1 players:1 institutional:1 need:1 seriously:1 other:2 shoe:2 they:1 taken:1 part:1 moves:1 first:1
stock_BMY r_up	slew:1 purchases:2 temporarily:2 aims:1 caused:1 some:1 unsold:1 rate:3 looks:2 throughout:1 its:3 market:2 help:1 pharmaceutical:1 cut:2 built:3 housing:2 government:1 next:1 deficit:1 exit:1 economy:1 meeting:1 supplies:1 newly:3 has:2 boost:2 stock:1 week:1 plant:1 parliament:1 's:1 business:1 shortages:1 drugs:1 tax:4 material:1 but:1 credits:1 lowered:1 new:2 change:1 homes:1 lower:2 extraordinary:1 --:4 corporate:1 budget:1 drug:1 part:1 policies:1 faces:1 ban:1 property:2 moribund:2 called:1
stock_BMY r_up	load:1 set:1 economists:1 unemployment:1 sales:1 rate:1 year:1 makers:1 market:1 new-vehicle:1 strength:1 pay:1 projected:1 forecast:1 increase:1 rewarding:1 bracing:1 which:1 then:1 9:1 9.1:1 expected:1 website:1 flat:1 's:5 gains:1 dividends:1 released:1 report:1 barrel:1 ago:1 --:1 later:1 companies:1 according:2 remain:1 residents:1 toward:1
stock_BMY r_up	summer:1 emerging:1 gold:3 being:1 developed:1 over:1 trade:2 session:4 touch:1 its:1 whose:4 $:2 rose:3 had:1 should:1 treatment:1 premarket:1 has:1 agreed:1 gains:1 rebound:1 continues:1 watch:2 consolidation:1 miners:1 artery:1 --:1 companies:4 fewer:1 thinners:1 significantly:1 some:1 actively:4 trading:4 2.2:2 2.7:1 said:1 marketed:1 patients:1 shares:5 254:2 new:2 teens:1 bird:1 recently:2 were:4 boosting:1 active:1 cities:1 box:1 prospects:1 study:1 drug:3 trial:2 traded:2 among:1 major:2 thinner:1 increased:2 market:1 start:1 2:1 expected:2 500:2 gained:2 mining:1 buy:1 bypass:1 company:1 wake:1 prices:1 than:1 those:1 showed:1 flu:1 up:1 pill:1 n't:1 record:1 while:1 amid:1 3.2:1 treated:1 could:1 1.7:1 associated:1 deaths:1 1.8:1 1.9:1 fellow:1 say:1 relatively:1 make:1 warfarin:1 highlighted:1 insurers:3 higher:2 week:1 's:7 may:1 approves:1 outperformed:1 blood:2 stocks:2 data:1 rallied:1 light:1 relief:1
stock_BMY r_down	shop:1 less:2 money:1 month:1 report:1 session:1 purchasing:1 using:1 whose:1 22:2 rose:1 had:3 shortcut:1 actually:1 0.5:1 has:1 them:1 increased:1 bonds:1 safe:1 break:1 they:1 not:1 during:1 argues:2 investor:1 lost:1 countries:1 identifying:2 companies:3 after-hours:1 set:1 list:1 some:2 back:1 past:2 cost:1 trading:1 3.3:1 2.3:1 home:1 insurance:1 even:1 provided:1 actively:1 appear:1 shares:1 research:1 500:1 closed:1 print:1 ability:1 were:3 story:1 credits:3 protection:1 put:1 dividend:1 safer:1 gained:1 protect:2 her:1 country:1 larger:1 discussed:1 against:2 times:1 credit:1 s:3 point:1 previously:1 betting:1 sovereign:1 corporations:2 use:1 stocks:1 would:1 two:1 been:1 their:1 way:1 survive:1 's:1 today:1 ``:1 funds:1 stress:1 gain:1 than:4 he:1 wherewithal:1 kind:1 made:2 default:2 while:1 2.8:1 can:1 many:1 property:1 risky:1 1.7:1 investors:1 almost:1 tax:1 argument:1 0.6:1 periods:1 have:3 seen:1 payers:1 information:1 compared:1 spreads:1 same:1 instance:1 recommended:1 arguments:1 which:1 subsidiaries:1 higher:1 bets:2 multiple:1 may:1 yesterday:1 tied:1 most:1 courtesy:1 70:4 multinationals:1 proxies:1 weekend:1 recent:1 lower:2 seize:1 3-7:1 starting:1 costs:1 corporate:1
stock_BMY r_up	prevent:1 already:1 best:3 storms:2 into:1 setback:1 down:3 earnings:1 weather:1 drug:2 purchased:1 markets:1 further:1 rest:2 fibrillation:1 staff:1 2011:2 now:2 atrial:1 advisers:1 writes:1 anticlotting:1 expectations:1 same:1 batten:1 recommended:1 potential:1 volatile:1 treatment:1 hold:2 boost:1 across:1 4:2 head:1 buy:2 's:1 sell-off:1 strokes:1 funds:2 today’s:1 lower:1 immediate:1 priced:1 records:1 market:2 valuable:1 approval:1 stocks:4 true:1 weathering:1 extreme:1 2:2 prospects:1 tactics:1 assets:1 being:1 level:1 rival:1 could:1 board:1 hatches:3 against:1 keep:1 patients:1 long-term:3 choppy:1 avoid:2
stock_BMY r_up	school:1 woman:1 's:1 lead:1 medical:1 institution:1 appointed:1 history:1 has:1 its:1 first:1
stock_BMY r_down	major:1 prompt:1 according:1 have:1 5:2 its:1 relatively:1 blue:1 use:1 make:1 indexes:1 far:1 returns:3 pile:1 performance:1 roughly:1 2011:1 dramatically:1 500:1 poor:1 product:1 's:1 posting:1 may:1 big:1 outperformed:1 five:1 8:1 despite:1 stocks:2 chips:1 analyst:1 10:2 pipeline:1 high-yield:3 double-digit:1 cash:1 large:1 slide:1 so:1 thin:1 -plus:2 acquisition:1
stock_BMY r_down	advisory:1 give:1 some:1 sales:1 one:1 committee:1 its:1 issues:1 seemed:1 abstention:1 voted:1 forces:1 ammunition:1 week:1 's:1 drugs:1 approval:1 approved:1 dim:1 prospects:1 rival:1 could:1 drug:2 rivaroxaban:1 approve:1
stock_BMY r_up	10:2 ``:1 sees:1 $:2 angels:1 low-priced:1 opportunities:1 '':1 editor:1 newsletter:1 fallen:1
stock_BMY r_up	heart:1 use:1 's:2 --:1 secured:1 health-care:1 drug:1 regulator:1 backing:1 key:1 new:1 has:1 cost-effectiveness:1 final:1
stock_BMY r_up	prospects:1 takeover:1 's:1 target:1 according:1
stock_BMY r_down	heart-rhythm:1 tougher:1 mounting:1 drug:1 regulators:1 steps:1 take:1
stock_BMY r_down	exclusive:1 right:1 heart:1 payment:1 $:1 held:1 privately:1 diabetes:1 protein:1 24:1 use:1 develop:1 21:1 make:1 research:3 2:1 which:1 struck:1 has:2 type:1 hormone:1 's:2 company:1 million:1 agreement:3 tied:1 failure:1 key:1 upfront:1 potential:1 areas:1 treating:2 well:1 aimed:1
stock_BMY r_up	already:1 adults:2 being:1 global:1 dose:1 authorities:1 stroke:1 tablets:1 daily:1 controlled:1 its:1 use:1 said:1 combination:3 positive:1 adequately:1 business:1 application:1 2:2 treatment:1 has:1 type:1 pill:1 exercise:1 's:3 risk:1 extend:1 separate:1 diet:1 regulators:1 blood:1 backed:1 those:1 diabetes:2 treating:1 received:2 include:1 --:2 treated:1 drug:2 n't:1 patients:1 opinion:1 fixed:1 appraisal:1 favorable:1
stock_BMY r_up	confirmed:1 's:1 rose:1 study:1 after:1 results:1 drug:2 patients:1 lives:1 optimism:1 prostate-cancer:1 pipeline:1 company:1 its:1 experimental:1
stock_BMY r_up	copper:2 all:1 financial:1 investors:1 heavily:1 almost:1 bellwether:1 metals:1 years:1 not:1 pullbacks:1 economic:1 trading:1 dropped:1 have:1 still:1 investment:1 viewed:1 weekly:2 tumbled:1 decline:1 plays:1 gold:1 1980:1 equities:1 one-day:1 since:2 recorded:1 three:1 crisis:1 dilemmas:1 healthier:1 attractive:1 widely:1 equity:1 crude:1 performance:1 construction:1 economy:1 knowing:1 industries:1 oil:2 's:1 after:1 due:1 but:1 depths:1 biggest:1 fell:1 worst:2 defensive:1 prices:1 during:2 precious:1 manufacturing:1 than:1 present:2 posted:1 last:2 17:1 --:5 drop:1 metal:1 say:1 fewer:1 turn:1 points:1 week:2 can:1 entry:1 2008:1 its:4 options:1 silver:1
stock_BMY r_down	operations:1 expects:1 substantial:1 likes:1 year:1 pharmacy:1 patent:1 next:1 branded:1 available:1 's:3 drugs:2 protection:1 those:1 versions:1 value:1 choices:1 supermarkets:1 generic:1 benefit:1 lose:1 become:1
stock_BMY r_up	saying:1 lupus:1 's:2 country:1 price:1 health-care:1 system:1 regulator:1 n't:1 recommended:1 treatment:1 pay:1 not:1 worth:1
stock_BMY r_up	code:1 financial:2 investors:1 results:1 general:1 inquiries:1 conference:1 information:1 27:5 review:1 live:1 call:2 announce:1 2011:5 public:1 listen:1 company:1 address:1 webcast:1 dialing:1 third:1 invited:1 a.m.:1 analysts:1 quarter:1 executives:1
stock_BMY r_up	versus:1 death:1 because:1 increased:1 combination:1 government:1 institute:1 study:1 halted:1 drugs:1 part:1 rates:1 alone:1 bleeding:1 has:1 linked:1
stock_BMY r_down	deck:1 money:3 unlikely:1 need:1 moves:2 yet:1 market:1 out:1 little:1 top:1 5:2 storm:1 instead:1 has:1 tolerance:1 yield-hunting:2 risk:1 get:1 most:2 now:2 borrowers:1 trader:3 points:1 making:2 corporate:1 bond:1
stock_BMY r_up	said:1 rare:1 risk:1 --:1 could:1 leukemia:1 drug:1 increase:1 pressure:1 hypertension:1 problem:1 called:1
stock_BMY r_down	limited:1 help:1 through:2 its:5 guidance:2 should:4 source:1 treatment:4 personality:1 13th:2 risk:1 therapy:1 effects:3 not:1 --:11 follows:1 turns:1 revision:2 out:1 side:3 because:1 says:5 national:1 cost:5 pain:1 subject:2 even:2 said:4 affects:1 per:2 version:1 health:2 new:1 appeal:2 evaluation:1 correct:1 body:2 patient:2 ability:1 wo:1 sixth:2 reaction:2 benefits:2 country:1 uncertainty:2 funded:3 keep:1 pick:1 2nd:1 watchdog:4 market:3 '':1 due:3 approved:2 draft:2 don’t:1 cost-effective:1 too:2 ``:1 insurer:1 incur:1 bull:2 longer-term:2 king:2 publicly:3 n't:5 pace:1 patients:1 10th:1 high:3 need:1 you:1 skin-cancer:4 stock:2 product:3 used:3 's:13 price:2 plan:1 health-cost:1 eighth:2 recent:2 cover:2 costs:5 time:1 order:1
stock_BMY r_up	awarded:1 thinner:2 violation:2 over:1 top:1 appeals:1 year:1 ruled:1 federal:1 court:2 $:4 granting:1 generic:2 make:2 had:1 copies:2 than:1 damages:1 interest:1 has:2 more:1 sold:2 million:4 blood:2 judge:1 100:2 payment:2 must:2 last:1 reduced:2 patent:2 2006:2 popular:2 having:2 erred:1
stock_BMY r_down	operations:2 sells:1 they:1 global:1 years:1 baby:2 businesses:2 higher:2 decisions:1 its:8 move:2 cut:1 dividing:1 valuation:2 charge:1 other:1 remaining:2 resources:1 divergent:1 customers:1 probe:1 risk:1 very:1 possible:1 updates:2 background:2 new:1 world:1 --:10 companies:1 each:1 stock:2 rheumatoid:1 says:1 trend:1 successfully:1 investment:1 out:1 said:5 while:1 comments:1 adapt:1 formula:2 approach:1 price:2 arthritis:1 jobs:1 continuing:1 380:3 add:1 diagnostics:1 generates:1 rises:2 planned:1 shift:1 industry:1 positioning:1 drug:2 products:6 analysts:1 maker:1 late-stage:1 named:1 revenue:3 into:1 down:2 throughout:1 unit:5 pharmaceutical:4 shareholders:3 would:1 needed:1 breakup:1 create:1 two:2 pharmaceuticals:2 more:2 wants:1 ``:1 drugs:1 company:7 but:2 hopes:2 spin:4 analyst:1 '':1 devices:2 remain:2 history:1 separated:1 proprietary:2 investors:3 diversification:1 health-care:1 weighed:2 plan:1 blockbuster:1 check:1 sell:2 different:2 things:1 make:1 45:1 able:1 complex:1 details:2 which:3 economy:1 development:1 's:2 plans:3 separate:2 footprints:1 sets:1 most:1 levels:1 restructures:1 recent:1 off:4 assets:1 charges:1 medical:7 later:1 command:2 allow:2 healthcare:1 organization:1
stock_BMY r_down	heart:1 use:1 's:2 --:1 secured:1 health-care:1 drug:1 regulator:1 key:1 approval:1 new:1 has:1 cost-effectiveness:1 final:1
stock_BMY r_up	named:1 executive:2 sales:2 3.5:1 shares:1 throughout:1 increase:1 management:2 $:1 profit:1 veteran:1 third-quarter:1 comments:1 1:1 other:1 details:1 9.4:1 new:2 net:1 tapped:1 company:1 stock:1 names:1 generic-drug:1 price:1 reported:1 updates:1 strong:1 beginning:1 manufacturer:1 made:1 incoming:1 effective:1 --:3 up:2 chief:2 products:1 become:1 higher:1 changes:2 8th:1
stock_BMY r_up	operations:1 saying:1 emerging:3 help:1 executive:1 raised:3 quarters:1 per:1 settlement:1 its:6 litigation:1 $:2 candidate:1 surprises:2 guidance:2 had:1 appointed:1 advisories:2 treatment:1 quarterly:1 2017:1 include:1 string:1 than:1 rise:2 watch:3 nation:1 121:1 increases:1 12:1 updates:1 dose:1 drugmaker:1 loss:1 --:9 companies:1 doubled:1 morning:1 higher:1 heavy:1 temporarily:1 due:2 begin:1 growth:2 begun:1 year:1 said:4 profit:5 contributed:2 comments:1 research:1 investigation:1 braces:1 sixth:1 net:3 boost:1 core:1 run:1 approvals:1 million:1 reported:4 regulatory:1 strong:2 beginning:1 roundup:1 received:1 dollars:1 months:1 forecast:1 drug:3 stock-buyback:1 rose:1 action:1 maker:4 comment:1 outlook:1 thinner:3 cancer:3 revenue:3 outcomes:1 reached:1 unit:1 would:1 positive:1 third-quarter:3 2:7 which:1 markets:3 prosecutor:1 more:2 selling:1 reaction:1 drugs:4 company:2 favorable:2 demand:1 hopes:1 analyst:2 11:2 has:5 versions:1 type:1 while:2 future:1 three:1 criminal:1 dapagliflozin:2 share:2 sales:4 high:1 currency:4 full-year:4 reports:2 moves:1 increased:2 reprieve:1 patent:2 detail:1 lifts:1 earnings:6 fourth:1 commentary:1 gets:1 stock:1 requested:1 administrator:1 extended:1 's:2 boosted:1 price:2 blood:3 date:1 diabetes:1 performances:2 generic:1 allow:1 corporate:2 latest:1
stock_BMY r_down	sell:1 commodity:1 business:1 shift:1 away:1 continuing:1 looking:1 chemicals:1 products:1 heritage:1 performance:1 coatings:1 toward:1 its:2
stock_BMY r_down	consolidate:2 organizations:2 jobs:2 expirations:1 face:1 weakness:1 sales:2 maker:1 facilities:2 restructuring:2 costs:2 economic:1 eliminate:2 drug-patent:1 partly:2 reducing:2 its:2 aimed:2
stock_BMY r_up	already:1 version:1 cancer:4 certain:1 head:2 agent:1 '':1 single:1 colon:1 wider:1 headline:1 since:1 radiation:1 been:1 p.m.:1 won:1 treatment:1 chemotherapy:1 has:1 ``:1 used:1 's:2 combination:1 corrected:1 therapy:1 approval:1 approved:3 types:1 neck:2 name:1 follows:1 drug:4 patients:1 2006:1 late-stage:1
stock_BMY r_up	already:2 cancer:9 revenue:1 certain:2 thinner:1 sales:1 agent:1 month:1 second:1 used:3 colon:2 year:1 wider:3 its:2 market:1 outperforming:1 whose:1 profit:1 since:1 radiation:1 while:1 been:1 won:1 role:1 treatment:1 fourth:1 quarterly:1 chemotherapy:2 gets:1 11:1 head:4 his:1 's:3 increased:2 combination:1 drugs:1 reported:1 contributed:1 therapy:1 blood:1 approval:3 stocks:1 approved:5 types:2 2:1 received:1 handily:1 has:1 neck:4 --:2 favorite:1 single:1 drug:5 patients:3 growth:1 2006:1 discusses:1 late-stage:3
stock_BMY r_down	benefit:1 heart:4 anticlotting:1 says:1 have:1 prevent:1 certain:1 blood-thinning:1 brain:1 preventing:1 another:1 pain:1 surgery:1 short-term:1 hospitalized:2 better:1 assessing:1 goal:1 people:1 brand:1 young:1 been:2 looking:1 failed:1 attack:1 treatment:1 under:1 new:1 has:1 clots:2 function:1 's:2 undergoing:1 apixaban:1 showing:1 screenings:1 failure:2 involving:1 blood:2 significant:1 contractors:1 sold:1 article:1 than:1 known:1 fraud:1 name:1 showed:1 --:2 study:2 drug:3 patients:2 'd:1 unstable:1 published:1 meet:1 athletes:1 incomplete:1 chest:1
stock_BMY r_up	past:1 over:1 six:1 statements:1 longer:1 issued:1 becoming:1 annual:1 companies:1 reports:1 years:1 large:1 length:1 complex:1 details:1 sharply:1 footnotes:1 increasing:1 other:1 more:1
stock_BMY r_down	weighs:1 deal:2 revenue:1 paid:1 win:1 into:1 challenges:1 against:1 tiny:1 trading:1 hepatitis:3 have:1 battle:1 yet:1 market:1 developer:1 bribes:1 $:5 million:1 pay:2 shares:1 than:1 does:1 expected:1 probes:1 announced:1 more:1 sinking:1 11:3 buy:1 's:3 virus:1 business:1 government:1 company:2 after:1 treatments:2 but:1 agreement:1 early:1 pricey:1 resolve:1 nearly:1 foothold:1 potential:1 10.4:1 billion:2 60:1 12:1 developing:1 --:2 involved:1 roughly:1 drug:2 n't:1 whether:1 overseas:1 maker:1
stock_BMY r_up	buck:1 turning:1 funds:1 exactly:1 n't:1 quick:1 likely:1 known:1 's:1 happen:1
stock_BMY r_up	improve:1 control:1 insulin:1 's:1 combination:1 --:1 blood:1 drug:1 sugar:1 patients:1 2:3 therapy:1 been:1 adult:1 has:1 approved:1 diabetes:2
stock_BMY r_up	emerging:1 significantly:1 warfarin:1 agreed:1 results:1 two:1 stroke:1 another:1 its:1 market:2 one:1 said:1 atrial:1 positive:1 review:2 anticlotting:1 patients:1 preventing:1 application:2 fibrillation:1 treatment:2 dose:1 new:2 has:1 authorization:1 's:1 combination:1 apixaban:2 marketing:1 company:1 outperformed:1 cover:1 regulators:1 27:1 blood:1 boosting:1 accepted:1 granted:1 prospects:1 showed:1 --:1 companies:1 drug:3 large:1 accelerated:1 speedy:1 victory:1 thinners:1 heartbeat:1 fixed:1 studies:2 called:2
stock_BMY r_up	status:1 praises:1 review:1 drug:1 priority:1 changes:1 gives:1
stock_BMY r_down	his:1 goes:1 business:1 interesting:1 age:1 some:1 predictions:1 reports:1 leaving:1 25,000:2 predicts:2 91:1 has:1 he:1
stock_BMY r_up	oncology:1 cancer:1 chronic:1 said:1 guidance:1 draft:1 treatment:1 medicine:1 product:1 's:3 offered:1 after:1 leukemia:1 but:1 discount:1 rejected:1 health-cost:1 backed:1 older:1 --:1 rival:1 drug:1 regulator:1
stock_BMY r_up	sector:1 raised:1 doing:2 well:3 share:1 cash:1 stepping:1 its:3 shareholders:1 $:1 bullish:1 pile:1 too:1 several:1 2012:2 do:2 good:3 return:1 plans:1 some:1 repurchase:1 dividend:1 stocks:1 he:1 billion:1 10:2 cautious:1 expanded:1 companies:1 up:2 efforts:1
stock_BMY r_up	unemployment:1 high:1 cost:1 year:1 confidence:1 said:1 weakened:1 patent:1 due:1 rash:1 next:1 low:1 2012:2 expirations:1 government:1 pressure:1 significant:1 demand:1 amid:1 companies:1 face:1 containment:1 consumer:1
stock_BMY r_up	heart:1 's:4 regime:1 --:1 country:1 medical:1 under:1 drug:2 rigorous:1 won:1 pricing:1 key:1 recommendation:1 authorities:1 new:1 has:1 evaluation:1 final:1 more:1
stock_BMY r_down	profitable:1 off:1 plans:1 business:1 medical-devices:1 into:1 focus:1 stand-alone:1 public:1 pharmaceuticals:1 company:1 franchise:1 increasing:1 spin:1 its:2 bigger:1 more:1
stock_BMY r_down	headwinds:1 health-care:1 related:2 likely:1 identify:2 year:1 protein:2 next:1 targets:2 acceleration:1 said:1 lead:2 patent:1 research:2 concerns:1 potentially:2 new:2 therapies:2 fiscal:1 's:6 expirations:1 fund:2 key:2 affect:2 abroad:1 stresses:1 industry:1 disease:2 remain:1 efforts:2 could:2
stock_BMY r_up	session:1 trading:1 's:1 7.9:1 its:1 index:2 said:1 shares:1 points:3 clinical:1 higher:1 added:1 recently:1 whose:1 survival:1 overall:1 90:1 stocks:1 advanced:1 improve:1 gained:1 14:1 did:1 companies:1 drug:1 n't:1 trial:1 patients:1 actively:1 were:1 traded:1 experimental:1 late-stage:1
stock_BMY r_down	among:1 retire:1 drug:1 moves:1 makers:1 market:2 rundown:1 stocks:2 $:1 exceeding:1 shares:1 35:1 largest:1 biggest:2 stock:1 gaining:2 executive:1 's:1 capitalization:1 upstart:1 sizable:1 world:1 now:1 former:1 declining:2 billion:1 succeeded:1 behemoth:1 industry:1 daily:1 making:1
stock_BMY r_down	decidedly:1 sector:1 all:1 least:1 languid:1 over:2 slashed:1 dollar:1 major:1 kickoff:1 trade:2 7.2:1 prices:1 interim:1 through:1 fear:1 its:2 developer:1 partners:1 giant:1 cut:1 overhaul:1 $:4 candidate:1 over-the-counter:1 much:1 including:1 better:1 offers:1 developments:1 pretty:1 tumbling:1 weeks:1 include:1 2011:2 2010:1 2012:3 executive:1 global:1 premium:2 gains:2 far:1 implants:1 watch:3 results:1 early:1 anxiety:1 five:1 breast:1 they:1 half:2 not:1 awaiting:1 now:1 realize:1 bigger:1 treating:1 aluminum:1 notes:1 morning:2 deals:1 banking:2 recalls:1 economy:1 mergers:1 development:1 says:2 deal:1 trend:1 some:1 batch:1 see:2 growth:2 trading:1 expect:1 year:3 headlines:2 2.5:4 out:1 index:1 said:2 stands:1 lead:1 unsettling:1 since:1 hepatitis:4 looking:1 new:2 announced:2 can:1 nervously:1 full:1 business:1 pharmaceutical:1 confusion:1 reported:1 takeover:1 become:1 news:1 strong:1 pipeline:1 ahead:1 many:1 industry:2 drug:3 trial:1 afternoon:1 rose:1 mixed:1 spotty:1 maker:1 first:1 among:1 outlook:1 already:1 casualty:1 revenue:2 squeezed:1 down:1 fast:1 market:1 bankruptcy:1 has:2 1938:1 eye:1 their:2 positive:1 been:4 start:1 clinical:1 treat:1 biggest:1 tells:1 oversupply:1 more:2 billion:2 ``:3 drugs:1 season:3 acquire:1 part:1 demand:1 kicks:1 buying:1 paying:1 fatal:1 gotten:1 likely:1 us:1 n't:1 while:1 500:1 growing:2 feeling:1 acquisition:1 biotech:1 investors:2 flat:3 health-care:1 slammed:1 '':2 player:1 reports:1 have:3 partner:1 worst:1 advancing:1 relatively:1 capture:1 things:1 deal-making:1 potentially:1 arguments:1 big:1 party:1 stock:3 week:2 's:6 hopes:1 earnings:4 upon:1 paid:1 forecasts:1 regulations:1 virus:1 souring:1 coming:1 stoke:1 data:1 recent:1 acquisitions:1 lower:1 off:3 futures:3 know:1 definitely:1 so:1 pay:2 banks:1 weigh:1 senior:1 latest:1 corporate:2 having:1 preparing:1
stock_BMY r_up	streak:1 heart:1 associated:1 generation:1 stroke:1 trading:1 increased:1 rose:1 takeovers:1 hepatitis:1 winning:1 note:1 attack:1 biggest:2 new:2 midday:1 gaining:2 risk:2 treatments:1 fund:1 part:1 blood:1 approval:1 hedge:1 stocks:2 declining:2 lower:1 developing:1 movers:1 study:1 companies:1 drug:1 fell:1 thinners:1 first:1 comes:1 gain:1
stock_BMY r_down	pony:1 learning:1 text:1 global:1 influence:1 brain:1 rate:1 another:1 gossip:1 sells:1 declined:1 little:1 ads:2 long:1 quickly:1 asking:1 online:1 clinical:1 more:1 selling:1 ages:1 genes:1 else:1 data:1 diabetes:1 abortion:1 drug:1 trick:1 upside:1 approve:1 display:1 experimental:1
stock_BMY r_up	medications:1 like:1 could:1 companies:1 fortunes:1 5:2 boost:1 2012:2
stock_BMY r_down	talked:1 classic:1 tax:1 sales:2 helped:1 rising:1 looks:1 have:2 home:1 still:1 any:1 skin-cancer:1 drugs:1 said:1 jobless:1 would:1 profit:1 durable:1 revenue:1 its:1 prevented:1 only:1 version:1 treatment:1 which:1 rookie:1 new:2 earnings:1 we:1 's:5 approached:1 provisions:1 far:1 bid:1 agreement:1 v.:2 includes:1 early:1 76:1 lift:1 but:1 goods:1 surged:1 hostile:1 lower:1 made:1 standstill:1 like:1 days:1 7:1 more:1 while:1 without:1 so:1 claims:1 first:1 mistake:1
stock_BMY r_down	cancer:1 developed:1 drug:1 cell:1 treat:1 skin:1 cases:1 approved:1 advanced:1
stock_BMY r_down	insurance:1 fourth-quarter:1 high-risk:1 cancer:1 pool:1 declines:1 over:1 each:1 ``:1 competition:1 ending:1 disappointing:1 drug:2 have:1 forecast:1 research:1 seemed:1 envy:1 generic:1 cliff:1 favor:1 patent:1 there:1 due:1 long:1 shares:1 weapons:1 few:1 earnings:1 which:2 new:1 skin-cancer:1 reporting:1 stock:1 scored:1 we:1 '':1 's:1 string:1 combat:1 drugs:1 after:1 hurt:1 reported:1 fell:1 device:1 during:1 drought:1 prostate:1 approved:1 advanced:1 recent:1 also:1 successes:1 rival:1 companies:1 disease:1 against:1 profit:1 were:1 slightly:1 maker:1
stock_BMY r_up	around:1 biotech:1 analysts:1 string:1 just:1 merger:2 could:2 according:1 hepatitis:1 shouldn’t:1 offers:1 takeover:1 bonanza:2 assume:1 corner:1 lucrative:1 eye-popping:1 miss:2 bid:1 recent:1
stock_BMY r_down	's:1 investors:1 payouts:1 companies:1 cash:1 increase:1 their:1 discusses:1
stock_BMY r_up	fourth-quarter:1 's:2 revenue:1 profit:1 year:1 purchase:1 34:3 acquisition-related:1 fueled:1 increase:1 costs:1 offset:1 last:1 more:1 than:1 declined:1 higher:1
stock_BMY r_up	said:1 relapse:1 trial:1 being:1 after:1 had:1 disease:1 hepatitis:1 one:1 their:1 majority:1 patients:1 clinical:1 drug:1 treated:1 arm:1 experimental:1
stock_BMY r_down	challenges:1 named:1 health-care:1 last:1 move:1 giant:1 should:1 past:1 few:1 finally:1 years:1
stock_BMY r_up	agency:1 provided:1 after:1 proposed:1 information:1 28:1 decision:1 months:1 anticlotting:1 delayed:1 drug:1 three:1 companies:1 regulators:1 new:2
stock_BMY r_down	use:1 stats:1 delays:1 anticlotting:1 drug:2 age:1 sleep:1 decision:1
stock_BMY r_up	them:1 12:1 's:1 look:1 give:1 been:1 years:1 past:1 most:1 fresh:1 have:1 time:1 biggest:1 laggards:1 stocks:1 might:1 market:1
stock_BMY r_down	disclosure:1 releasing:1 investors:1 selective:1 critics:1 certain:1 medical:1 changed:1 drug:1 society:1 said:1 policy:1 data:1 its:1 after:1
stock_BMY r_up	cut:1 center:1 million:1 houses:1 supercomputer:1 3.3:1 technology:1 ribbon:1 $:1
stock_BMY r_up	closely:1 investors:3 had:1 energy:1 global:3 some:1 ``:3 disappointing:1 soaring:1 growth:3 caution:3 advising:1 skin:1 moves:1 orders:1 run-up:3 given:1 dump:1 fell:1 rose:1 offer:1 fears:2 due:1 shares:1 should:1 add:1 other:1 percolate:2 lock:1 durable-goods:1 advise:2 volatility:1 company:1 stock:3 massive:1 quarter-end:1 's:1 pharmaceutical:1 keep:1 bid:1 after:1 tied:1 reported:1 game:1 takeover:1 but:1 sharply:1 fall:1 report:2 stocks:4 additional:1 billion:1 '':3 made:1 proceed:1 amid:2 drop:2 $:1 3.5:1 analysts:3 profits:1
stock_BMY r_down	gaining:2 rundown:1 moves:1 daily:1 sizable:1 market:1 shares:1 biggest:2 making:1 stocks:2 declining:2 stock:1
stock_BMY r_down	drugs:1 patients:1 hepatitis:1 two:1 most:1 virus:1 small:1 studies:1
stock_BMY r_down	closely:1 see:1 responds:1 open:1 remains:1 offer:1 rejecting:1 should:1 interested:1 board:1 's:1 reportedly:1 watching:1 company:1 takeover:1 letter:1 demand:1 now:1 investor:1 blasted:1 pursue:2 sale:2 drug:2 maker:2
stock_BMY r_down	followed:1 one:1 through:1 ready:1 seem:1 its:1 if:1 sue:1 court:1 reportedly:1 does:1 board:2 has:1 company:1 extend:1 offer:1 blasting:1 after:1 stop:1 takeover:1 members:1 he:1 case:1 did:1 days:1 drug:1 n't:2 threat:1 deadline:1 passing:1 maker:1
stock_BMY r_down	extend:1 effort:1 company:1 continues:1 its:1 up:1 drug:1 maker:1 pressure:1 deadline:1 against:1 push:1 sale:1 lawsuit:1 filing:1 he:1
stock_BMY r_up	sector:1 control:1 sees:1 help:1 people:1 trend:1 one:1 rising:1 opportunities:1 year:2 close:1 its:1 decade:1 deals:1 said:1 $:1 would:1 leading:1 least:2 low:1 largest:1 9:1 percentage:1 has:1 2010:1 selling:1 business:1 far:1 familiar:1 fell:1 investor:1 billion:1 last:1 amid:1 study:1 companies:2 according:1 large:1 matter:1 costs:1 so:1 downward:1
stock_BMY r_up	session:1 play:3 's:1 investors:1 positive:1 companies:1 back:3 drug:3 trade:1 actively:1 shares:1 were:1 expected:1 specialists:1 stocks:2 data:1 experimental:1
stock_BMY r_up	trio:1 financial:1 slipped:1 reeling:1 into:1 global:1 back:1 according:1 disappointing:1 rate:1 economic:1 combining:1 slumped:1 crisis:1 recession:1 unemployment:1 treatment:1 hepatitis:1 2009:1 recommended:1 earnings:1 new:1 weeks:1 has:1 sent:1 higher:1 's:3 drugs:1 after:2 rejected:1 most:1 regulators:1 others:1 approval:1 than:1 diabetes:1 four:1 regimen:1 14.6:1 country:2 completing:1 virus:1 drug:3 regulator:1 patients:1 economy:1 study:1 experimental:2 better-than-expected:1
stock_BMY r_down	strongly:1 outlook:1 futures:3 deal:1 almost:1 troubles:1 bribery:1 scandal:1 its:2 cut:1 $:3 rose:1 political:1 alleged:1 doubt:1 5:1 buying:1 new:1 stock:3 hit:2 ability:1 combat:1 fell:2 sharply:1 news:1 debt:1 expand:1 billion:1 pipeline:1 medicines:1 uncertainty:1 drug:1 maker:1 cast:1 while:1 thin:1 2012:1 1.26:3
stock_BMY r_up	extra:1 into:1 month:1 '':1 see:1 trading:1 dropped:1 sought:2 multiple:1 said:2 lawsuits:1 had:1 fight:1 state:1 activist:1 dismissing:1 suit:1 nice:1 ``:1 his:1 's:1 extend:1 earlier:1 watch:2 drug:1 proxy:1 filed:1 active:1 stocks:1 lawsuit:1 appears:1 he:2 look:1 likely:1 against:2 playing:1 time:1 release:1 deadline:1 voluntarily:1 maker:1 launched:1
stock_BMY r_down	chew:1 financial:1 cancer:1 issued:1 over:1 sales:1 helped:1 rising:1 decline:1 investors:1 profit:1 anticlotting:1 increase:1 updated:1 drugs:1 handful:1 watch:2 forecasts:1 early:1 reported:1 plenty:1 offset:1 12:3 companies:1 drug:1 provide:1 tech:1
stock_BMY r_down	roundup:1 saying:1 surprises:2 companies:1 reports:1 quarters:1 advisories:2 earnings:1 future:1 corporate:1 latest:1
stock_BMY r_up	tumbled:1 product:1 generic:1 first-quarter:1 profit:1 amid:1 top:1 sales:1 drug:1 copies:1 19:1 competition:1 71:1 's:1 its:1 declined:1
stock_BMY r_down	advisory:2 into:1 product:1 active:1 one:1 '':1 known:1 experts:1 vote:1 antiviral:1 market:1 before:1 combines:1 27:1 ingredients:1 federal:1 decision:1 agency:1 backs:1 comments:1 1:1 details:1 which:2 medicine:2 final:1 meant:1 ``:1 's:4 seeking:1 drugs:1 company:1 taken:1 backed:1 approval:2 reviewed:1 beginning:1 panel:3 four:1 13:1 made:1 third:1 --:3 medical:1 up:1 daily:1 pill:1 make:1 experimental:1 once:1
stock_BMY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_BMY r_up	week:1 molecular:1 releases:1 cancer:2 society:1 drugs:1 shift:1 away:1 continuing:1 treatments:1 cells:1 medical:1 clinical:1 features:1 unique:1 data:1 display:1 target:1
stock_BMY r_down	code:1 says:1 blood-thinning:1 report:1 aged:1 children:1 death:1 21:1 generic:1 regulation:1 1:1 genetic:1 stalled:1 injury:1 cause:1 map:1 food:2 breast:1 groups:1 press:1 approved:1 drowning:1 versions:1 companies:1 drug:1 cancers:1 consumer:1 researchers:1
stock_BMY r_down	1.5:1 companies:1 estimates:1 quarters:1 3.0:1 2.0:1 2.5:1 based:1 agency:1 anticlotting:1 per:1 current:1 recommended:1 income:1 =:5 's:2 share:1 operating:1 included:1 approval:1 expand:1 medical:1 list:1 drug:1 survey:1 analysts:2
stock_BMY r_up	narrowly:1 advisory:1 use:1 's:2 federal:1 expanded:1 anticlotting:1 against:1 drug:1 voted:1 panel:1
stock_BMY r_up	respond:1 heart:2 thinner:1 3.0:1 world-wide:1 century:1 increasingly:1 companies:1 estimates:1 sales:1 month:1 included:1 clinic:1 drug:2 have:1 year:1 our:1 blockbuster:1 your:2 2.5:1 if:1 counting:1 based:1 21:1 patent:1 affects:1 people:1 question:1 per:1 current:1 secret:1 're:1 advanced:1 which:1 income:1 2.0:1 you:1 cause:1 analysts:2 status:1 them:1 's:3 ability:1 forming:1 clots:1 earlier:1 variation:1 important:1 operating:1 blood:2 share:1 not:1 last:1 password:1 bank:1 $:2 billion:2 account:1 off:2 name:1 limits:1 prevent:1 =:5 30:1 list:1 disease:1 us:1 n't:2 turn:1 patients:1 accounted:1 survey:1 can:1 quarters:1 went:1 gene:2 1.5:1
stock_BMY r_down	upgraded:1 cancer:1 low-cost:1 joints:1 health-care:1 share:1 including:1 its:1 relatively:1 profitable:1 ratings:2 upgrade:1 over-the-counter:1 leading:1 make:1 six:1 range:1 artificial:1 production:1 criteria:1 short-term:2 markets:1 's:1 drugs:2 stable:1 medications:1 five:1 others:1 medical:1 changed:1 companies:2 large:1 while:1 products:1 model:1 notch:1 issuers:1
stock_BMY r_up	prevent:2 2.5:1 evidence:1 investors:1 1.5:1 companies:1 estimates:1 years:4 four:2 added:1 3.0:1 past:1 headlines:1 2.0:1 stole:1 its:2 kidney:2 '':1 said:2 based:2 show:1 three:2 per:1 current:1 genetic:1 treatment:2 interest:1 income:1 receiving:2 =:5 can:1 ``:1 after:4 's:5 drugs:1 share:1 safe:2 watch:2 early:1 operating:1 two:1 included:1 targeting:1 quarters:1 weekend:1 improve:1 down:1 prospects:1 rejection:2 effective:2 meeting:1 study:2 list:1 patients:5 survey:1 analysts:2 found:2 corporate:1 tumors:1
stock_BMY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_BMY r_up	even:1 uncertain:1 investors:1 leading:1 companies:1 cheap:1 environment:1 economic:1 they:1 shun:1 riskier:1 problem:1
stock_BMY r_up	1.5:1 companies:1 estimates:1 quarters:1 3.0:1 2.0:1 investment:1 2.5:1 based:1 per:1 its:1 current:1 income:1 new:1 type:1 's:4 drugs:1 boosted:1 operating:1 included:1 buying:1 rights:1 =:5 list:1 disease:1 drug:1 survey:1 analysts:2 share:1 experimental:1
stock_BMY r_down	adviser:1 informed:1
stock_BMY r_up	die:1 der:1 350:1 bis:1 das:1 für:1 mit:1
stock_BMY r_down	quarters:1 being:5 developed:3 reviewed:5 session:3 per:1 blocked:3 whose:2 based:1 atrial:5 treatment:2 premarket:2 has:2 multibillion-dollar:2 additional:3 trade:3 now:1 lost:3 --:6 companies:9 disorder:2 shed:3 set:2 list:1 estimates:1 back:4 actively:6 trading:7 3.0:1 2.3:2 blocks:2 2.0:1 2.5:1 index:3 said:5 decision:2 anticlotting:1 while:2 shares:8 current:1 closed:1 new:5 recently:2 months:2 hours:1 regulators:2 operating:1 approval:4 $:4 reaction:2 last:2 rejects:1 drug:8 trial:2 survey:1 analysts:2 studies:2 thinner:2 heart-rhythm:2 down:2 smaller:2 throughout:2 market:3 pushes:2 their:2 support:2 anti-clotting:5 least:3 few:2 2:1 expected:3 clinical:3 more:7 share:1 but:2 fibrillation:5 patients:5 were:2 already:2 called:2 1.5:1 1.6:3 1.7:1 1.1:2 1.2:1 1.8:1 sales:2 stroke:5 dropped:2 further:2 seen:2 seek:2 information:10 4.6:2 no:2 application:3 potential:4 which:7 income:1 =:5 stock:2 requested:5 used:2 's:12 after:1 fell:3 blood:2 included:1 stocks:3 data:3 approved:2 lower:3 traded:2 request:2 having:2 prevention:5
stock_BMY r_up	financial:1 have:1 over:1 share:1 years:1 capital:1 date:1 reflects:1 looks:1 unveiled:1 balanced:1 its:3 pharmaceutical:1 said:2 adds:1 $:5 expiration:1 next:1 application:1 3:4 program:3 340:1 take:1 which:1 under:1 expected:1 has:2 boost:1 2010:1 authorization:2 stock:1 added:1 company:1 million:1 shareholder:1 repurchase:2 strong:1 drugmaker:1 billion:2 couple:1 approach:1 value:1 remaining:1 n't:1 place:1 does:1 position:1 latest:2
stock_BMY r_up	issued:2 over:1 expects:2 trade:5 session:5 looks:1 headlines:1 its:9 reluctant:1 rundown:1 $:7 application:1 guidance:2 same-store:2 expectations:2 analyst:2 two-day:1 stock-market:1 340:1 under:1 has:2 2010:1 earnings:6 gains:1 beat:2 couple:1 watch:2 early:1 years:1 day:1 drugmaker:1 approach:1 companies:5 financial:1 estimates:2 actively:5 year:2 's:8 margins:2 said:4 adds:1 mood:1 jumped:2 recorded:2 shares:5 increase:2 3:4 does:1 capital:1 new:2 boost:1 million:1 hours:2 aircraft:2 repurchase:2 strong:1 ahead:1 prior:3 place:1 unmanned:2 fourth-quarter:2 outlook:2 revenue:2 appeared:1 retailer:2 reflects:1 balanced:1 pharmaceutical:1 next:1 program:3 low:2 interest:1 expected:6 upbeat:2 9.1:2 authorization:2 fiscal:4 company:5 lowered:2 second-quarter:2 up:2 value:1 remaining:1 n't:1 expiration:1 creeping:1 0.9:2 risk-averse:1 have:1 investors:1 share:1 sales:2 unveiled:1 take:1 end:2 weakened:2 also:2 build:1 which:1 auto-parts:2 stock:1 added:1 edged:2 though:2 after:2 shareholder:1 date:1 billion:2 lower:1 futures:1 summit:1 position:1 corporate:1 latest:2
stock_BMY r_up	share:1 total:1 unanimously:1 $:5 5.3:3 approved:1 7:1 net:1 announced:1 buy:1 's:1 said:2 debt:1 payment:1 billion:2 both:1 transaction:2 boards:1 31:1 companies:3 value:1 directors:1
stock_BMY r_up	help:1 proposed:2 global:1 obtain:2 trade:1 bright:1 session:4 per:1 headlines:1 its:4 rescue:1 rundown:2 whose:2 certainly:1 based:1 just:1 rose:2 analyst:2 4:1 pretty:1 has:2 might:1 sent:1 take:1 plate:1 his:1 ingredient:1 gains:1 very:1 big:1 watch:2 focus:1 early:2 imperil:1 gridlock:1 got:1 not:1 quarters:1 investor:1 advanced:1 lost:3 level:1 sluggish:1 companies:5 morning:1 deals:1 activity:1 worries:1 higher:2 added:1 diabetes-drug:1 reactions:1 says:1 often:1 list:1 estimates:1 elections:1 actively:4 trading:3 accelerate:2 3.0:1 close:1 2.0:1 2.5:2 3.9:1 index:3 stands:2 weakness:1 clock:1 jumped:1 shares:5 current:1 3:2 closed:1 new:1 approach:1 announced:1 gives:1 measures:1 recently:2 extend:1 commercial:1 agreement:1 hours:1 operating:1 key:1 put:1 business:1 declining:2 $:3 38:1 last:1 ahead:1 reinforces:1 could:1 larger:1 drug:3 prior:1 range:1 survey:1 analysts:2 mixed:2 traded:2 maker:2 seeing:1 major:1 own:1 point:1 period:1 one:2 down:1 soaring:1 65:1 market:2 leaders:1 conference:1 confidence:1 area:1 remains:1 there:1 political:2 spots:1 few:1 lot:1 expected:1 assessment:1 500:2 summit:1 rallied:1 ``:1 interest:1 share:1 acquire:1 but:1 sizable:1 economic:1 hopes:2 second-quarter:1 '':1 16:1 markets:1 edged:1 up:4 healthy:1 while:1 stall:1 growing:1 making:1 toward:1 takeovers:1 1.5:1 barely:1 1.1:1 investors:1 moved:1 sales:2 biggest:2 continued:1 hover:1 2.2:1 been:1 moves:1 around:1 5.3:3 uncertainty:2 write:1 indexes:1 1:1 faults:1 setting:1 economy:1 which:2 income:1 9:1 stepped:1 out:1 =:5 holiday-shortened:1 stock:2 gaining:2 recovery:1 's:16 after:1 fast-growing:1 fell:2 included:1 stocks:5 diabetes:3 billion:3 purchase:3 lower:1 calls:1 downbeat:1 futures:3 daily:1 dent:1 points:9 week:2 muscle:1 corporate:2 heft:1 profits:1 latest:1
stock_BMY r_down	sector:2 global:1 share:1 surprisingly:1 one:1 hopes:1 ended:1 pharmaceutical:1 sessions:1 highlighting:1 fourth:1 spending:1 positive:1 since:1 increase:1 concerns:1 which:1 territory:1 500:1 higher:1 buybacks:1 finish:1 's:2 plans:1 loss:1 company:2 weak:1 banks:1 helped:1 five:1 report:2 manufacturing:2 downgraded:1 recent:1 acquisitions:1 sending:1 2009:1 central:1 showed:2 could:1 borrowing:1 time:2 action:1 notch:1 first:1
stock_BMY r_down	's:1 flow:1 discounted:1 cash:1 rising:1 sees:1
stock_BMY r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_BMY r_down	control:1 sector:1 broader:1 number:1 competition:1 past:1 have:1 year:1 exclusivity:1 blockbuster:1 lower-priced:1 market:1 bolster:1 generic:1 struggles:1 been:1 makers:1 their:1 raft:1 firms:1 pipelines:1 cope:1 drugs:1 industrywide:1 during:1 cliff:1 loss:1 coping:1 drug:2 deals:1 patent:1 costs:1 entry:1
stock_BMY r_down	control:1 sector:1 81:1 have:1 raft:1 firms:1 industrywide:1 number:1 competition:1 struggles:1 past:1 88:1 been:1 performed:3 triple:1 year:1 pipelines:1 partner:3 exclusivity:1 blockbuster:4 its:3 market:1 bolster:1 containing:1 said:1 patent:1 48:1 their:1 generic:1 had:1 two:1 shares:1 makers:1 better:4 pressures:1 clinical:4 details:1 biggest:1 new:3 newly:1 pill:3 shows:1 weeks:1 product:1 lower-priced:1 's:7 combination:1 cope:1 drugs:2 coping:1 joint:1 virus:1 compared:1 entry:1 during:1 broader:1 beginning:1 than:4 cliff:1 loss:1 regimen:3 novel:1 showed:1 older:1 --:5 rival:1 implications:1 drug:7 deals:1 trial:5 patients:2 costs:1 superiority:1 diagnosed:1 venture:1 did:1 inhibitor:1 oral:1 maker:2 late-stage:3
stock_BMY r_up	1.5:1 own:1 hoping:1 investors:1 companies:1 mind:1 quarters:1 included:1 3.0:1 2.0:1 find:1 2.5:1 caveats:1 per:1 next:1 current:1 income:1 new:1 =:5 good:1 's:1 some:1 company:1 bear:1 operating:1 groups:1 prices:1 based:1 must:1 pipeline:1 target:1 list:1 drug:1 while:1 estimates:1 survey:1 analysts:2 time:1 share:1 acquisition:1
stock_BMY r_up	hold:1 remains:1 bull/bear:2 volatile:1 market:1 have:1 taken:1 technicals:1 battleground:2 backdrop:1
stock_BMY r_up	prices:1 limited:1 cancer:3 reported:1 profit:1 some:1 we:1 '':2 medical:1 including:1 committed:1 need:1 sells:1 its:3 said:2 trial:1 remains:1 28:1 hepatitis:2 3:3 treatment:3 objective:1 lower-than-expected:1 net:1 company:1 treat:1 versus:1 ``:2 added:1 's:3 diseases:1 drugs:1 survival:1 rise:1 primary:2 met:1 generic:1 fell:1 liver:3 sharply:1 serious:1 not:1 president:1 disappointed:1 advanced:2 fiscal:1 endpoint:1 vice:1 considered:1 medicines:1 developing:1 unmet:1 drug:3 maker:1 n't:3 did:1 patients:2 meet:1 senior:1 quarter:1 options:1 first:1
stock_BMY r_down	limited:2 chain:4 less:4 trade:4 session:4 including:2 hepatitis:4 committed:2 its:9 $:6 expectations:5 treatment:6 premarket:2 has:4 versus:2 11:1 diseases:2 survival:2 endpoint:2 traffic:4 not:2 disappointed:2 advanced:4 loss:1 lost:1 did:2 medicines:2 drop:1 companies:5 fewer:1 restaurants:8 strengthened:1 shed:1 people:4 unmet:2 some:4 slowed:4 actively:5 trading:6 result:4 margins:1 index:1 said:8 projected:1 shares:5 below:5 3:6 masking:1 we:2 recently:5 possibility:4 hours:2 met:2 108:1 31:1 drug:6 trial:2 analysts:5 options:2 cancer:6 revenue:5 primary:4 down:4 narrowed:1 market:2 remains:2 treat:2 expected:4 ``:4 fast-food:4 company:1 pricey:4 liver:6 second-quarter:5 raising:4 customer:4 12:2 uncertain:4 17:2 developing:2 n't:6 charges:1 patients:4 growth:8 were:1 meet:2 chip:1 sales:5 '':4 dropped:1 need:2 saw:1 tumbled:4 objective:2 economy:4 added:2 's:10 after:2 fell:5 president:2 stocks:1 lower:1 vice:2 considered:2 medical:2 maker:3 points:3 serious:2 senior:2
stock_BMY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_BMY r_up	among:1 investors:1 28:4 sales:2 see:1 including:2 headlines:1 declined:2 rundown:1 profit:2 anticlotting:2 interest:1 expected:1 pill:2 's:2 expirations:2 drugs:2 watch:4 early:1 active:1 stocks:1 second-quarter:2 recent:2 eroded:2 patent:2 were:2 trading:1 corporate:1
stock_BMY r_up	advisory:1 emerging:2 global:1 expects:1 years:1 quotes:1 via:1 through:1 shares:1 cuts:2 exclusivity:1 its:5 1.17:1 cut:1 $:5 euros:2 rose:2 environment:1 going:1 quarterly:1 has:1 earnings:4 expirations:1 which:4 bonds:9 big:3 rise:2 13:1 top-quality:1 records:1 boost:1 fall:3 high-quality:1 austerity:2 governments:2 1.01:1 loss:3 30-year:6 ended:1 --:13 cause:2 companies:2 facing:2 three-year:1 each:1 quarter:1 bond:3 few:1 because:2 deal:2 some:3 back:1 competition:1 past:1 growth:3 pricing:2 year:4 further:1 margins:1 makers:2 2.5:1 even:2 said:5 profit:5 since:1 comments:1 increase:1 yields:1 net:4 ever:1 earlier:1 business:1 closings:1 sold:1 million:1 pressure:2 job:1 five-:3 debt:1 coupons:1 both:1 hits:1 cautious:1 ahead:1 reported:1 region:2 30:1 according:1 drug:4 keep:2 prior:1 range:1 products:1 banker:1 context:1 fallen:1 maker:2 patents:3 first:1 major:1 benefited:1 tough:1 coupon:3 message:2 throughout:1 market:4 pharmaceutical:2 rated:1 record-low:2 pushes:1 would:1 warned:2 leading:1 top:2 their:5 2:2 9.8:1 combined:1 strong:2 expected:1 markets:2 500:1 lowest:2 flat:2 ``:1 way:1 drugs:3 company:4 took:1 part:3 known:1 despite:3 second-quarter:4 posted:2 case:1 '':1 financing:1 1995:1 16:1 19:3 expanded:1 up:1 optimism:1 record:2 cost:1 were:3 industry:1 1.4:1 firm:2 investors:3 sales:5 helped:2 full-year:2 attain:1 return:1 blockbuster:3 string:1 ratings:1 patent:2 detail:2 3.25:2 details:1 fourth:1 income:1 forge:1 offered:1 five-year:1 's:9 measures:2 problems:2 dented:1 much:1 issuance:1 restructuring:2 cleared:1 eighth:1 cliff:1 billion:7 purchase:1 lower:2 off:1 borrowing:1 sale:2 generic:1 costs:4 rallies:1 2008:1 looking:1 profits:1
stock_BMY r_up	bearing:1 set:1 investors:1 coupon:2 borrowing:1 global:1 back:1 according:1 750:1 attain:1 another:1 market:1 earlier:1 ratings:1 rated:1 record-low:1 pushes:1 prior:1 leading:1 2.5:1 2:2 3.25:1 combined:1 three-year:1 ever:1 company:1 500:1 five-year:1 lowest:2 million:2 's:1 bonds:8 month:1 going:1 offered:1 each:1 30-year:5 top-quality:1 records:1 part:2 low:1 sold:2 five-:3 1995:1 debt:1 coupons:1 $:5 billion:3 purchase:1 lower:1 high-quality:1 --:4 companies:1 sale:2 record:4 range:1 costs:2 yields:1 rallies:1 bond:3
stock_BMY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_BMY r_down	exceed:1 selected:2 proposed:1 executive:4 results:1 expenses:2 helped:2 industrial:2 animal-health:1 close:2 exclusivity:3 blockbuster:2 its:2 market:3 sell:1 25:4 20:1 profit:3 bringing:2 stake:1 expectations:1 comments:1 former:2 increase:2 pressures:1 permanent:2 unit:1 erosion:2 company:2 details:1 's:6 price:1 arthritis:1 seventh:1 sales:3 reported:2 updates:1 cushion:2 services:2 president:2 beginning:1 second-quarter:2 loss:2 lower:2 five-month:2 --:3 hunt:2 up:1 drug:4 leader:2 chief:2 analysts:1 cholesterol:1 stock:1 maker:1 20th:1
stock_BMY r_up	play:1 upcoming:1 could:1 drug:1 options:1 action:1 small:1 surge:1 company:1 higher:1
stock_BMY r_down	being:4 developed:5 glut:2 executive:5 focus:4 setback:3 trade:2 prices:2 session:2 shares:6 questions:5 its:16 move:5 24:1 grappling:3 26:1 promote:2 based:3 $:16 300,000:3 rose:1 guidance:4 had:4 expectations:2 second-quarter:4 production:2 notes:1 premarket:2 suspension:3 suffered:4 has:10 details:6 global:2 confidential:1 wide:2 could:3 results:2 early:1 boost:2 stock-option:2 updates:2 background:4 despite:2 report:1 immediately:1 cancer:1 17:2 lost:3 countries:2 --:21 issue:7 tumors:1 developing:2 arrested:2 leave:1 race:3 found:1 cells:1 shed:1 says:4 companies:5 testing:1 second:1 actively:5 trading:8 expected:2 year:5 82:2 patient:4 targets:5 declined:1 plans:2 index:3 said:4 adds:2 missed:2 3rd:2 profit:2 jumped:2 hepatitis:15 access:2 include:2 safety:7 closed:1 medicine:2 cause:4 halts:1 rundown:1 earlier:5 recently:2 business:2 pose:3 weak:3 giant:1 stem:1 hours:1 discount:1 protection:3 meet:2 major:3 beginning:6 declining:2 reaction:2 essentially:2 potential:5 study:11 trades:1 drug:28 illicit:2 analysts:2 mixed:1 traded:1 maker:3 experimental:2 first:2 raised:2 slipped:1 low-cost:2 retailer:2 down:1 rising:2 raises:5 suspended:7 throughout:4 market:3 '':5 analyst:2 anti-clotting:3 two:1 been:3 start:1 treat:10 biggest:2 more:3 searches:1 ``:5 buy:5 allegedly:2 season:1 company:11 peers:1 sizable:1 lowered:2 brain:1 liver:4 demand:2 known:4 92:1 than:3 he:2 10:2 made:1 high-quality:2 places:1 versions:2 inside:1 n't:4 growth:2 nine:1 can:1 were:4 making:1 margin:2 called:2 acquisition:7 1.4:1 heart:8 1.2:1 flat:2 sales:7 13th:1 full-year:2 tag:5 partner:2 moves:1 information:2 blockbuster:3 generic:2 make:2 topped:2 other:2 2.5:9 which:7 stock:3 gaining:2 used:2 's:24 intended:7 price:5 after:5 paid:5 fell:3 authorities:2 stocks:5 soared:2 billion:9 lower:2 off:2 solar-panel:2 failure:8 charges:3 disease:4 daily:1 options:1 patent:3 points:7 apparel:2 serious:5 12:2 profits:3
stock_BMY r_up	being:1 developed:1 executive:5 focus:1 prices:1 comments:1 questions:1 appetite:1 its:2 move:1 $:5 300,000:3 graph:1 had:1 blog:1 suspension:1 suffered:2 has:2 might:1 good:2 which:1 confidential:1 read:1 stock-option:1 updates:1 immediately:1 17th:1 --:3 issue:1 arrested:2 piling:1 leave:1 bad:2 stock:1 unexpected:1 says:1 computer:1 trading:2 year:1 targets:3 2.5:2 hepatitis:5 safety:2 cause:1 earlier:1 patient:2 news:2 post:1 debt:1 beginning:2 search:1 secrets:1 study:3 trades:1 drug:11 illicit:1 analysts:3 traded:1 maker:3 experimental:1 into:1 rising:1 raises:1 suspended:2 illegal:1 dud:1 rivals:2 returns:1 treat:2 more:3 ``:2 buy:1 option:1 allegedly:3 company:2 capitalizing:1 but:1 failure:3 liver:2 known:1 than:3 he:1 made:1 places:1 rival:1 work:1 appearance:1 n't:1 tag:1 making:1 called:2 acquisition:4 heart:3 investors:1 '':2 say:1 his:1 investment-grade:1 ratings:1 court:1 combination:1 credit:1 make:1 potential:1 details:2 boon:1 developers:1 higher:1 used:1 's:6 intended:2 information:1 may:1 price:1 after:2 paid:1 authorities:1 billion:2 elusive:1 charges:2 6th:1 disease:2 options:1 serious:1 corporate:1 profits:3
stock_BMY r_down	1.5:1 companies:1 estimates:1 quarters:1 3.0:1 2.0:1 2.5:1 based:1 generic:1 per:1 current:1 largest:1 violations:1 =:5 's:1 drugs:1 share:1 income:1 possible:1 operating:1 included:1 world:1 law:1 manufacturer:1 list:1 survey:1 analysts:2 investigating:1
stock_BMY r_down	$:1 federal:1 pay:1 into:1 million:1 bribery:1 settle:1 investigation:1 overseas:1
stock_BMY r_down	month:2 brain:1 per:1 appetite:1 its:5 issues:1 previous:1 completion:3 $:9 guidance:2 had:2 other:1 has:2 2011:1 meanwhile:1 undisclosed:1 made:1 difficult:1 30:1 day:1 volatility:1 following:3 --:1 underscores:1 higher:2 disorder:1 week:1 because:1 financial:1 companies:1 revised:2 past:1 trading:3 year:3 close:1 84:1 said:3 shares:2 research:1 above:1 capital:1 new:1 payoff:1 scientific:1 months:1 million:2 understanding:1 reported:1 although:1 brokerage:2 debt:1 faced:1 climate:1 last:3 working:1 ahead:1 discount:1 dollars:1 trades:1 drug:2 retail:1 experimental:1 search:1 number:1 use:1 would:1 initial:1 sovereign:1 billion:4 offering:1 offer:2 successful:1 company:1 lower:1 but:1 priced:1 volume:1 failure:1 surged:1 than:3 posted:1 12:1 edged:1 up:3 were:1 wild:1 3.2:1 medical:1 acquisition:3 1.6:1 weaker:1 investors:1 outstanding:1 share:1 purposes:1 general:1 high:1 full-year:2 have:2 need:1 proceeds:1 totaled:1 4.4:3 5.3:3 end:1 1:4 potential:2 online:1 9:2 stock:1 development:1 's:8 price:1 earlier:1 treatments:1 reflect:2 payment:3 recent:1 acquisitions:1 peers:1 assets:1 average:2 disease:1 daily:1 client:2 1.26:6
stock_BMY r_down	500:2
stock_BMY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_BMY r_up	steel:1 video-game:1 holdings:1 stake:1 maker:2 late:1 reported:1 reduced:1 regulatory:1 filing:1 higher:1
stock_BMY r_up	heart:4 raised:2 partial:2 compound:2 setback:2 actively:1 trading:2 hepatitis:4 67:2 patient:3 its:2 previous:1 index:1 given:2 27:1 competitor:2 additional:1 rose:1 plans:1 placing:2 shares:1 rival:2 potential:2 safety:2 details:1 fourth:1 commentary:1 higher:1 added:1 's:3 halt:1 timeline:2 company:1 dealt:2 treatments:2 76:1 lift:2 testing:1 new:2 hold:6 beginning:1 analyst:1 after:2 stocks:1 failure:2 --:6 follows:2 taking:2 companies:1 up:1 drug:6 patients:2 points:3 nine:1 planned:2 concerns:2 were:1 further:2 similar:2 treated:2 study:2 trials:2
stock_BMY r_down	partial:1 issued:1 setback:1 month:1 hepatitis:1 its:1 poorly:1 high-grade:1 $:1 rose:1 weeks:1 has:1 bonds:3 nearly:1 difference:1 secondary:1 entire:1 --:4 performing:1 companies:1 50:1 yield:2 deals:1 yields:2 shots:1 dealt:1 bond:1 some:1 actively:1 trading:1 further:1 flock:1 85:1 index:1 since:1 shares:1 closed:1 between:1 new:1 firms:1 comparable:1 recently:1 sold:1 hours:1 debt:1 getting:1 climbed:1 drug:1 issuers:1 already:1 offerings:1 market:2 figure:1 placing:1 been:2 their:1 call:1 selling:1 but:1 demand:1 hold:1 than:1 those:1 10:1 up:1 similar:1 investors:2 have:1 fill:1 sell:1 trials:1 spreads:1 able:1 1:2 higher:2 meets:1 begin:1 's:3 may:2 after:1 forecasts:1 robust:1 stocks:1 recent:1 billion:1 lower:1 points:2
stock_BMY r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_BMY r_up	sell:1 week:1 blockbuster:1 cost:1 get:1 may:1 much:1 company:1 controversy:1 drug:1 next:1 already:1 but:1 faces:1 expected:1 become:1 clearance:1 over:1
stock_BMY r_up	development:1 said:1 patient:2 intended:1 hepatitis:1 hospitalized:1 after:1 disease:1 drug:1 were:1 safety:1 treat:1 interest:1 others:1 has:1 discontinued:1 died:1 liver:1
stock_BMY r_up	caused:1 trade:4 produced:1 session:4 shares:4 skin:1 headlines:1 year-earlier:3 its:14 staff:3 rundown:1 $:19 23:1 guidance:3 had:3 expectations:3 late:3 charge:4 premarket:1 developed:3 safety:2 tax:3 has:3 pill:3 stop:1 early:4 closely:4 during:1 salmonella:1 loss:3 companies:4 benefit:3 stopped:4 people:1 acquired:3 testing:5 crown:3 actively:4 result:1 year:3 2.5:3 intended:2 said:9 missed:3 profit:3 decision:1 hepatitis:7 tainted:1 patient:9 decline:1 million:3 hours:2 reported:1 restructuring:2 others:7 strong:3 21:2 getting:1 shift:3 drug:13 maker:6 experimental:3 software:3 fourth-quarter:3 named:1 revenue:6 address:3 one:5 aimed:4 cloud:3 pharmaceutical:3 would:1 third-quarter:3 their:1 clinical:1 growth:3 treat:6 interest:3 expected:4 9.3:3 fiscal:6 hospitalized:7 reduce:3 company:8 lowered:3 liver:6 known:3 effort:2 second-quarter:3 posted:3 abandoned:3 developing:1 plunged:3 record:3 officials:1 were:7 acquisition:3 investors:1 computing:3 infections:1 1.8:10 full-year:3 ink:1 watched:4 swung:3 linked:1 dozen:1 tattoo:1 deadly:4 recommended:1 take:1 which:3 outbreak:1 impairment:3 development:9 's:11 plans:3 though:3 farm:1 watch:2 after:9 most:1 fell:2 eight:5 two:1 revealed:1 died:7 billion:7 mobile:3 jewel:3 disease:6 discontinued:2 corporate:1
stock_BMY r_up	limited:1 managed:1 setback:3 quarters:1 cardiologist:1 per:1 its:2 developer:2 25:1 based:1 rose:2 better:1 has:1 uptake:1 physicians:1 good:1 risk:1 not:1 advanced:1 list:1 investigators:1 because:1 significantly:1 bleeding:1 companies:3 estimates:1 actively:2 trading:3 3.0:1 recently:2 2.0:1 2.5:1 index:2 said:3 missing:1 shares:2 current:1 does:1 cardiovascular:1 patient:1 whose:1 operating:1 article:1 change:1 attacks:1 study:2 drug:4 trial:3 carries:1 survey:1 analysts:2 published:1 mixed:1 efforts:1 blood:1 thinner:1 heart:1 one:3 would:1 anti-clotting:1 three:1 been:1 doing:1 clinical:3 flat:1 ``:1 hold:2 than:1 population:1 up:1 n't:1 placed:2 patients:2 were:2 outcome:1 1.5:1 share:1 '':1 say:1 dropped:1 our:1 relatively:1 six:1 preventing:1 widely:1 income:1 =:5 higher:1 used:1 's:4 strokes:1 treatments:2 eight:1 two:1 included:1 stocks:2 data:1 expand:1 hepatitis:2 principal:1 points:5 serious:1 latest:2
stock_BMY r_up	people:2 previously:4 into:2 ``:1 one:3 four:2 have:2 causes:1 combines:2 said:1 ingredients:2 brand:2 been:2 other:2 treat:2 provides:1 under:2 medicine:2 new:2 pill:4 treatment:1 meant:2 product:2 's:2 complete:1 sold:2 infection:1 virus:3 approved:2 '':1 regimen:1 name:2 --:1 medicines:2 n't:2 treated:2 called:1
stock_BMY r_down	10:6 said:2 voluntary:2 initiated:2 lots:2 recall:2 after:2 agent:2 one:2 routine:2 testing:2 drug:2 during:2 chemotherapy:2 its:2 discovery:2
stock_BMY r_up	development:2 emerging:2 investors:3 fish:1 skin:1 reassure:1 expects:1 clear:1 growth:2 type:1 strategy:1 its:2 unit:1 mercury:1 n't:2 use:1 develop:1 links:1 showcase:1 spending:1 highlights:1 omega-3:1 next:1 bacteria:1 also:1 vials:1 study:1 mid-stage:2 meeting:2 expected:1 markets:2 tell:1 more:1 week:1 oils:1 increased:1 than:1 targeted:1 between:1 focus:1 lives:1 recalls:1 find:1 hold:1 grow:1 pipeline:2 benefits:1 --:4 presentation:1 medicines:1 drug:3 try:1 form:1 researchers:1 diagnostics:1 making:1 balance:1 maker:1 talk:1
stock_BMY r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_BMY r_down	billion:1 pharmaceutical:1 cut:1 develop:1 $:1 spending:1 industry:1 costs:1 new:1 find:1 drugs:1 continue:1 defying:1 year:1 wider:1 8:1 trend:1 than:1 more:1
stock_BMY r_up	``:2 after:2 name:2 merger:2 into:2 executive:2 '':2 planned:2 chief:2 combined:2 discussions:2 entered:2 has:2 company:2 advanced:2 developer:2
stock_BMY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_BMY r_up	0.9:1 1.6:2 sees:2 session:1 1.3:1 0.1:2 minutes:2 some:2 back:2 trade:1 down:2 actively:4 trading:5 downside:2 slip:2 seen:2 pulls:2 stimulus:2 open:2 market:2 weekly:2 index:3 5.4:1 jobless:2 multi-year:2 rose:3 point:1 run:2 29:1 shares:4 also:2 inflation:2 investors:2 closed:1 expected:1 jumped:1 higher:3 added:2 's:8 statement:6 tap:2 highs:4 after:1 new:2 20:2 hours:1 policy:4 109:1 key:2 demand:2 90:2 stocks:3 recent:2 gained:3 solid:2 13:1 15:1 announcing:2 ahead:6 --:10 wholesale:2 taking:2 futures:6 companies:4 measures:2 breather:2 auction:2 points:7 follow:2 were:2 following:2 claims:2 stock:2 slightly:1 bond:2
stock_BMY r_down	gaining:2 among:1 moves:1 market:1 sizable:1 could:1 daily:1 biggest:2 see:1 trading:1 shares:1 rundown:1 active:1 making:1 stocks:3 declining:2 stock:1
stock_BMY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_BMY r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_BMY r_up	said:2 positive:2 move:2 results:2 drug:4 clinical:2 hepatitis:2 trials:2 forward:2 its:4 allowing:2
stock_BMY r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_BMY r_down	blood-thinner:1 sales:2 high:1 world-wide:1 year:1 sell:1 pharmaceutical:1 said:1 $:1 also:1 same:1 1:1 their:1 outside:1 2018:2 markets:1 until:2 treat:1 200:1 used:1 exchange:1 drugs:1 company:1 million:1 agreement:1 pressure:1 royalty:2 blood:1 they:1 alone:1 changing:1 payment:1 --:1 drug:1 final:1 receive:2 payments:2
stock_BMY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_BMY r_up	help:1 proposed:1 developed:1 into:1 results:1 damage:1 helped:1 medical:1 hepatitis:2 reducing:1 causes:1 said:1 based:1 treat:1 would:1 positive:1 there:1 three:2 comments:1 late:2 also:1 genetic:1 clinical:3 details:1 fourth:1 reviewers:1 new:1 cause:1 drug:2 choose:1 's:1 drugs:4 company:1 cholesterol:2 but:1 reported:1 virus:1 updates:1 decide:1 prices:1 data:2 analyst:1 stage:2 high:1 regimen:3 potential:1 rare:1 effective:1 most:1 --:4 disorder:1 taking:1 larger:1 reports:1 trial:2 patients:1 experimental:2 trials:1 very:1 stock:1 studies:1 guide:1 20th:1 liver:1
stock_BMY r_up	health-care:2 gains:1 sectors:2 showing:1 rise:2 sales:1 reports:1 increase:1 also:1 market:1 lift:1 buoyed:2 investors:1 retail:1 data:1 bank:3 consider:1
stock_BMY r_down	injections:1 demand:1 patient:1 meningitis:1 offer:1 wake:1 seeking:1 doctors:1 desperation:1 but:1 remains:1 say:1 safety:1 relief:1 questions:1 outbreak:1 pain:2 people:1
stock_BMY r_down	bevy:1 major:1 fashion:1 well:1 executive:2 domestic:1 slated:1 three:1 offerings:1 report:1 likely:1 close:1 heels:1 follow:1 strategy:1 its:1 market:1 gross:1 industrials:1 since:1 housing:1 initial:1 airlines:1 same:1 next:1 turnaround:1 earnings:2 expected:2 details:1 watching:1 public:1 more:1 week:2 product:1 after:1 's:2 though:1 season:1 continues:1 wave:1 most:1 portal:1 web:1 former:1 others:1 not:1 along:1 stocks:1 data:1 struggling:1 companies:1 premature:1 chief:1 became:1 tech:2 release:1
stock_BMY r_up	woman:1 's:2 people:1 drugs:1 ill:1 testing:1 obtain:1 one:1 death:1 seriously:1 program:1 brush:1 path:1 still:1 gives:1
stock_BMY r_down	adjusted:2 ninth:1 through:1 comments:2 still:1 antipsychotic:3 continued:1 expectations:2 former:2 program:1 details:1 2012:2 hit:2 rise:2 watch:2 results:1 updates:1 background:1 investor:1 loss:4 17th:1 --:9 12th:1 drop:5 including:1 view:2 estimates:1 fuels:1 competition:5 makers:3 profit:2 shares:2 research:1 increase:2 misses:2 7:6 15th:1 after:2 sixth:1 reported:2 offset:2 along:1 beginning:1 reaction:2 pipeline:1 30:6 drug:10 analysts:2 maker:2 experimental:3 executives:2 major:1 revenue:3 feel:1 third-quarter:7 down:3 throughout:1 miss:2 decline:3 wrath:1 anti-clotting:3 due:1 one-time:2 eighth:1 but:2 scrutiny:1 failure:3 analyst:2 11:2 while:3 drops:1 costly:3 investors:1 sales:6 helped:2 pushed:3 optimistic:1 partner:2 swung:3 information:1 generic:5 backs:2 other:1 earnings:7 fourth:1 stock:1 development:1 draw:1 's:4 overall:3 price:1 reporting:1 driven:3 fell:1 payment:4 hepatitis:4 short:1 reports:1 components:1 termination:1
stock_BMY r_up	saying:1 surprises:2 steroids:1 linked:1 quarters:1 '':1 its:1 said:1 deadly:1 had:1 pharmacy:1 advisories:2 earnings:1 outbreak:1 ``:1 meningitis:1 drugs:1 lab:1 tested:1 roundup:1 companies:1 reports:1 future:1 were:1 corporate:1 latest:1
stock_BMY r_up	over:2 through:2 exclusivity:7 its:4 fifth:1 giant:4 $:8 workers:1 expectations:2 former:1 late:2 program:4 board:4 quarterly:1 has:4 take:2 updated:2 get:1 updates:3 loss:4 excluding:2 lost:5 --:15 positions:1 drop:1 continue:4 cholesterol:5 because:2 result:1 year:4 slumped:1 profit:4 comments:4 spokesman:1 investigation:4 eliminate:2 jobs:3 marketing:4 million:4 agreement:4 reported:5 antipsychotic:2 reaction:2 last:2 met:2 items:2 drug:7 analysts:2 maker:8 executives:2 comment:1 adjusted:2 revenue:2 market:3 pharmaceutical:4 authorizes:4 third-quarter:4 one-time:2 share-repurchase:4 expected:1 but:2 hurt:4 sharply:4 analyst:2 pact:1 10:4 14:15 10th:2 sales:11 promotional:2 12th:2 partner:2 blockbuster:1 information:2 end:2 responsibilities:2 other:3 earnings:7 which:4 stock:5 settle:4 's:16 plans:2 may:1 price:5 after:1 fell:6 restructures:1 eighth:2 480:7 billion:4 lower:4 short:2 third:2 medical:2 principle:4
stock_BMY r_down	1.5:1 named:2 3.0:1 companies:1 executive:2 estimates:1 years:1 down:2 governor:1 stepping:2 2.0:1 2.5:1 pharmaceutical:2 said:2 based:1 while:2 per:1 current:1 generics:4 income:1 new:1 successor:2 =:5 meant:1 his:2 's:8 business:4 government:1 share:1 company:2 operating:1 included:1 president:4 quarters:1 senior:2 he:1 kind:1 vice:2 list:1 35:1 chief:2 became:1 survey:1 analysts:2 2008:1 first:1 promised:1
stock_BMY r_down	among:2 says:2 certain:2 alternatives:2 its:2 expensive:2 away:2 other:2 low:2 conditions:2 available:2 's:1 business:2 drugs:2 pharmacy-benefit:2 treatments:2 members:2 testosterone:2 taking:2 glaucoma:2 aim:2 push:2 steer:2 latest:2
stock_BMY r_down	emerging:1 results:1 quarters:1 hepatitis:3 its:3 ground:1 impact:1 based:1 investigational:1 treatment:3 mid-stage:1 hope:2 combination:1 now:1 medicines:1 early-stage:1 list:1 race:1 contain:1 injectable:1 drop:2 companies:2 estimates:1 potent:1 3.0:1 2.0:1 2.5:1 skin-cancer:1 said:2 per:1 current:1 favor:1 conduct:1 new:4 power:1 operating:1 article:1 along:1 appears:1 many:1 study:2 drug:5 trial:3 survey:1 analysts:2 published:1 studies:1 experimental:3 cancer:1 promise:1 system:1 fight:1 rivals:1 clinical:2 more:1 company:2 eliminates:1 part:1 sustained:1 than:1 regimen:3 showed:3 tolerate:1 patients:5 future:2 can:1 staking:1 1.5:1 share:1 containing:2 develop:1 1:1 immune:1 potential:1 which:2 income:1 =:5 difficult:1 's:3 plans:1 treatments:1 most:3 virus:2 plan:1 included:2 unleash:1
stock_BMY r_down	people:1 results:1 frontrunner:1 world-wide:1 its:2 impact:1 containing:1 said:1 develop:1 deadly:1 investigational:1 hepatitis:2 1:1 favor:1 180:1 clinical:1 treatment:2 which:1 affecting:1 new:3 hope:1 combination:1 million:1 treatments:1 most:2 virus:2 liver:1 sustained:1 along:1 future:1 regimen:1 showed:2 many:1 study:1 drop:1 companies:1 drug:2 trial:1 patients:2 race:1 contain:1 position:1 experimental:1 plan:1
stock_BMY r_down	said:1 --:1 company:1 2:1 tablets:1 treatment:1 diabetes:1 has:1 type:1 approved:1 dapagliflozin:1
stock_BMY r_down	raised:1 alliance:1 210:3 show:1 major:1 because:2 sense:1 work:1 said:1 $:3 trials:1 make:1 hepatitis:1 clinical:1 treatment:2 new:1 do:2 business:1 drugs:1 forming:1 company:1 million:1 but:1 fund:1 they:2 not:1 diabetes:1 die:1 sometimes:1 drug:1 n't:2 without:1 can:1 promising:1 biotechnology:1 late-stage:1 maker:1 derailment:1
stock_BMY r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_BMY r_up	medicines:1 distributors:1 doctor:1 drugs:1 illegal:1 into:1 versions:1 guilty:1 purchasing:1 foreign:1 clinics:1 other:1 part:1 investigation:1 unapproved:1 fake:1 overseas:1 has:1 sold:1
stock_BMY r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_BMY r_up	1.5:1 2.5:1 force:2 people:1 certain:1 move:1 estimates:1 sales:2 quarters:1 '':1 3.0:1 cuts:1 our:3 2.0:1 its:1 best:1 current:1 said:2 based:1 would:1 efficient:1 segments:1 per:1 strategy:1 spokesman:1 companies:1 allocate:1 statement:1 income:1 scope:1 =:5 shrink:1 resources:1 more:1 cost-cutting:1 ``:1 analysts:2 's:1 plans:1 evaluate:1 serve:1 but:1 we:2 part:1 operating:1 included:1 article:1 investments:1 areas:1 survey:1 effective:1 did:1 list:1 drug:1 maker:1 n't:1 patients:1 customers:1 can:1 published:1 share:1 reduced:1 latest:1
stock_BMY r_up	development:2 terminated:1 's:3 efficacy:1 saying:1 far:1 testing:1 disease:1 results:1 n't:1 did:1 clinical:1 so:1 treatment:1 further:1 has:1 its:1 experimental:1 justify:1
stock_BMY r_up	1.5:1 companies:1 estimates:1 quarters:1 not:1 3.0:1 year:1 go:2 2.0:1 2.5:1 roiling:1 based:1 question:1 per:1 next:1 current:1 market:2 income:1 =:5 2013:2 more:1 big:1 share:1 but:1 operating:1 included:1 stocks:1 10:2 uncertainty:1 list:1 up:2 survey:1 analysts:2
stock_BMY r_up	control:2 1.5:1 sees:1 deal:2 up:2 bleeding:2 agreed:2 reduce:2 ninth:1 years:5 price:1 held:2 including:1 privately:2 during:2 reached:2 surgery:2 reducing:1 seek:1 its:2 fifth:1 drugs:1 deals:1 adds:1 additional:1 may:1 two-year:2 next:3 also:3 reduction:1 potential:2 treatment:3 185:2 instead:1 leader:3 stock:1 development:1 reshape:3 over:5 million:2 's:6 older:1 wo:1 collaboration:2 acquire:2 agreement:2 but:1 includes:1 2:3 five:5 acquisitions:1 milestone:2 regulatory:1 approval:1 details:1 spend:1 new:4 $:7 billion:5 10:1 pipeline:1 divestitures:1 --:5 study:1 annual:3 disease:1 drug:3 maker:3 n't:1 costs:4 plus:2 payments:2 time:1 starting:1 conduct:1 experimental:1 licensing:2
stock_BMY r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_BMY r_up	development:1 pharmaceutical:1 business:1 big:1 companies:1 one:1 job:1 does:1 complicated:1 so:1 research:1 best:1
stock_BMY r_up	distributors:1 parties:2 allegations:1 ``:1 '':1 nothing:1 29.4:2 its:1 millions:1 pharmaceutical:1 little:1 $:2 chosen:1 pay:1 agreements:1 accusations:1 offshore:1 knowing:1 complaint:1 used:1 which:1 government:1 marketing:1 company:1 despite:1 included:1 subsidiary:1 those:1 deny:1 third:2 did:1 n't:1 admit:1 customers:1
stock_BMY r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_BMY r_down	prevent:1 there:1 heart-rhythm:1 less:1 developed:1 move:1 domestic:1 trade:2 stroke:1 session:2 rising:1 7.4:1 seats:1 fibrillation:1 operation:1 its:1 considering:1 marking:1 8.2:1 actively:2 $:1 initial:1 anti-clotting:1 two:1 shares:3 approved:1 also:1 carrier:1 treatment:1 closed:1 months:1 expected:2 holiday:1 markets:1 public:1 higher:1 available:1 's:2 premarket:1 offering:1 year:1 than:1 company:1 said:1 reiterated:1 regulators:1 jumping:1 approval:1 potential:1 atrial:1 ago:1 third:1 17:1 drop:1 companies:2 drug:1 patients:1 continue:1 disorder:1 called:1
stock_BMY r_down	comment:1 exceed:1 annual:1 heart-rhythm:1 slipped:1 less:1 developed:1 approved:1 sales:1 two:1 stroke:1 actively:1 trading:1 shares:1 1.2:1 close:1 fibrillation:1 1.1:1 index:1 26:1 $:1 rose:1 anticlotting:1 three:2 declined:1 than:2 2:1 treatment:1 fourth:1 expected:1 closed:1 eventually:1 after:2 's:2 risk:1 earlier:1 hours:1 fell:1 five:1 approval:1 stocks:1 analyst:1 atrial:1 billion:1 both:1 lower:2 --:4 could:1 months:2 companies:2 drug:1 patients:1 points:1 disorder:1 called:1 comes:1
stock_BMY r_up	less:1 developed:1 midnight:1 trade:2 bright:1 session:3 deadline:1 fifth:1 25:1 giant:1 atrial:1 23:1 rose:2 add:1 treatment:1 rich:1 poised:1 congressional:1 2012:1 around:1 therapy:1 awaiting:1 developments:1 --:1 companies:2 did:1 stock:1 disorder:1 leaders:1 edition:1 actively:2 index:2 jumped:1 anticlotting:2 patients:1 shares:4 new:2 we:1 avert:1 hours:2 approval:2 $:2 payout:1 ahead:2 31:1 losses:1 drug:2 plus:1 gene:1 slightly:1 heart-rhythm:1 cancer:1 into:1 innovations:1 dividend:1 open:1 pharmaceutical:1 transform:1 fight:1 fibrillation:1 way:1 expected:2 meeting:1 500:1 flat:1 offer:1 company:1 extended:1 than:1 fiscal-cliff:1 11:1 look:1 up:1 devices:1 n't:1 while:2 2013:1 were:1 called:1 months:1 investors:1 cents:1 0.3:1 0.2:1 1.9:1 stroke:1 reports:1 have:1 moves:1 negotiations:1 risk:1 4.1:1 equities:1 six:1 fourth:1 higher:1 added:1 's:4 after:3 treatments:1 two:1 approved:1 cliff:1 fiscal:1 lower:1 medical:1 futures:2 disease:1 points:2 came:1
stock_BMY r_up	own:1 sales:1 have:1 year:1 's:1 its:2 unit:1 said:1 $:1 would:1 began:1 makers:1 1:1 potential:1 5:2 2013:2 life:1 pipelines:1 our:1 after:1 treatments:1 here:1 most:1 spin:1 billion:1 off:1 14:1 medicines:1 months:1 list:1 up:1 drug:1 promising:1 maker:1
stock_BMY r_up	1.5:1 outlook:1 sees:1 background:1 share:1 sales:3 one:1 growth:3 blockbuster:1 its:3 expirations:1 even:1 current:1 throughout:1 grapples:1 $:1 patent:3 struggles:1 least:1 late:1 potential:1 potentially:1 earnings:1 upbeat:1 erosion:1 2013:6 gave:1 program:1 plans:1 commits:1 rise:1 expects:1 modest:2 protection:1 share-buyback:1 despite:1 repurchase:1 dividend:2 details:1 level:1 recent:1 billion:1 battling:1 --:3 industry:1 losses:1 drug:1 antidepressant:1 profit:2 drug-patent:1 lose:1 cliffs:1 maker:2 affirmed:1
stock_BMY r_up	adds:1 four:1 broader:1 year:1 throughout:1 market:1 compared:1 end:1 trials:1 submit:1 clinical:2 details:1 said:1 efficacy:1 collaboration:1 levels:1 goals:1 background:1 regulatory:1 approval:1 beginning:1 diabetes:2 hits:1 third:1 --:3 companies:1 drug:5 insulin:1 placebo:1 studies:1 reduced:1 experimental:1 plan:1
stock_BMY r_up	comment:1 raised:2 proposed:2 stroke:2 measure:2 cardiovascular:1 information:1 said:2 adds:1 would:1 review:1 agency:2 sugar:2 concerns:3 safety:2 treat:1 new:1 panel:1 type:2 seeks:1 fractures:1 lowering:2 risk:1 but:3 analyst:1 blood:2 key:2 approval:1 potential:2 diabetes:4 calls:1 effective:3 --:4 drug:5 flags:1 risks:2 8th:1
stock_BMY r_up	advisory:1 cardiovascular:1 proposed:1 less:1 patients:1 drug:1 benefit:1 concerns:1 risks:1 despite:1 backed:1 panel:1 potential:1 diabetes:1
stock_BMY r_up	scheduled:1 injured:1 last:1 dollars:1 year:1 drug:1 hundreds:1 trial:1 patients:1 settle:1 during:1 talks:1 claims:1 hold:1 killed:1 millions:1
stock_BMY r_up	faced:1 's:1 investors:1 government:1 federal:1 headwinds:1 attention:1 actions:1 one:1 likely:1 drug:1 provides:1 drawn:1 diabetes:1 insights:1
stock_BMY r_up	billion:1 biotech:1 sees:1 $:1 rise:1 continuing:1 manages:1 6:1 stocks:1 investor:1 than:1 2013:2 more:1
stock_BMY r_up	fourth-quarter:1 futures:4 agendas:1 investors:1 heavily:1 companies:1 agreed:1 testing:1 tax:1 sales:1 competition:1 due:1 weighed:1 active:1 see:1 economic:1 trading:1 shares:1 pushing:1 80:1 should:1 its:1 plans:1 tumbled:1 whose:1 use:1 encouraging:1 $:1 8.6:1 profit:1 pay:1 top:1 anti-clotting:1 benefit:1 hepatitis:1 former:1 note:1 insider:1 add:1 session:1 earnings:2 quarterly:1 firms:1 oversight:1 patients:1 disappointed:1 product:1 after:4 's:5 sinks:2 company:1 million:1 results:1 yesterday:1 clients:1 hurt:1 expected:1 rise:1 gain:2 report:1 during:1 100:1 law:1 data:3 killed:1 trade:1 ``:1 executive:1 '':1 15:1 boards:2 warned:1 23:1 ramp:1 up:1 drug:2 their:1 generic:1 while:2 arrangements:1 rose:1 corporate:1 called:1 experimental:1
stock_BMY r_down	firm:1 seven:1 initial:1 tap:1 deal:1 revenue:1 estimates:1 years:1 bring:1 unit:1 article:1 go:1 home:2 market:2 giant:1 $:2 housing:1 since:4 looking:1 public:2 earnings:1 which:2 largest:4 poised:1 bubble:1 company:4 week:2 's:4 plans:1 offering:2 brisk:2 lowered:1 world:1 2.2:2 --:4 builder:2 drug:1 prepping:1 published:1 become:2 maker:1 first:2
stock_BMY r_down	partnership:1 buyer:1 have:1 still:1 $:1 separate:1 late:1 their:2 much:1 new:1 them:1 750:1 seeking:1 marketing:1 company:1 million:1 collection:1 moving:1 bidding:1 brands:2 diabetes:1 auction:1 could:1 companies:1 headquarters:1 drug:1 teams:1 merging:1 either:1 handful:1 stages:1 consumer:1 fetch:1 diabetes-drug:1
stock_BMY r_up	billion:1 raised:1 since:1 last:1 $:3 offering:1 company:1 initial:1 begin:1 deal:1 public:1 symbol:1 trading:1 shares:1 under:1 largest:1 expected:1 2.2:3 maker:1
stock_BMY r_down	significantly:1 revenue:1 tax:2 involves:1 rate:1 taxed:1 aggressive:1 makers:1 pharmaceutical:1 20:1 bottom:1 ways:1 pay:1 away:1 better:1 their:4 rates:3 details:1 boon:1 finding:1 firms:1 higher:1 do:2 's:1 some:1 company:1 but:1 shifting:1 others:1 than:1 lower:3 effective:1 taking:1 lines:1 taxes:1 n't:1 steps:1 can:2 usually:1 strategies:1 overseas:1 looking:1 writes:1 vary:1
stock_BMY r_down	sell:1 438:1 rights:1 $:1 deal:1 exclusive:1 pay:1 medicines:1 million:1 three:1 years:1 certain:1 which:1 under:1 struck:1 has:1 across:1 over-the-counter:1
stock_BMY r_down	sector:1 deal:1 announcing:1 over-the-counter:1 profit:1 many:1 medicines:1 presence:1 sales:1 days:1 second:1 embracing:1 boost:2 its:2
stock_BMY r_up	billion:1 because:1 's:2 $:1 may:1 2011:1 sold:1 up:1 drug:1 copies:1 hook:1 exclusivity:1 damages:1 patent:1 2.1:1 before:1 expired:1 heartburn:1 generic:1
stock_BMY r_up	purchase:1 quietly:1 fraud:1 money:1 laundering:1 producer:1 warned:1 into:1 weapons:1 them:1 fraudsters:1 large:1 authorities:1 organic:1 opposition:1 were:1 not:1 investigating:1 egg:1 duped:1 possible:1
stock_BMY r_down	sector:1 fades:1 averaged:1 lagging:1 show:1 tepid:1 headwinds:1 tax:2 we:1 month:3 '':1 likely:1 growth:1 higher:1 another:1 go:1 jobs:2 tells:1 bankruptcy:1 impact:2 little:1 space:1 spending:1 translate:1 plethora:1 had:1 behind:1 add:1 under:1 expected:1 so:1 previous:1 into:1 economy:1 holiday:1 ``:1 's:2 payroll:1 delayed:1 biggest:1 increases:1 report:1 news:1 payrolls:1 declining:1 acquisitions:1 nonfarm:1 retail:3 2012:1 look:1 refunds:1 notes:1 changed:1 gasoline:1 morning:1 banking:1 microscope:1 expecting:1 have:1 headcount:1 more:1 consumer:1 mergers:1 expect:1
stock_BMY r_up	cancer:1 generation:1 number:1 promise:1 choosing:1 dice:1 new:2 recent:1 roll:1 available:1 life:1 multiple:1 extend:1 drugs:2 putting:1 blood:1 become:1 approved:1 wait:1 off:1 months:1 myeloma:1 patients:2 growing:1 therapy:1
stock_BMY r_up	pharmaceutical:1 giant:1 winner:1 like:1 generic:1 lack:1 yield:1 low:1 robust:1 all-weather:1 valuation:1 its:1 competition:1 looks:1
stock_BMY r_up	information:1 changes:1 drugs:1 cause:1 suggests:1 reviewing:1 they:1 pancreas:1 might:1 class:1 diabetes:1
stock_BMY r_up	sector:1 deal:2 share:1 niche:1 existing:1 trading:1 value:1 another:1 year:1 market:1 gross:1 shareholders:1 documents:1 based:1 opened:1 giving:1 rose:1 six:1 shares:3 their:1 above:1 recent:1 price:1 more:1 head:1 run:1 offering:1 targeted:1 company:2 million:2 filed:1 sold:3 strong:1 continued:1 than:1 $:6 --:1 up:1 35:1 while:1 were:1 first:1
stock_BMY r_down	behavior:1 executive:2 including:1 have:1 cancel:1 recover:3 violates:2 pharma:1 would:1 also:1 make:2 able:1 bad:1 next:1 makers:1 their:2 biggest:1 firms:1 easier:2 's:1 buckling:1 payouts:3 rules:2 big:1 pressure:1 pay-for-performance:1 report:1 ethics:2 investor:1 level:1 --:1 should:1 taking:1 companies:2 drug:1 compensation:2 future:1 stopped:1 payments:1 policies:2 revising:2 executives:1 otherwise:2
stock_BMY r_up	named:1 old:1 executive:1 years:1 61:1 succeeding:1 adding:1 said:1 retiring:2 veteran:1 since:2 research:1 1:1 2006:1 has:1 2011:1 discovery:1 development:1 head:1 retire:1 scientific:2 company:1 director:1 succeed:1 president:2 both:1 58:1 effective:1 vice:2 positions:1 30:1 joined:1 drug:3 2003:1 chief:2 responsibility:1 officer:2 2004:1 served:1 senior:1 maker:2
stock_BMY r_up	recorded:1 revenue:1 season:1 months:1 flu:1 sales:1 prolonged:1 three:1 which:1 boosted:1 year:1 cold:1 first:1 higher:1
stock_BMY r_up	eyebrows:1 named:1 unclear:1 deal:1 over:1 capitalists:1 raised:1 three:1 motive:1 have:1 partner:1 aggressive:1 next:1 its:1 announcement:1 unusual:1 deceptive:1 $:1 start:1 remains:1 had:1 two:1 co-head:1 arrangement:1 makers:1 few:1 behind:1 marketing:1 firms:1 several:1 's:3 worth:1 more:1 lawyers:1 some:1 million:1 years:1 states:1 up:1 drug:1 drug-discovery:1 venture:1 become:1
stock_BMY r_down	heart:1 parade:1 formerly:1 among:1 sales:1 likely:1 year:1 decline:1 patent:1 45:1 cooling:1 start:1 finally:1 earnings:1 first-quarter:1 drugs:1 continues:1 watch:2 reported:1 protection:1 nearly:1 defensive:1 active:1 stocks:4 continued:1 loss:1 off:1 pressure:1 blazing:1 profit:1
stock_BMY r_up	firm:1 roundup:1 says:1 saying:1 surprises:2 could:1 future:1 companies:1 drug:1 hurt:1 reports:1 advisories:2 earnings:1 slip:1 quarters:1 's:1 latest:1 corporate:1 stock:1
stock_BMY r_down	president:1 global:1 ``:1 general:1 discovered:1 manager:1 year:1 ready:1 excludes:1 said:1 potential:1 sodium:1 trials:1 investigational:1 3:1 2:3 treatment:1 scientists:1 expected:1 firms:1 has:1 glucose:1 development:1 begin:1 's:2 innovative:1 collaboration:2 agreement:2 leadership:1 build:1 believe:1 struck:1 diabetes:2 '':1 we:2 later:1 can:1 position:1 inhibitor:2 oral:1 noted:1 care:1
stock_BMY r_down	fare:1 among:1 conventional:1 pay:1 tend:1 wisdom:1 finds:1 contrary:1 best:1 dividends:1 dividend:1 500:1 highest:1 payers:1 analyst:1 those:1
stock_BMY r_up	pharmaceutical:1 8.3:1 patent:1 's:1 lost:1 protection:1 profit:1 amid:1 sales:1 competition:1 generic:1 fell:1 which:1 year:1 last:1 declined:1
stock_BMY r_down	session:1 's:1 companies:1 shares:1 trade:1 actively:1 expected:1
stock_BMY r_up	provided:1 emerging:1 cancer:1 weapon:1 early-stage:1 system:1 against:1 evidence:1 immune:1 studies:1 harnessing:1
stock_BMY r_down	undervalued:1 reduce:1 spinoff:1 looks:1 year:1 high-profile:1 still:1 sell:2 start:1 holdings:1 since:1 two:1 shares:2 their:1 stumbles:1 funds:3 after:1 but:1 hedge:1 lower:2 33:1 up:1 movers:2 maker:1
stock_BMY r_up	all:1 's:2 ahead:1 presents:1 possibly:1 know:1 need:1 you:1 meeting:1
stock_BMY r_up	deal:1 down:3 actively:2 trading:3 owner:1 shopping:1 80:1 index:2 recently:1 generally:1 shares:2 window:1 potential:1 session:1 closed:1 new:1 higher:1 's:3 may:1 after:1 39:1 hours:1 most:1 were:1 upbeat:1 stocks:2 day:3 96:1 11:1 10:1 lower:1 14:1 third:3 movers:2 companies:2 up:3 reports:1 points:6 analysts:1 rallies:3
stock_BMY r_up	set:1 retired:1 into:1 coming:1 replace:1 past:1 course:1 reached:1 its:3 out:1 embattled:1 stocks:3 suggest:1 comments:1 program:1 new:1 meeting:1 begin:1 gains:1 months:1 may:1 after:1 wiping:1 fall:1 strong:1 bringing:1 bank:1 central:1 tapering:3 drop:2 chief:1 future:1 worries:2 minutes:1 latest:1
stock_BMY r_down	named:1 right:1 headed:1 executive:1 '':1 president:2 pleased:1 said:2 retiring:1 since:4 been:3 research:1 member:1 also:1 role:1 board:1 leadership:1 has:4 2011:1 take:1 development:1 ``:1 's:1 scientific:2 very:1 company:2 moment:1 succeed:1 immediately:1 him:1 he:1 transition:1 chief:3 2001:1 officer:2 2004:2 believed:1
stock_BMY r_up	develop:1 like:1 cancer:1 thing:1 drugs:1 big:1 drive:1 system:1 immune:1 harness:1 looks:1 next:1
stock_BMY r_down	blood-pressure:1 drugs:1 unusual:1 regulator:1 source:1 attack:1 under:1 senior:1 class:1
stock_BMY r_up	four:1 oncology:1 because:1 office:1 certain:1 preliminary:1 ``:2 evidence:1 '':2 substantial:1 trading:4 dropped:1 year:1 go:1 recently:2 improvement:1 market:1 increased:1 24:1 index:2 stocks:2 based:1 cancer:2 suggests:1 fell:1 breakthroughs:1 agency:1 two:2 been:1 should:1 clinical:1 session:2 helps:1 which:1 transformative:1 has:1 higher:1 development:1 eyes:1 added:2 's:5 diseases:1 drugs:2 safe:1 took:1 effect:1 75:1 important:1 actively:2 decide:1 new:1 law:1 treating:1 breakthrough:1 last:1 58:1 effective:1 --:1 could:1 climbed:1 companies:2 drug:2 whether:1 points:6 products:1 shares:2 were:2 mixed:1 serious:1 head:1 experimental:1 view:1
stock_BMY r_down	saying:1 outlook:1 trade:2 its:2 weekly:1 impact:1 designates:1 based:1 $:4 disorders:1 application:1 reentry:2 improvement:1 late:3 investigational:1 treatment:1 inherited:1 customers:1 diseases:1 designated:1 boxes:1 now:1 treating:1 1.04:1 designation:1 fully:1 companies:1 world-class:1 after-hours:1 acquired:1 some:1 back:1 year:1 equalweight:1 jumped:1 breakthroughs:1 factory:1 shares:1 leap:2 activity:1 hours:2 others:1 rises:2 downgraded:1 software:1 gained:1 received:1 license:1 many:1 could:1 losses:1 biologics:1 suggests:1 products:2 planned:2 maker:1 first:1 raised:1 into:1 prefer:1 featured:1 market:1 clinical:1 expected:1 500:3 ``:2 drugs:2 bouncing:1 company:1 but:1 cases:1 than:1 disappointing:1 these:1 work:1 believes:1 n't:1 while:2 paints:1 uncertainty:1 associated:1 investors:1 certain:1 share:1 agent:1 evidence:1 '':2 substantial:1 drug:1 have:2 rally:2 moves:1 physical:1 maturing:1 rather:1 make:2 field:1 potential:1 picture:1 after:3 said:1 preliminary:1 stocks:3 data:1 why:1 so:1 apparel:1 serious:1 reward:1
stock_BMY r_up	versus:1 work:1 cancer:3 show:3 reasons:1 into:1 focus:1 potent:1 years:1 high:1 promise:1 have:1 skin:1 go:1 patient:1 stole:1 find:1 relatively:1 n't:2 shown:1 additional:1 may:2 system:1 immune:1 other:1 rates:1 which:1 time:1 deal:1 new:1 translate:1 meeting:1 can:1 body:1 's:1 triggered:1 drugs:3 survival:1 unleash:1 combination:1 treatments:1 doctors:2 alone:1 class:1 types:1 also:1 suspect:1 improved:1 older:1 whether:2 turns:1 tumors:1 early-stage:1 against:1 tumor:1 --:2 so:1 analysts:1 promising:1 far:1 making:1 studies:2 experimental:1 first:1
stock_BMY r_down	information:1 giant:1 's:3 ahead:1 confidential:1 biotech:1 granting:1 review:1 executive:1 according:1 drug:2 maker:1 priority:1 remains:1 trading:1 attractive:1 has:1 former:1 acquisition:1 stock:1
stock_BMY r_down	froth:1 profits:1 executive:3 years:1 manager:1 trading:3 drug:1 targets:2 pharmaceutical:1 said:1 $:1 300,000:1 illegal:1 three:1 than:1 insider:2 returns:1 potential:1 finding:1 several:1 stock:1 company’s:1 's:1 gains:1 here:1 admits:2 trade:1 former:1 those:1 acquisitions:1 prosecutors:1 ahead:1 avoiding:1 value:1 maker:1 deals:1 illicit:1 planned:1 evaluating:1 involved:1 making:1 more:1 options:1 acquisition:1
stock_BMY r_down	some:1 including:1 welcomes:1 pharmaceutical:1 said:1 opened:1 review:2 also:1 call:1 which:1 safety:1 several:2 week:1 independent:1 's:2 company:1 after:1 treatments:2 regulators:1 data:1 diabetes:1 --:2 months:1 comes:1
stock_BMY r_up	billion:1 $:1 generic:1 launches:1 patent-infringement:1 their:1 damages:1 have:1 reached:1 2.15:1 settlement:1
stock_BMY r_down	development:1 giant:1 collaborate:1 's:1 $:1 million:1 agreeing:1 sold:1 expanded:1 partnership:1 drug:2 shares:1 15:1 their:1 treatment:1 insiders:1 rheumatoid:1 than:1 arthritis:1 more:1
stock_BMY r_down	's:2 --:2 explain:1 opportunities:1 experts:1 2013:2 way:1 under:1 highlight:1 markets:1 appears:1 change:1 risks:1
stock_BMY r_down	non:1 said:1 not:1 efficacy:1 met:1 --:1 primary:2 but:1 superiority:1 did:1 trial:1 patients:1 clinical:1 safety:1 adult:1 groups:1 meet:1 objective:2 2:1 type:1 diabetes:1
stock_BMY r_up	chronic:1 experts:1 drug:1 another:1 its:1 explain:1 opportunities:1 safety:1 treatment:2 way:1 under:1 new:1 type:1 five-year:1 efficacy:1 leukemia:1 includes:1 approval:1 data:1 appears:1 change:1 secondary:1 received:1 resistant:1 markets:1 well:1 labeling:1 patients:1 three-year:1 risks:1 highlight:1
